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ABSTRACT
Rag1-/- mutant zebrafish lack lymphocytes and were used to study the basis of
acquired protective immunity in the absence of lymphocytes to the intracellular
bacterium Edwardsiella ictaluri. This study morphologically identified and quantified
lymphocyte like cells (LLCs) present in the liver, kidney and spleen of these fish. LLCs
included Natural Killer (NK) cells and non-specific cytotoxic cells (NCCs) and were
discriminated by size, and by the presence of cytoplasmic granules. The antibodies antiNITR9, anti-NCCRP-1 (5C6) and anti-MPEG-1 were used to evaluate these cell
populations by flow cytometry. Gene expression profiles in these tissues were evaluated
after the rag1-/- mutants were intra coelomically injected with the toll like receptor
(TLR)-2 ligand, β glucan, TLR3 ligand, Poly I:C, or TLR 7/8 ligand, R848. The genes
interferon  (infγ), expressed by activated NK cells and macrophages, tumor necrosis
factor α (tnfα), expressed by activated macrophages, myxovirus resistance (mx) expressed
by cells induced by IFNα, T-cell transcription factor (t-bet) expressed by NK cells and
novel immune type-receptor 9 (nitr-9) expressed by NK cells were evaluated. The TLR

ligands induced different patterns of expression and stimulated both macrophages and
NK cells.
Then fish were vaccinated with an attenuated mutant of E. ictaluri (RE33®) with
or without the TLR ligands then challenged with WT E. ictaluri to evaluate protection.
RE33® alone and each TLR ligand alone provided protection. Co-administration of β
glucan and RE33® or R848 and RE33® resulted in survival higher than RE33® alone
showing an adjuvant effect. Tissue specific gene expression of ifnγ, t-bet, nitr9, NK cell
lysin a (nkla), nklb, nklc and nkld were correlated to protection.
The final component of this study was the development of tools to discriminate
NK cell populations and evaluate the contribution of macrophages. Rag1-/- zebrafish were
modified to express cherry red in lymphocyte like cells using the Lymphocyte specific
tyrosine kinase (lck) promotor. Also, rag1-/- zebrafish were modified so that the gene
encoding the proto-oncogene serine/threonine-protein kinase that is involved in
macrophage training (raf1) is disrupted. This study indicated that the acquired protection
in the absence of lymphocytes likely involves NK cells with possible contribution by
macrophages.
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CHAPTER I
INTRODUCTION – LITERATURE REVIEW
1.1

Natural killer (NK) cells
Innate immune cells are extending the frontiers of immunology. Cells that were

once thought to be limited in their response to pathogens are now seen as dynamic
players in vaccination and protection. Innate immune cells include macrophages,
neutrophils, basophils, eosinophils, dendritic cells, non-specific cytotoxic cells, natural
killer (NK) cells and innate lymphoid cells (ILCs). NK cells belong to the innate
lymphocyte like cell (LLC) group. NK cells distinguish between normal healthy cells and
abnormal cells by using a sophisticated repertoire of cell surface receptors. These NK cell
receptors control activation, proliferation and functions (Spits, Blom et al. 1998).
Germline genes that do not undergo somatic recombination encode these receptors. Thus,
NK cells represent an arm of the innate immune system. They lack the ability to generate
antigen-specific receptors by somatic cell genetic alterations. NK cells are similar to
cytotoxic T cells, with which they share a common bipotential progenitor (Spits, Blom et
al. 1998, Colucci, Caligiuri et al. 2003). NK cells can provide protection quicker than T
cells, especially in conditions where T cell responses are limited (Bauer, Groh et al.
1999).
NK cells were first identified in 1975 (Kiessling, Klein et al. 1975, Herberman
and Holden 1978). They had a lymphocyte like morphology but lacked known surface
1

markers/receptors; hence these cells were initially called “null” cells. Later, the null cells
were given the name “Natural Killer/NK cells” because in the normal state they can kill
tumor and infected cells. Mammalian NK cells are a heterogeneous population of
lymphocytes that can be morphologically and phenotypically characterized and isolated
based on size and the expression of cell surface activation markers. NK cells can also be
characterized by intracellular cytolytic proteins like granzymes and perforins
(Voskoboinik, Whisstock et al. 2015). In humans, NK cells are divided into two subsets
based on their function. CD56bright/CD16- expressing cells are cytokine producers and
CD56dim/CD16+ expressing cells are cytotoxic NK cells (Poli, Michel et al. 2009).
Murine NK cells do not express CD56. Murine cytokine producers express surface
CD27hi and the cytotoxic NK cells express surface CD27lo (Marquardt, Wilk et al.
2010). In contrast to T and B cells, NK cells are larger than T and B cells ranging in size
from ~4.8 to 10. These cells express cytoplasmic granules containing cytotoxic proteins.
NK cells have the ability to kill certain tumor cells and virus infected cells. When in
contact with a tumor cell, the NK cell functions by releasing proteins from cytotoxic
granules (granzymes and perforins) onto the surface of the target cell. Perforins form
pores on the target cells and the cytotoxic granules (granzymes) penetrate the cell surface
of the target cell through the pores and cause the target cell to undergo programmed cell
death (Lanier 2005). NK cells are the main source of Fas ligand (L). Fas L is a soluble
surface marker that is associated with enhanced NK cell dynamics and cytotoxicity via
the cytokine mediated regulation Fas L pathway (Medvedev, Johnsen et al. 1997)
(Szymanowski, Li et al. 2014).

2

In vertebrates with a healthy mature immune system, cells of the adaptive
immune system, i.e., the T and B cells, mediate a memory response following reexposure to a homologous antigen (Murphy, Travers et al. 2008). NK cells are very
similar to T cells in their cytolytic activity. However, they have activating and inhibiting
receptors. These receptors sense the presence or absence of MHC class 1 molecules on
the surface of target cells. NK cells are very important in the host as they help control
certain viral infections while the adaptive immune system is preparing to mount a
response (Murphy and Weaver 2016). Following the recognition of target cells (absence
of MHC class 1), activation of NK cells is followed by increased release of
proinflammatory molecules like interferons and cytokines, which enhance the cells
killing ability (Berrien-Elliott, Wagner et al. 2015).
NK cell activation can occur through one of two pathways, the indirect or the
direct pathway. Most activation occurs through the indirect pathway that involves
accessory cells. These macrophages, dendritic cells and few epithelial cells, produce
cytokines and participate in cell contact dependent signals. The direct pathway is
characterized by the direct binding of pathogen associated molecular patterns (PAMPs) to
TLRs on the NK cells (Horowitz, Stegmann et al. 2011). During an immune response,
TLRs and NK cells provide regulatory roles for each other by direct TLR activation on
NK cells or via accessory cells leading to the production of IFNγ and activation of
cytotoxicity (Hart, Athie-Morales et al. 2005) (Romee, Schneider et al. 2012).
1.2

NK cell receptor gene families in mammals
Mammalian NK cells have immunoglobulin (Ig) like receptors as well as lectin

like receptors. These act as both activating and inhibitory receptors. The killer like
3

immunoglobulin receptors (KIR) are present in humans and the killer like lectin receptors
(KLR) are present in mice. NK cells lack the ability to generate antigen-specific receptors
by somatic recombination (Lanier 1998, Parham 2005, Vivier, Tomasello et al. 2008).
Instead, they express a repertoire of cell surface receptors that control their activation,
proliferation and effector functions (Lanier 2005). These receptors can be classified into
two structural types depending on whether their extracellular ligand binding domains are
C-type lectin domains or immunoglobulin (Ig) type domains. Gene families that encode
the type II transmembrane (TM) receptors with C-type lectin domains are present in the
chromosomal region known as the NK complex (NKC). Gene families that encode the
type I TM receptors with Ig-like domains cluster in the leucocyte receptor complex
(LRC) (Burshtyn and Long 1997, Sawicki, Dimasi et al. 2001, Yokoyama and Plougastel
2003). The NKC and LRC regions, which include both inhibitory and activating
receptors, have been well described in rodents and primates. In mice and rats, the Ly49
genes of the NKC encode an entire family of C-type lectin receptors. In humans, the
NKC encode the single Ly49 pseudogene. Human KIRs of the LRC functionally replace
the rodent Ly49 genes and encode an entire family of Ig-like NK cell receptors. The rat
LRC encodes a single KIR, and two murine KIR genes are not linked to the LRC
(Nylenna, Naper et al. 2005, Parham 2005). These are the differences. The function,
expression and diversity of human KIRs and mouse Ly49 family members are very
similar (Kelley, Walter et al. 2005).
The KIR and Ly49 genes belong to small gene families of 10-15 closely linked
genes that demonstrate genetic polymorphism. These genes encode inhibitory receptors
that inhibit NK cell function. Inhibitory receptors have immune receptor tyrosine based
4

inhibition motif (ITIMs) in their cytoplasmic domains. Phosphorylation of the specific
tyrosine motif in the ITIM involves activation and recruitment of phosphatases like src
homology -1 (SHP-1), SHP-2 and SHIP for the delivery of inhibitory signal to the cell
interior to silence NK cell mediated cytotoxicity. The KIR and Ly49 genes also encode
activating receptors that possess a positively charged amino acid in their transmembrane
region. This amino acid associates with immuno-receptor tyrosine based activation motif
(ITAM) that contains adaptor proteins. This activates protein tyrosine kinases such as
Syk/ZAP70 or PI3K that leads to target cell lysis. KIRs and mouse Ly49 are expressed
primarily on NK cells, and interact with MHC-I molecules (Lanier, Corliss et al. 1998,
Yokoyama and Plougastel 2003, Kelley and Trowsdale 2005, Lanier 2005, Barrow and
Trowsdale 2006, Lanier 2008).
Other receptors that are common to both humans and mice include the C-type
lectin, NKG2 and NKRP1 families and the activating NKG2D receptor. Single copy
activating receptors such as NKp46 and NKp30 that recognize viral hemagglutinins are
also present in both humans and mice (McQueen and Parham 2002, Litman, Yoder et al.
2003, Lanier 2008). The fact that various species use different genetic solutions to
conserve NK cell receptor function through evolution indicates the importance of these
receptor gene families and their functions. It has been hypothesized that NK cell receptor
function is also conserved in zebrafish, where the NITR gene family, described later, may
be involved in mediating NK cell receptor function.
MHC-I is a ubiquitous cell surface marker expressed on normal host cells.
Inhibitory receptors on the NK cells recognize MHC-1 molecules as ‘self’ ligand and
inhibit destruction of normal host cells. In contrast, transformed, infected or stressed cells
5

can lose expression of self-MHC class 1 molecules. If MHC class I is not present, the
inhibitory KIR receptor is not activated and NK cell activation and target cell lysis is
initiated. This phenomenon is known as missing-self recognition. Most tumor or virus
infected cells down regulate MHC I as a means of evading cytolysis by CD8 T cells. But
this escape mechanism makes these cells targets for NK cells (Lanier 2005). In some
cases, untransformed or uninfected cells that do not express a full complement of MHC I
molecules are susceptible to NK cell lysis. M157 is a protein encoded by MCMV and has
a putative major histocompatibility complex class I (MHC I) structure (Tripathy, Smith et
al. 2006) that is recognized by the murine Ly49H NK cell activation receptor.
1.3

NK cell receptors in zebrafish
Teleost possess receptors that are structurally homologous to the mammalian Ig-

type and lectin-type receptors (Panagos, Dobrinski et al. 2006, Yang 2009). Immune
related, lectin like receptors (illrs) and novel immune type receptors (NITRs) have been
identified in zebrafish. These receptors are homologous to the immunoglobulin like
receptor and the lectin like receptor and have an activating role. The NK cell receptors
that recognize target cells and either induce killing or prevent killing have a C-type lectin
like domain (CTLD). This domain has highly conserved cysteine residues that bind to
carbohydrates or protein ligands, either Ca2+ dependently or independently (McQueen
and Parham 2002). Studies on zebrafish illrs show a multi gene family of type-II immune
related illrs. Their members contain activating and/or inhibiting signaling motifs similar
to the mammalian type V NK activating or inhibitory receptors (Panagos, Dobrinski et al.
2006). Illrs include a type II transmembrane receptor with an extracellular CTLD and a
coiled region. They are found in myeloid and lymphoid cells in the hematopoietic tissue
6

(Panagos, Dobrinski et al. 2006). Illrs play a role in triggered immune responses and
specifically in NK cell immune functions during those responses in zebrafish. The
zebrafish illr gene has two additional cysteines forming a characteristic extra disulphide
bond specific to zebrafish NK cells receptors (Weis, Taylor et al. 1998). RT-PCR
revealed isoforms of illrs. Illr1 (inhibitory receptor), illr3 (activating receptor) and illrL
(inhibitory receptor) were expressed in zebrafish kidney and spleen, but not in liver
(Panagos, Dobrinski et al. 2006). Additionally, while illr2 did not show any expression,
illrL was expressed in intestine and myeloid cells. Illr1 was expressed in lymphoid cells
and illr3 was expressed in both myeloid and lymphoid lineages (Panagos, Dobrinski et al.
2006). Illr3 is a major NK cell receptor that plays a role in targeting cell for killing,
similar to human NK cell cytotoxic function (Yang 2009). The zebrafish genes for group
II CTLD receptors are illrs on NK like cells, and are similar to mammalian NK cell
receptors (Panagos, Dobrinski et al. 2006).
The novel immune type receptors (NITRs) belong to the immunoglobulin super
family (IgSF) and have structural similarities with mammalian NK cell receptors (KIRs)
(van den Berg, Yoder et al. 2004). NITR cDNA was originally cloned from puffer fish
(Rast, Haire et al. 1995). NITRs have been identified in 13 different species: zebrafish,
rainbow trout, channel catfish, Japanese flounder, medaka, fugu and Tetraodon
nigroviridis (Strong, Mueller et al. 1999, Hawke, Yoder et al. 2001, Yoder, Mueller et al.
2001, Yoder, Mueller et al. 2002, Yoder, Litman et al. 2004, Piyaviriyakul, Kondo et al.
2007, Yoder, Cannon et al. 2008, Yoder 2009). NITRs encode a type I transmembrane
glycoprotein with an extracellular variable (V) and intermediate (I) domain, a
transmembrane region and a cytoplasmic tail. Both ecto-domains may contain joining (J)
7

like sequences, even though there is no evidence of somatic recombination (Yoder,
Litman et al. 2004, Yoder 2009). The NITR variable domains possess highly conserved
residues that are also conserved in T cell receptors (TCR) and immunoglobulin (Ig) V
domains. The V domains include three hypervariable regions that correspond to the
complementarity determining regions in TCRs and Igs (Litman, Hawke et al. 2001,
Yoder, Litman et al. 2004, Wei, Zhou et al. 2007). The NITR V domains are structurally
similar to the V domain of antigen receptors (Yoder, Litman et al. 2004, Yoder 2009).
The NITR I domain contains six conserved cysteine residues and many of the same
conserved residues observed in the V domains of NITRs, TCRs and Igs (Giudicelli,
Duroux et al. 2006). It has been hypothesized that NK cell receptor function is also
conserved in zebrafish, where the NITR gene family may be involved in mediating NK
cell receptor function. It is likely that NITRs represent either modern forms of progenitor
genes or derived products of TCR and Ig loci of innate function.
The NITRs were identified in and are best characterized in zebrafish (Yoder,
Mueller et al. 2001, Trede, Langenau et al. 2004). An extracellular immunoglobulin like
V domain, a transmembrane region and a cytoplasmic tail containing an immune receptor
tyrosine base motif structurally characterize them. Twelve different NITR gene families
(nitr1 – nitr12) encode approximately 36 different zebrafish NITR genes. These genes
are located within the NITR gene cluster on chromosome 7. Chromosome 7 may be
derived from the ancient chromosome that gave rise to the human chromosome that
encodes the LRC region 19q (Yoder, Litman et al. 2004). Additionally, nitr13 and nitr14,
located on chromosome 14 have also been described. Observations and results from
previous studies on NITR gene families have led to a model suggesting that NITRs are
8

functionally linked to human KIRs. NITRs and KIRs are encoded by rapidly evolving
multigene families that include both inhibitory and activating forms. Like mammalian
NKRs, NITRs can be classified into two primary functional groups: 1) inhibitory and
activating. Inhibitory receptors have a cytoplasmic ITIL or ITIM like sequences.
Activating receptors are based on the presence of a positively charged residue (ITAM
like) within the transmembrane domain (Yoder, Mueller et al. 2001). Similar to
mammalian NKRs, fish NITRs have more inhibitory functions than activating functions.
There are 12 distinct NITR families. Nitr5 and nitr9 are the only receptors that play
activating roles (Wei, Zhou et al. 2007, Yoder 2009). The remaining nitrs are inhibitory.
1 out of 39 NITRs in zebrafish have activating potential. The remaining are either
inhibiting or a combination of both. A quantitative estimation of NITRs on a single cell is
unclear. It is hypothesized that the higher number of inhibitory receptors may contribute
to a functional redundancy ensuring that activating pathways are normally suppressed. It
is not known if NITRs are ligand specific. However, due to the high level of diversity
within each NITR family, NITRs could recognize a wide range of ligands. It has been
postulated that similar to mammalian NK cell receptors, inhibiting NITRs may recognize
viral and stress related proteins and/or MHC-1 molecules. Channel catfish express
IpNITR11 (activating receptor) on a clonal cytotoxic NK-like cell line. IpNITR11 binds
to a ligand on the surface of a non-self allogeneic target B cell line. Like the polygenic
and polymorphic nature of the KIR loci, the NITR genes show high interindividual
heterozygosity and are mostly expressed in the lymphoid cell population in zebrafish.
Nitr14 is expressed in lymphoid and myeloid cells (Yoder, Turner et al. 2010).
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Of the several inhibitory NITRs, the nitr3 gene family is interesting since it is
expressed during embryogenesis and in mature lymphocytes (Yoder, Turner et al. 2010,
Moore, Garcia et al. 2016). In addition, in vitro studies have demonstrated that crosslinking of nitr3 in transfected human NK92 cells (a NK cell line), leads to downregulation of the MAPK pathway, when incubated with Raji tumor cells (Yoder, Mueller
et al. 2001). This inhibition is regulated at the level of the ITIM, indicating that inhibitory
NITRs may utilize similar intracellular signaling pathways as mammalian inhibitory
NKRs in zebrafish (Yoder, Mueller et al. 2001). Both activating NITRs and KIRs utilize
Dap12 as an adaptor protein for signaling. The only inconsistency to this model is that the
extracellular domains of NITRs contain (V) and (I) domains whereas KIRs contain C2
type domains. Nevertheless, NITRs and KIRs possess similar signaling domains so that
the receptors can couple with appropriate signaling adaptors (DAP10 or DAP12) (Kelley,
Walter et al. 2005).
Nitr9 is the only zebrafish gene that encodes an activating receptor. It contains a
positively charged amino acid, arginine, in its transmembrane region. The nitr9 gene
encodes three splice variants, which encode three distinctly different receptor isoforms:
Nitr9-long (Nitr9-L), Nitr9-short (Nitr9-S) and Nitr9-supershort (Nitr9-SS). All three
splice variants possess identical trans membrane and cytoplasmic domains as well as an
extracellular Ig intermediate (I) domain. Nitr9-L transcripts possess an additional exon
encoding an extracellular N-terminal Ig variable (V) domain whereas nitr9-S transcripts
include only part of this exon. The nitr9-SS gene encodes only the (I) ecto-domain as the
entire V domain is eliminated due to internal splicing (Yoder, Nielsen et al. 2002, Kärre
2008). Similar to human activating KIRs, zebrafish Nitr9 shares a similar down-stream
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signaling pathway. RT-PCR analysis indicated that both zebrafish Nitr9 and the adaptor
protein, DAP12 are expressed in lymphocytes.
The identification, purification and characterization of different blood cell
lineages in humans and mice have become possible with the abundance of commercial
monoclonal antibodies available. However, the availability of monoclonal antibodies
against blood cells of zebrafish is limited making it difficult to isolate and generate cell
lines. Generation of zebrafish monoclonal antibodies is a challenging process possibly
due to the different glycosylation patterns that are recognized as foreign by the rodent
immune system (Traver, Paw et al. 2003), which has led to a paucity of antibodies to
study zebrafish blood cells (Yoder 2008). In order to identify NK cells and elucidate their
role in fish immune responses, Shah et al 2012 identified a cell surface marker (Nitr9)
expressed on teleost NK cells and then generated antibodies against it (Shah 2009, Shah,
Rodriguez-Nunez et al. 2012). They developed and characterized mouse anti-nitr9
monoclonal antibody (IgG isotype) that is raised against the zebrafish NK cell putative
receptor Nitr9 (Shah, Rodriguez-Nunez et al. 2012). 293T cells were transfected with
plasmids encoding FLAG-tagged Nitr9 isoforms and EGFP. The results generated from
their study suggest the labeling of FLAG tagged Nitr9 proteins with anti-FLAG mAb, the
90.10.5 anti-Nitr9 mAb and the 19.1.1 anti-Nitr9 mAb. After FACS analysis in zebrafish,
no antibody labeling was observed. For this reason, the above study could not justify the
application of the anti-Nitr9 antibody to purify and characterize zebrafish NK cells,
suggesting that the anti-Nitr9 antibody was not working in zebrafish or it needed further
characterization and optimization. Based on its predicted protein structure, Shah et al
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hypothesized that Nitr9 is an activating transmembrane receptor and is expressed on NK
cells or cytotoxic T cells.
Similar to activating receptors previously described in human NK cells, antibody
cross linking Nitr9 functions via the Dap 12 intracellular adaptor molecule (Wei, Zhou et
al. 2007) and results in increased phosphorylation of AKT and ERK. AKT is downstream
of PI3K, thereby indicating the activation of the PI3K-AKT-ERK pathway. Mutation of
the ITAM present in the cytoplasmic tail of Dap12 fails to activate this pathway,
indicating that this pathway is dependent on the presence of the ITAM (Barclay 1999,
Hawke, Yoder et al. 2001, Yoder, Mueller et al. 2001, van den Berg, Yoder et al. 2004,
Yoder, Litman et al. 2004, Wei, Zhou et al. 2007). These observations led to the
hypothesis that Nitr9 is expressed on NK cells or cytotoxic T cells and can activate
similar downstream signaling pathways as mammalian activating NKRs. Thus, it would
follow that Nitr9 provides cytotoxic function, killing virally infected and tumor cells as is
the case with activating mammalian NKRs.
1.4

Toll Like Receptors (TLRs) in mammals
Pathogen Associated Molecular Patterns (PAMPs) are specific conserved

structural motifs on microbial pathogens. They play vital functional roles and are
essential for the survival and proliferation of the pathogen. Key players in the immune
responses are special extracellular or intracellular receptors known as Pattern Recognition
Receptors (PRRs) that bind to PAMPs (Goldstein 2004). There are several classes of
PRRs: RIG-1 like receptors (RLRs), NOD-like receptors (NLRs), DNA receptors
(cytosolic sensors for DNA) and Toll Like Receptors (TLRs). The receptors that
recognize the most diverse array of PAMPs are the TLRs. TLRs are present on innate
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immune cells like antigen presenting cells (APCs) and NK cells (Lauzon, Mian et al.
2007). These type I transmembrane receptors activate a TLR signal transduction event
via a MyD88 dependent or independent pathway (Akira and Takeda 2004). The toll gene
was first identified in Drosophila melanogaster (fruit fly) and was responsible for
embryonic development for dorso-ventral patterning embryo (Belvin and Anderson
1996). Up-regulation of Toll genes induce antimicrobial peptide secretion and defended
against gram-positive bacteria and fungal pathogens (Netea, Van der Meer et al. 2007). In
Drosophila larvae, Toll signaling is required for melanization (Belvin and Anderson
1996). Receptors analogous to the toll receptor have been found in both vertebrates and
invertebrates and represent an ancient and evolutionarily conserved host defense
mechanism. Nine Toll related receptors have been identified in the Drosophila genome.
Toll, or Toll1 was the first Toll identified and is responsible for antimicrobial protein
(AMP) induction via Toll pathway (Belvin and Anderson 1996). The Drosophila Toll 9
has only one cysteine residue between the leucine rich repeat and the transmembrane
domain, a structure very similar to the human TLRs.
Similarities to the Toll receptor have been shown to a lesser degree in proteins
encoded by plant resistance (R) genes as the N gene in Nicotiana glutinosa. Vertebrate
TLRs arose from an ancient gene duplication that has given rise to two large gene
families of TLRs. This observation was based on the calculation of phylogenetic
reconstructions of the TLRs from both full-length gene and amino acid sequence.
Subsequent evolution of the two large families has resulted from a complex interaction
between gene duplication, gene conversion and co-evolution. PAMP recognition
specificities in vertebrates are determined by the N terminal extracellular leucine rich
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repeats (LRR) domain. Signal transduction takes place through a Toll/interleukin 1
receptor (TIR) domain (Baratin, Roetynck et al. 2005).
Toll like receptors are structurally characterized by an extracellular domain
containing leucine rich repeats (LRR) and a cytoplasmic tail having conserved regions
called toll/IL-1 receptor (Baratin, Roetynck et al. 2005) domains (Jault, Pichon et al.
2004). It is a type I transmembrane receptor. Each TLR can recognize and bind to a
specific PAMP. So far, 10 human TLRs (Takeda, Kaisho et al. 2003), 12 murine TLRs
and 22 zebrafish TLRs have been characterized (Meijer, Gabby Krens et al. 2004). TLRs
are found on antigen presenting cells (macrophages, dendritic cells and B-cells), NK cells
and certain epithelial cells. When TLRs bind to a specific ligand, it drives an intracellular
signal transduction cascade of events that ultimately leads to activation of transcription
factors including (but not limited to) AP-1 (Hu, Paik et al. 2006), NF-κB (Frantz, Kelly et
al. 2001, Kawai and Akira 2006) and IRF3 (Doyle, Vaidya et al. 2002, Fitzgerald, Rowe
et al. 2003, Moynagh 2005). The activated transcription factors present in the cytoplasm
translocate into the nucleus to induce transcription of pro-inflammatory cytokines,
interferons and a variety of cellular responses and effector cytokines that eventually
direct an enhanced immune response. In mammals all TLRs except TLR3 can mediate
an MyD88 dependent or MyD88 independent adaptor signaling pathway (Kawai and
Akira 2007). Mammalian TLR3 is the only TLR that cannot induce a MyD88 pathway.
Drosophila Toll 9 is the only member of the toll family that groups with the
vertebrate Toll. Following phylogenetic analysis of Toll/IL-1 (TIR) domains of the TLRs
together with their adaptor molecules, it suggests that the adaptor molecule usages and
signaling pathways are ancestral characteristics of TLRs. Further, phylogenetic analyses
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indicated an independent evolutionary origin for the MyD88-dependent and MyD88
independent pathways. Roach et al 2013, reported a common ancestor for vertebrate and
invertebrate MyD88, suggesting a very ancient origin for the MyD88 dependent pathway
(Roach, Racioppi et al. 2013). This work reported the importance of the adaptor
molecules in TLRs to mediate an immune response and how these adaptor molecules are
evolutionary conserved.
1.5

Specific binding of TLRs to their ligands
TLR2/TLR1 or TLR2/TLR6 recognize lipoteichoic acid, a component of gram-

positive bacterial membranes and di and tri acyl lipoproteins. The 2 chains of the PAMP
bind onto the convex of LRR of TLR2 and the third chain binds to the convex of LRR of
TLR1 dimerizing the two TLRs and bring their TIR cytoplasmic domains in close
proximity to each other in the cytoplasm. A similar interaction occurs for TLR2/TLR6
that binds to long chain fatty acids and a cell wall component of yeast (B glucan).
Binding to TLR2/TLR6 requires the help of a scavenger receptor CD36 (88KD
glycoprotein) for diacylglyceride recognition or a co-receptor Dectin-1 for binding B
glucan (Hoebe, Georgel et al. 2005, Stewart, Stuart et al. 2010). Both cooperate with
TLR2 in binding the ligand. CD36 is required by B cells and is expressed by myeloid
cells, platelets, endothelial cells, erythroid precursors and adipocytes (Hoebe, Georgel et
al. 2005). TLR2 and TLR4 require a second adaptor molecule called TIRAP in the
MyD88 pathway.
TLR 3 binds to dsRNA in virus (rotavirus). The mammalian RNA is not dsRNA
and so the TLRs can distinguish the dsRNA and bind to it. The TLRs that recognize
nucleic acid are located in the endosomal membrane and are transported via the
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endoplasmic reticulum. The dsRNA is internalized either by endocytosis of virus or by
phagocytosis of dying cells in which virus are replicating. The ectodomain of TLR 3
binds the dsRNA in two contact sites: one the amino terminal and the other the carboxy
end. Because of the 2-dimensional nature of the ds-RNA, it can bind to two TLR3
molecules and form a homodimer. TLR4 recognizes lipopolysaccharide (LPS) a
glycolipid in the cell wall of gram-negative bacteria.
TLR7, 8 and 9 are intracellular TLRs in the endosomal membranes. TLR 7 and 8
(in mice) recognize and bind to ssRNA (flavivirus and rabies). This is the RNA in the
endosomal compartment and not the host ssRNA. The ssRNA of healthy host cells is
normally confined to the nucleus and cytoplasm and is not present in the endosomes.
When extracellular viruses are endocytosed by macrophages and plasmacytoid DC, they
are uncoated in the acidic environment of the endosomes and lysosomes and the ssRNA
is presented to TLR7/8. Normally, extracellular RNase releases and degrades the ssRNA
that is released from injured tissues. In the human genome, TLR 7 and TLR 8 are on the
X chromosome. TLR 3, 7, 8 and 9 are transported to the endosome from the endoplasmic
reticulum by a specific protein UNC93B1.
1.6

TLRs in zebrafish
TLR ligands function as immunostimulants and are promising tools to enhance

animal production in intensive aquaculture. They boost the natural defenses already
present, increase survival rates and can also enhance protection offered by vaccination.
TLR ligands have been shown to activate both specific and non-specific immune
responses (Sakai 1999). The observed induction of zTLR1, zTLR2 and zTLR18 (zTLR1
and zTLR18 are homologous to human TLR1) in response to Mycobacterium marinum
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suggest that the recognition mechanisms of microbial patterns were already established in
the common vertebrate ancestor and that the functions of receptors in the TLR1 and
TLR2 groups may be conserved between mammals and teleost (zebrafish). Microbial
infection also induced the expression of zTLR20a and zTLR22 genes, suggesting that
receptors of the fish specific TLR cluster may also function in microbial infections.
Meijer et al 2004, have shown that the zebrafish genome contains at least 17 expressed
TLR genes as well as expressed homologues of IL-1R, IL-18R and four different TIR
domain adaptors genes. Previously it was suggested that early vertebrates contained few
TLRs and that the TLR4 gene, which is the LPS sensor in mammals, might have emerged
as a distinct entity only 180 million years ago (Du, Poltorak et al. 1999). Further, a recent
analysis of the TLR family in the genome of pufferfish, F. rubripes, suggested that TLR4
is absent from the fish lineage. These hypotheses are contradicted by data showing that
zebrafish contains 2 sets of TLR4 genes in tandem duplication (Meijer, Gabby Krens et
al. 2004). The full-length gene corresponding to one of the zTLR4 copies was cloned,
and this demonstrated that zTLR4 and hTLR4 display conserved intro-exon structure.
These findings supported evolutionary calculations indicating that TLR4 diverged more
than 400 million years ago. The zebrafish genome also contains a conserved homologue
of TLR2, which like its human counterpart is encoded by a single exon. The phylogeny
reconstruction indicates the presence of a fish-specific TLR cluster, consisting of
zTLR19, zTLR20a/b, zTLR21 and zTLR22 and their homologues in Fugu. This cluster is
closely related to the Drosophila Toll-9 gene, which is the only member of the
Drosophila Toll family that groups with vertebrate TLRs. More recently, TLRs have
been identified in NK cells. TLRs can activate NK cells either directly or indirectly
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(Adib-Conquy, Scott-Algara et al. 2014). Direct activation is by NK cell specific
receptors. Indirect activation is by TLR-ligand association on NK cells or by accessory
cells like dendritic cells, macrophages or by accessory cytokines like IL-2, IL-12, IL-15
and IL-18.
1.7

Background
In rag2-/- mutant murine models, adoptive transfer of previously exposed NK cells

resulted in an adaptive immune like response coupled with a memory response to
chemical haptens 2.4 dinitroflurobenzene (DNFB) and oxazolone (OXA) (O'Leary,
Goodarzi et al. 2006). Adoptive transfer of NK cells in the same model resulted in
protection to re-infection with murine cytomegalovirus (MCMV) encoded m157 protein
(Sun, Beilke et al. 2009). M157 is a protein encoded by MCMV and has a putative major
histocompatibility complex class I (MHC I) structure (Tripathy, Smith et al. 2006) that is
recognized by the murine Ly49H NK cell activation receptor. Rag2-/- mutant mice
showed that previously exposed NK cells follow 4 phases of adaptive immune cells i.e.,
expansion, proliferation, contraction and memory cell formation, followed by the
expansion phase on re-exposure to MCMV (Sun, Beilke et al. 2009). Protective
secondary responses against bacteria were observed in rag1-/- mutant zebrafish (Hohn and
Petrie-Hanson 2012). Adoptive transfer of kidney leukocytes isolated from vaccinated
rag1-/- mutant zebrafish provided protection for naïve mutants when they were exposed to
bacteria. The mechanism mediating the memory response has not been determined. The
murine NK cell mediated adaptive/memory immune response has been reported against
virus (Sun, Beilke et al. 2009), but how zebrafish NK cells mediate a similar response to
intracellular bacteria, such as Edwardsiella ictaluri is not clear.
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The innate immune system in zebrafish is like the mammalian innate immune
system and this makes it a powerful model to study the function of immune cells and
immune related genes. In the case of a wild type (healthy subject) with fully functional T
and B cells, the NK cell memory response would act synergistically with adaptive
immunity. It is difficult to dissect the role of NK cells in a protective immune response in
the wild type model. In comparison to wild types, the rag1-/- mutant zebrafish have a
similar phagocytic (monocytes/macrophage) population, higher numbers of granulocytes
(neutrophils), a higher number of myelomonocyte cells and lymphocyte like cells (PetrieHanson, Hohn et al. 2009). The lymphocyte like cell population is comprised of NK cells
and Nonspecific cytotoxic cells (NCCs) (Petrie-Hanson, Hohn et al. 2009). Fish kidney
(mammalian bone marrow equivalent) is where antigen phagocytosis and processing
occurs. Like the spleen, the fish kidney houses plasmacytes, lymphocytes (T cells, B cells
and NK cells), monocytes, granulocytes and natural cytotoxic cells (Fischer, Koppang et
al. 2013).
A better understanding of the basis of protective immunity in T and B cell
deficient zebrafish could be possible by carrying out adoptive transfers of sensitized NK
cells. But this process is not feasible because in-spite of the vast resources available to
study various aspects of the immune system in a variety of model organisms, zebrafish
research is still lacking the tools to do basic immunology research. Availability of a pure
NK cell population would help us define the phases of the memory response following
reinfection with intracellular bacteria. Anti-Nitr9 antibody is available to detect zebrafish
NK cells. However, the application of this monoclonal antibody has not been extensively
explored in zebrafish due to its inconsistent positive cell labeling. It is critical to
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characterize specific zebrafish NK cell markers to study the detailed functions of NK
cells and to understand how these cells mediate a secondary memory response.
1.8

Objectives
1. To determine differential expressions of immune cell genes ifnγ, mx, tnfa, t-bet
and nitr9 following targeted TLR stimulation in rag1-/- mutant zebrafish tissues.
2. To determine differential expression of NK cell genes ifnγ, t-bet, nitr9, NK-lysin
(nkl)a, nklb, nklc and nkld in previously exposed and then challenged (4 weeks
later) rag1-/- mutant zebrafish tissues.
3. To administer R848 and VTX at two doses to further define differential
expression of NK cell specific marker genes ifnγ, t-bet, nitr9, nkla, nklb, nklc
and nkld in rag1-/- mutant zebrafish, and nitr9 expression
4. To characterize the morphology of zebrafish NK cells.
5. To develop transgenic zebrafish models that will enable visualization of NK
cell development and functions.
The main objectives of this project were designed to identify and describe

zebrafish NK cells. Immunological reagents or tools were not commercially available, so
indirect methods had to be used. The first objective exposed zebrafish to TLR ligands and
evaluate gene expression to determine the ligand to which NK cells and
myelomacrophages are stimulated. These gene expressions were quantified in liver,
kidney and spleen tissues. These findings gave us an initial understanding of the NK cell
populations in different tissues. The TLR ligands we used were β-glucan, Poly I:C and
R848. β glucan binds to TLR2, Poly I:C binds to TLR3 and R848 binds to TLR 7/8. We
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used ifnγ expression as an indicator of NK cell activation, tnfα expression as an indicator
of macrophage activation, and mx (mxa) expression as an indicator of ifn and ifnβ
production (Haller, Staeheli et al. 2007). Nitr9 is an NK cell receptor, so nitr9 expression
indicates NK cell activation. T-bet is a T cell and NK cell transcription factor, so
increased t-bet expression in rag1-/-mutant zebrafish (which lack T cells) indicates NK
cell development.
The second objective of our study was to determine the NK cell specific gene
expression associated with the protective/memory to bacteria (E. ictaluri) infection. We
injected rag1-/- mutant zebrafish with a combination of live attenuated E. ictaluri vaccineRE33 or TLR ligands β-glucan, Poly I:C and R848 or a combination of RE33 and TLR
ligands. After 4 weeks, the fish were challenged with a virulent wild type E. ictaluri
strain and protection evaluated. NK cell activation by gene expression of NK cell specific
markers nitr9, t-bet, nkla, nklb, nklc and nkld was determined in tissues.
The third objective of our study involved the administration of two NK cell
stimulators: R848 and VTX, to elucidate NK cell activation by gene expression of NK
cell specific markers nitr9, t-bet, nkla, nklb, nklc and nkld and protein expression of Nitr9
in liver, kidney and spleen tissues. Protein expression of Nitr9 in liver, kidney and spleen
was correlated to gene expression. Flow cytometric analyses determined tissue locations
of Nitr9+ cells and the cellular location of the Nitr9 receptor.
The fourth objective used isolated kidney leukocytes for flow cytometry analyses.
Monoclonal antibodies for Nitr9, non-specific cytotoxic cell receptor protein -1 (Nccrp-1)
and macrophage protein expressing gene (Mpeg) were used. Cytospins were also
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prepared from kidney, liver and spleen leukocytes. The cells were stained, viewed and
photographed.
The fifth objective of this study was to develop transgenic and knock zebrafish
models to be able to study the function of NK cells. The results from this study reveal the
role of NK cells in teleost innate immune responses.
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CHAPTER II
THE CHARACTERIZATION OF LYMPHOCYTE-LIKE CELL POPULATIONS IN
RAG1-/- MUTANT ZEBRAFISH
Abstract
This study morphologically characterized lymphocyte-like cells (LLCs) with
mammalian NK cell morphology from liver, kidney and spleen tissues of rag1-/- mutant
zebrafish. The LLC population included Natural Killer (NK) cells and non-specific
cytotoxic cells (NCCs). The LLC populations could be discriminated by size, and further
by the presence of cytoplasmic granules. These cell populations were also discriminated
by flow cytometric side scatter (SSC) and forward scatter (FSC) characteristics. The
monoclonal antibodies anti-NITR9, anti-NCCRP-1 (5C6) and polyclonal antibody antiMPEG-1 were also used to discriminate and evaluate these cell populations by flow
cytometry.
2.1

Introduction
The zebrafish model is well established for studying vertebrate hematopoiesis and

immune cell interactions (Trede, Langenau et al. 2004). NK cells possess the most
primitive and advanced biochemical and physiological process of cellular cytotoxicity of
tumor and transformed cells. NK cells from other species appear to share some of these
target specificities, but NK cells in fish are not well described.
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Non-specific cytotoxic cells (NCCs) were first described in catfish (Evans,
Carlson et al. 1984). The cells were described as monocyte like cells with a reniform
nucleus (with peripheral chromatin), non-phagocytic, prominent Golgi apparatus, low
nucleus to cytoplasm ratio and no NK cell like cytoplasmic granules but contain
osmiophilic granules in the cytoplasm. NCCs have been well characterized in fish. NCCs
are morphologically variable ranging from agranular small monocyte-like cells in catfish
to a mix of lymphocytes, acidophilic granulocytes and monocyte-macrophages in
seabream (Evans, Carlson et al. 1984), (Cuesta, Esteban et al. 2002).
NCCs form close contact with the target without fusion or fragmentation. They
form a bond with the target cell by extending their moderate surface filament-like surface
projections to the target cell membranes. NCCs account for 5-7% of leukocyte population
in the teleosts. Nonspecific cytotoxic cells (NCC) (Evans, Jaso-Friedmann et al. 1988,
Evans, Leary et al. 2001) are found in the anterior kidney, liver, spleen, and peripheral
blood in teleosts including channel catfish (Evans and Jaso-Friedmann 1992), tilapia
(Jaso-Friedmann, Ruiz et al. 2000) and carp (Markkula, Salo et al. 2005), (Salo, Jokinen
et al. 2000), (Jokinen, Salo et al. 2000). Though NK cells and NCCs are known to kill the
same type of target cells (reviewed by (Ristow, Evans et al. 2000), the cytotoxic effect of
NCCs is not as robust as NK cells because of NCCs incapability to recycle or the long lag
period they require to replenish the cytotoxic capability following prior contact with
target cell (Graves, Evans et al. 1984). Further, large numbers of NCCs are required to
kill an individual transformed target cell. NK cells and NCCs also differ based on
density, killing kinetics, target antigen specificities and radiation sensitivity (Mazia,
Schatten et al. 1975). NCCs were considered to be a possible phylogenic precursor of NK
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cell (Evans, Hogan et al. 1984) because of their physiological characteristics during
contact with target cell. NCCs display characteristics such as margination of nuclear
chromatin, polarization of the golgi toward the target cell contact area and movement of
the bulk of cytoplasm at the concave aspects of the nucleus towards the target cell contact
area. NCCs also possess anti-parasitic cellular immunity functions (Graves, Evans et al.
1985). Moss et al describe NCCs to have a smooth ruffled outer membrane surface and
containing small cytoplasmic granules (Moss, Monette et al. 2009).
Monoclonal antibodies anti- NITR9 (non-specific immune type receptor 9), antiNCCRP1 (non-specific cytotoxic cell receptor protein-1), anti-MPEG-1 (macrophage
protein expressing gene) and anti-IgZ (polyclonal antibody) can be used to label zebrafish
NK cells, NCCs, macrophages and IgZ+ cells, respectively. Anti-NITR9 recognizes novel
immune type receptor 9 (NITR9) that is believed to be present on zebrafish NK cells.
NITR9 is the homologue of human killer like immunoglobulin (KIR) and mouse Ly49
activating inhibitors on NK cells. Novel immune type receptors (NITRs) are unique to
multiple bony fish species including zebrafish. They are encoded by large multi gene
families and share structural and signaling similarities to mammalian natural killer
receptors Ly49 in mice (Ortaldo and Young 2005, Mason, Willette-Brown et al. 2006)
and KIRs (Farag and Caligiuri 2006) in humans. NITRs can be classified as: inhibitory,
activating and functionally ambiguous based on peptide signaling motifs (Yoder 2009).
Bony fish possess cytotoxic NK-like cells (TCRα−β−γ−IgM−) as well as cytotoxic T cells
(TCRα+β+IgM−) (Shen, Stuge et al. 2002) and inhibitory and activating NITRs may play
significant roles in the functional regulation of both of these lymphocyte populations.
NITR expression is observed in spleen, kidney and intestine, and is more abundant than
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in muscle and liver (Strong, Mueller et al. 1999, Hawke, Yoder et al. 2001, Yoder,
Mueller et al. 2002, Evenhuis, Bengtén et al. 2007). There are 14 families of NITRs that
are expressed in hematopoietic kidney, spleen and intestine. NITR9 functions as either an
activating or inhibitory receptor. NITR9 structurally consists of an extracellular Ig-type
domain, transmembrane region, an activating region that possesses a positively charged
amino acid and a cytoplasmic tail, or an inhibitory receptor that possesses 1 or 2 ITIMs or
ITIM-like sequences (Yoder 2009). The activating receptor associates with ITAM
containing adaptor protein, zebrafish Dap12, to initiate downstream signaling (Wei, Zhou
et al. 2007, Yoder, Cannon et al. 2008). The inhibitory receptor mediates ITIM dependent
inhibition of MAPK activation by activating phosphatases which dephosphorylate any
active MAPKs (Wei, Zhou et al. 2007).
Anti-NCCRP-1 labels the non-specific cytotoxic cell receptor protein on nonspecific cytotoxic cells (NCCs). This receptor was isolated and characterized in channel
catfish, tilapia and zebrafish (Jaso-Friedmann, Leary et al. 1997). NCCRP-1 is a
membrane protein on NCCs and binds to antigens present on target cells or to cognate
synthetic peptides. This binding initiates a biochemical signaling response leading to
increased cytotoxicity. NCCRP-1 is a member of the lectin-type subfamily of F box
proteins. It is proline rich (9%), has two glycosylation sites and 18% of all amino acids
are potential phosphorylation sites (serine, threonine, tyrosine). The NCCRP-1 proteins
have no signal peptides or transmembrane domain (Kallio, Tolvanen et al. 2011).
Structurally, NCCRP-1 has one extracellular proline-rich domain, a transmembrane
portion of 15-18 aa and a cytoplasmic tail composed of a high frequency of
phosphorylation sites. In teleost, NCCRP-1 is mainly responsible for innate immune
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responses (Evans, Kaur et al. 2005), target cell recognition and cytolytic function of
NCCs (Moss, Monette et al. 2009). Reports suggest that the zebrafish NCCRP-1 protein
may function as an antigen recognition molecule and, as such, may participate in innate
immunity in teleost. NCCs are a lymphocyte like population and are specific to teleost
(Jaso-Friedmann, Peterson et al. 2002). The anti-NCCRP-1 antibody (5C6) is mouse
monoclonal antibody that is specific for teleost NCCRP-1(Evans, Jaso-Friedmann et al.
1988).
Anti-mpeg-1 binds to the protein encoded by the macrophage protein expressing
gene (mpeg) in zebrafish macrophages (Ellett, Pase et al. 2011). Mpeg is expressed in
macrophage-lineage cells. The purpose of this study was to isolate and describe the
cellular morphology of LLCs in the kidney, liver and spleen tissues of rag1-/- mutant
zebrafish. These cells were also evaluated for the presence of NCCRP-1, NITR9, MPEG1 and IgZ using flow cytometry.
2.2
2.2.1

Materials and methods
Zebrafish care
All zebrafish used in this study were bred from a homozygous colony of rag1-/-

mutant zebrafish previously established in the specific pathogen free hatchery in the
College of Veterinary Medicine, Mississippi State University (MSU) (Petrie-Hanson,
Hohn et al. 2009). The MSU Institutional Animal Care and Use Committee (IACUC)
approved the propagation and experimental protocols. Both adult males and females of 6
months age and weighing on an average 0.5g, were used in this study.

34

2.2.2

Flow cytometry

2.2.2.1

Cell isolations and cytospins
Liver, kidney and spleen tissues were removed from 3 rag1-/- mutant zebrafish

and individually weighed. Each tissue type from 3 fish were pooled and comprised one
replicate. The weight of each tissue was recorded. Tissues were collected in cold FACS
buffer (2% BSA in Hank’s buffer) and disrupted on ice with a teflon homogenizer. The
homogenate was passed through a sterile 40µm nylon cell strainer to make single cell
suspensions. The liver sample was passed through the cell strainer twice to remove cell
clumps. Filtered cells were placed on a histopaque 1119 gradient (Sigma –Aldrich) and
the cells at the gradient interface layer were collected. This suspension was centrifuged at
400 x g for 20 minutes, and the supernatant decanted off. Pellets from the kidney and
liver were resuspended in 2.5 ml and the spleen pellet was resuspended in 1 ml of cold
Hank’s buffer without Ca2+ and Mg2+. Cells were counted with a BioRad TC20TM
Automated Cell Counter and viability was assessed by Trypan blue (Invitrogen)
exclusion.
The cytospin cartridges were filled with 400µl of cell suspension containing 10 4 to
106 cells/ml and centrifuged in a Cyto-tech centrifuge at 500 x g for 1 minute. The
cytospin slides were air dried for 20 minutes and stained with Wrights-Giemsa stain
(Fisher Scientific Company) following the manufacturer’s instructions. Slides were
viewed on an Olympus BX43 at 1000x magnification. Differential leukocyte counts were
performed in each tissue. Cell classifications were based on morphology. Lymphocytelike cells (LLCs) were classified as small, large, and agranular or granular. Briefly, each
cell preparation was transferred into 3 mL tube containing 2 mL cold Hank’s buffer
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without Ca2+ and Mg2+ with 1% fetal bovine serum, Sigma-Aldrich, St. Louis, MI.
Zombie green cell viability dye (Biolegend) was used to determine cell survival. Cells
were kept on ice until analyzed by forward scatter and side scatter on a FACS Calibur
flow cytometer (Becton Dickinson). One hundred thousand events were analyzed per
tissue. Forward scatter (FSC) represents cell diameter. The running parameters were amp
gain 3.0 and the threshold 80. Side scatter (SSC) represents cell granularity or
complexity. The amp gain was 1.0 and the threshold was 80.
2.2.2.2

Preparing, staining and fixing cells for viability assay
Rag1-/- mutant zebrafish (n=15) kidney cells were used in this experiment. Kidney

cells were sampled and pooled in HBSS w/o Ca2+- Mg2+ or HBSS w/ Ca2+- Mg2+ or
RPMI w/ 5% channel catfish serum. The steps were as follows: (1) directly from fish; (2)
1st rinse before gradient; (3) after gradient; (4) post 1h incubation, rinsed; (5) post 30 min
incubation, not rinsed; (6) post 30 min, rinsed. During each step cells were stained with a
zombie green viability dye (BioLegend) and immediately fixed in 4% paraformaldehyde
and kept at 4C in dark. The positive control for this experiment was cells treated with
0.01% triton X 100, stained with viability dye and fixed. The cells were stained after
separation on the gradient. Negative control was a “cells only” tube i.e., cells not stained
with the viability dye zombie green but fixed. This experiment was done in triplicate.
2.2.2.3

Flow cytometry
Kidney cells were sampled from rag1-/- mutant zebrafish. Tissues were macerated

and strained through a 40micron filter in HBSS buffer w/o Ca2 + and Mg2+ (Sigma,
H4891-10x1L). Cells were washed and separated on a histopaque 1119 gradient (11191).
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Buffy coat layer was aspirated and washed, fixed with 4% Paraformaldehyde and
permeablized in BD Perm/Wash buffer (BD, 51-2091KZ). We analyzed two noncommercial/in-house monoclonal antibodies (mAb): anti-NCCRP-1 (5C6) and antiNITR9, as well as a commercial anti-NCCRP-1 (5C6) mAb. Cells were incubated with
primary antibodies: IgG mouse anti-NITR990.10.1 monoclonal antibody (gift from Dr.
Jeffrey Yoder), anti-MPEG polyclonal antibody (Anaspec), anti-NCCRP-1 monoclonal
antibody (gift from Dr. Jaso-Friedmann) and anti-IgZ polyclonal antibody 9 (Anaspec)
for 1 hour at 4C. This was followed by incubation with secondary antibodies: goat antimouse IgG-PE (Biolegend), goat anti-rabbit IgG-FITC (Thermo fisher), goat anti-mouse
IgM-APC, goat anti-rabbit IgG-FITC (Thermo fisher) respectively, for 30 minutes at
4C. Cells were also incubated with monoclonal antibody: Rat IgG2b (commercial
5C6/NCCRP-1) conjugated to FITC. Cells were washed after each step twice with 1ml
FACS buffer at 500 x g. Labelled cells were analysed on the FACS NovoCyte with
NovoExpress software.
2.2.2.4

Cellular location
We developed a working protocol for intracellular staining of anti-NITR9 mAb (a

gift from Dr. Jeffrey Yoder, NCSU) using the rag1-/- mutant zebrafish model. Cells (from
kidney or liver) were fixed in 4% paraformaldehyde and incubated with commercial 5C6
(rat anti-mouse CD11b FITC) (Imgenex), in-house anti-NCCRP1 (5C6) or in-house antiNITR9 monoclonal antibodies in 1X permeation buffer (BD Bioscience) for 1h, washed
and incubated for 30 min with an phycoerythrin (PE) conjugated anti-mouse IgG
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secondary antibody (BD Bioscience). Labeled cells were washed and resuspended in
FACS buffer (HBSS w/o Ca2+- Mg2+) and subjected to flow cytometric analysis.
2.2.3

Data analysis and statistical evaluation
All slides were viewed on an Olympus BX43 microscope and photographed using

an Infinity Luminera camera and Infinity Analyze software. The different cell sizes were
averaged and a Student’s t-test statistical analyses was preformed to compare the cell size
within each tissue. ANOVA was performed to compare cell sizes between tissues. An
alpha level of 0.05 was used to determine the significance of all analyses. Flow cytometry
analyzed cells by forward scatter (FSC) and side scatter (SSC) properties. The data from
FACS caliber was analyzed using Flowjo software. The data was statistically analyzed
by followed by student t-test using GraphPad Prism version 7.00 for Windows, GraphPad
Software, La Jolla California USA.
2.3
2.3.1

Results
Morphological descriptions of lymphocyte-like cells (LCCs) in the liver,
kidney and spleen of T and B cell deficient rag1-/- mutant zebrafish
The average weights of liver, kidney and spleen tissues were 43.33mg, 15mg and

2.66mg respectively. The average number of cells isolated from the histopaque 1119
gradients were 1x 106 cells from liver tissue, 6.75 x105 cells from kidney tissue, and
1.4x105 cells from spleen tissue. Leukocyte differentials revealed different predominant
cell populations in liver, kidney and spleen tissues (Fig 2.1). Liver preparations were 36%
hepatocytes, 34% small agranular LLCs, 20% large agranular LLCs and 12%
macrophages/monocytes. Kidney preparations were 10% small agranular and granular
LLCs, 28% agranular and granular large LLCs, 23% megakaryocytes, 15% granulocytes,
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4% dendritic cells, 9% monocytes and 9% macrophages. Spleen preparations were 27%
small agranular and granular LLCs, 50% large granular LLCs, 16% macrophages and 7%
monocytes. We found 90% cell survival with HBSS w/o Ca2+- Mg2+, 86.1% with RPMI
and 80.1% HBSS w/ Ca2+- Mg2+. The 90% live cell count is an acceptable cell count to
proceed with primary-mAb staining procedures and HBSS w/o Ca2+ and Mg2+ were used
in subsequent assays.
Examination of rag1-/- mutant zebrafish kidney, liver and spleen cells by flow
cytometry demonstrated different cell populations (Fig 2.1). On the basis of forward
scatter (FSC) and side scatter (SSC) properties and location in a FSC vs. SCC plot, liver
small agranular LCCs were included in gate 1 and large agranular LCCs were included in
gate 2 (Fig. 2.1A), the kidney small agranular and granular LCCs were included in gate 1
and large agranular and granular LCCs were included in gate 2 (Fig. 2.1B), and
macrophages, large granulocytes (NK like cells) and megakaryocytes were included in
gate 3. Spleen small agranular and granular LCCs were included in gate 1 and large
granular LCCs were included in gate 2 (Fig. 5.1C).

39

Figure 2.1

Leukocytes from liver (A), kidney (B) and spleen (C) tissues, based on
morphological appearance and FACS forward scatter (FSC) and side
scatter (SSC) characteristics.

Figure 2.2

Leukocytes in rag1-/- mutant zebrafish liver included: (A)
monocytes/macrophages, (B) large LLCs, (C) small LLCs.

Cells were stained with Wright Giemsa and examined under oil immersion by light
microscopy and viewed at 1000x magnification. The size bar represents 10m.
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Figure 2.3

Leukocytes in rag1-/- mutant zebrafish kidney included: (A)
megakaryocytes, (B) neutrophils, (C) mast cells, (D) basophils, (E)
eosinophils, (F) dendritic cells, (G) monocytes, (H) macrophages, (I) large
LLCs, (J) small LLCs, (K) precursor cell, (L) myeloblasts and (M)
megakaryoblast.

Cells were stained with Wright Giemsa and examined under oil immersion by light
microscopy and viewed at 1000x magnification. The size bar represents 10m.
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Figure 2.4

Leukocytes in rag1-/- mutant zebrafish spleen included: (A) monocytes, (B)
macrophages, (C) large granular and small granular and agranular LCCs.

Cells were stained with Wright Giemsa and examined under oil immersion by light
microscopy and viewed at 1000x magnification. The size bar represents 10m.
Table 2.1

Size analyses of lymphocyte-like cells from liver, kidney and spleen tissues
in rag1-/- mutant zebrafish.

Tissues

Cells

Size  Sd

t-test
p value

ANOVA

Liver

Large
Small
Large
Small
Large

7.4m1.1m
4.8m0.8m
8.8m1.1m
6.2m1.3m
9.8m1.1m

0.0039*

A
B
A
B
A

Kidney
Spleen

0.0096*
0.0005*

Small
B
6.45m+0.5m
Cells with the same letter are not significantly different from each other. *significant
when alpha value is <p value. (p=0.05).
2.3.2

Cell membrane integrity and cell viability
The results from this experiment provide interesting information about the

different range of cellular viability as an effect of the 3 buffers used for the cell isolations
and sample preparations. The cells form the HBSS w/o Ca2+- Mg2+ treatment (Fig. 2.4)
had better survival (90%) when compared with the other buffers (80.1%) and (86.1%)
i.e., HBSS w/ Ca2+- Mg2+ (Fig. 2.5) and RPMI (Fig. 2.6) respectively. Samples/tubes 1
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and 2 had less live cells compared to 3. This can be justified by the fact that we gated out
the lymphocyte cells from forward and side scatter plot for analysis and there were less
cells in the gate before enrichment/gradient separation. The cells in tubes 1 and 2 were
aliquoted from the cell suspension before the gradient separation and these cell
suspensions had more red blood cells and less LLCs. The cells separated on the gradient
(tube 3) (Fig. 2.5) had an enriched lymphocyte population and showed more live cells
compared to buffers 1 and 2. The flow cytometry results were consistent with the
cytospin observations. The cytospins for the HBSS w/o Ca2+- Mg2+ had morphologically
healthier looking cells (data not shown) with distinct nucleus and cytoplasm as well as
intact cell membrane when viewed at 1000X magnification on a light microscope. The
cell membranes in the cells in RPMI were intact, but the cells did not stain well with
Wrights-Geimsa stain (data not shown). The cell cytoplasm did not take up the stain and
were very lightly stained. This could be a result of the serum in the RPMI media. The
cells for HBSS w/ Ca2+-Mg2+ did not have an intact cell membrane and most of the cells
looked stressed and damaged.
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Figure 2.5

Create a short, concise figure title and place all detailed caption, notes,
reference, legend information, etc in the notes secti Rag1-/- mutant
zebrafish head-kidney (hematopoietic) cells were sampled in HBSS w/o
Ca2+- Mg2+ buffer.

At every step during the cell prep, aliquots were taken aside and stained with a viability
dye and fixed.
Cell viability – HBSS w/ Ca2+ and Mg2+
Cells only

0.01% Triton X 100

Tube 3 (A er gradient)

Figure 2.6

Tube 4 (Post 1h incuba on, rinsed)

Tube 1 (straight from
h fis )

Tube 5 (Post 30 min incuba on, not rinsed)

Tube 2 (1st Rinse, before gradient)

Tube 6 (post 30 min, rinsed)

Rag1-/- mutant zebrafish head-kidney (hematopoietic) cells were sampled in
HBSS w/ Ca2+- Mg2+ buffer.
44

Cell viability – RPMI w/ 5% serum
Cells only

Tube 3 (A er gradient)

Figure 2.7

0.01% Triton X 100

Tube 4 (Post 1h incuba on, rinsed)

Tube 1 (1st Rinse, before gradient)

Tube 6 (post 30 min, rinsed)

Rag1-/- mutant zebrafish head-kidney (hematopoietic) cells were sampled in
RPMI media with 5% catfish serum.

At every step during the cell prep, aliquots were taken aside and stained with a viability
dye and fixed.
2.3.3

Cell staining with anti-NITR9 and anti-NCCRP-1 antibodies
To evaluate the Fc blocking ability, rag1-/- mutant zebrafish cells were blocked

with either mouse Fc block (Fig. 2.7) or zebrafish serum (Fig. 2.8) and stained with
primary antibodies: Commercial 5C6 (anti-NCCRP-1), In-house 5C6 (anti-NCCRP-1) or
anti-NITR9 antibody. There was no discernible staining difference between the cells
blocked with zebrafish serum or the mouse Fc block.
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Mouse Fc block - Lymphocytes
FITC only

APC-FITC only

In house 5C6-FITC

APC

APC only

FITC
NITR9-In house 5C6 NITR9-commercial 5C6
APC-FITC
APC-FITC

NITR9 -APC

APC

Commercial 5C6-FITC

FITC

Figure 2.8

Rag1-/- mutant zebrafish head-kidney (hematopoietic) cells were blocked
with mouse Fc block and stained with primary antibodies: Commercial 5C6
(anti-NCCRP-1), In-house 5C6 (anti-NCCRP-1) or anti-NITR9.
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Zebrafish serum block - Lymphocytes
APC-FITC only

FITC only

In house 5C6-FITC

APC

APC only

FITC
NITR9-In house 5C6 NITR9-commercial 5C6
APC-FITC
APC-FITC

NITR9 -APC

APC

Commercial 5C6-FITC

FITC

Figure 2.9

Rag1-/- mutant zebrafish head-kidney (hematopoietic) cells were blocked
with zebrafish serum and stained with primary antibodies: Commercial 5C6
(anti-NCCRP-1), In-house 5C6 (anti-NCCRP-1) or anti-NITR9.

The experiment was repeated with antibody staining in triplicate and blocked with
zebrafish serum. The fixed samples were analyzed on two different days. In the second
run (Fig. 2.9), the cells in the FSC and SSC showed a slight shift downwards (but still
had separated clear population) compared to the first run. Again, this shift in the cell
population could be due to the fixed cells sitting for 5 days at 4C. However, this shift in
the population did not affect the staining patterns of antibodies. By using the Flowjo
software, cells were gated into granulocyte and LLC populations. After comparing the
data from the two days, there is not much difference in the staining patterns. Anti-NITR9
did not stain any cells LLC gate (0.26  0.12) and granulocyte gate (0.11  0.09). In47

house (IH) 5C6 did stain the cells LLC gate (7.35  1.76) but not any in the granulocyte
gate (0.57  0.71). However, the percentage of staining reduced to half following storing
fixed cells at 4C for 5 days (Fig. 2.10). It could infer that the intensity of fluorescence
wears off with time in-spite of fixing the cells. The commercial (new) 5C6 stained the
LLC population (1.52  0.84) and less of the granulocyte population (1.43  0.88).
Staining with the commercial 5C6 is not as good as the in-house 5C6. The dual staining
of anti-NITR9 w/ In-house (IH) 5C6 or commercial (new) 5C6 did not give any double
stained cells; anti-nitr9 w/ In-house (IH) 5C6: LLC = 0.27  0.07; granulocyte = 0.03 
0.01; anti-NITR9 w/ commercial (new) 5C6: LLC = 0.77  0.56; granulocyte = 0.29 
0.24.

APC only

FITC only

APC

Kidney cells only

FITC
In-house 5C6

Commercial 5C6

Anti-NITR9 +
In-house 5C6

Anti-NITR9 +
commercial 5C6

Anti-NITR9

Anti-NITR9

Anti-NCCRP-1 (5C6)

Figure 2.10
5/4/17

Rag1-/- mutant zebrafish head-kidney (hematopoietic) cells were blocked
with zebrafish serum and stained with primary antibodies: Commercial 5C6
(anti-NCCRP-1), In-house 5C6 (anti-NCCRP-1) or anti-NITR9.
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2.3.4

Extracellular and intracellular staining of NITR9
Extracellular and intracellular staining of NITR9 on WT and rag1-/- mutant

zebrafish kidney cells demonstrated extracellular staining in both WT (63.47.72;
p=0.0079) and mutant zebrafish (43.123.04; p=0.111), staining was not statistically
significantly different in mutant kidney cells (Fig. 2.11). This could be explained by the
absence of cytotoxic T cells in the rag1-/- mutant zebrafish. The extracellular staining in
the WT is due to the presence of cytotoxic T cells and NK cells/NITR9+ cells. However,
following intracellular staining, there was a shift in the histogram peak with a significant
rise in NITR9 (93.321.98; p=0.0079) for WT and (88.865.02; p=0.0079) for rag1-/mutant zebrafish staining intensity. This NITR9+ staining is similar in the WT and
mutant. This could be due to the increase of NK cells in the absence of T and B cells in
the mutant fish.

Extracellular

Intracellular

WT zebrafish

Cells only
PE only

rag1-/- mutant
zebrafish

NITR9 - PE

Figure 2.11

Extracellular and intracellular NITR9 expression of lymphocyte cell
population, analyzed by flow cytometry after cells were stained with PElabeled secondary antibody.
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Kidney leukocytes

MPEG-1+ cells

-/-

Rag1 mutant

Figure 2.12

Extracellular MPEG-1 expression of kidney cell population, analyzed by
flow cytometry after cells were stained with FITC-labeled secondary
antibody.

Kidney leukocytes

NCCRP-1+

-/-

Rag1 mutant

Figure 2.13

Extracellular NCCRP-1 expression of kidney cell population, analyzed by
flow cytometry after cells were stained with APC-labeled secondary
antibody.
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Kidney leukocytes

IgZ+ cells

-/-

Rag1 mutant

Figure 2.14

Extracellular IgZ expression of kidney cell population, analyzed by flow
cytometry after cells were stained with FITC-labeled secondary antibody.

Figure 2.15

Adopted from Wei et al 2007, In this study, the authors have shown that
Nitr9L and Dap12 can physically associate and that cross-linking Nitr9L
results in increased phosphorylation of AKT and ERK (Wei, Zhou et al.
2007).

2.4

Discussion
Cytology demonstrated the presence of LLCs with NCC and NK cell morphology.

The size of zebrafish LLCs varied in size depending on their tissue locations, and similar
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variations in NK cell populations have also been observed in mammals (Trinchieri 1989).
In this study, we identified small agranular and large agranular LLCs in the livers, small
agranular and granular and large agranular and granular LLCs in the kidneys and small
agranular and granular and large granular LLCs in spleens of rag1-/- mutant zebrafish
(Table 2.1). Two NK cell homologues have been described in teleosts: NCCs and NKlike cells. Based on RT-PCR, lymphocyte-like cells from the rag1-/- mutant zebrafish
express Nk-lysin and NCCRP-1 (Petrie-Hanson, Hohn et al. 2009). NK lysin is expressed
by NK cells (Andersson, Gunne et al. 1996), and NCCRP-1 is expressed by NCC cells
(Harris, Kapur et al. 1992), suggesting that NCCs and NK cells are included in the LCC
populations we observed. The morphology of the larger zebrafish LLCs was similar to
mammalian NK cells. The smaller LCCs we observed in our rag1-/- mutant zebrafish had
granules and were not morphologically similar to zebrafish NCCs described by Moss et
al. (Moss, Monette et al. 2009). Flow cytometry findings were similar to similar analyses
in zebrafish (Pereiro, Varela et al. 2015).
Circulating lymphocytes with morpho-functional similarities to mammalian NK
cells were also reported in catfish (Shen et al 2004). We recently reported the presence of
NK cells in zebrafish that are morphologically similar to mammalian NK cells. They are
described as large lymphocyte like cells (LLCs), with cytoplasmic granules and reniform
nucleus (Muire et al 2017). NK cells are commonly found in peripheral blood and were
indentified in liver (Fig 2.2), kidney (Fig 2.3), spleen (Fig 2.4) and intestine (data not
shown).
We saw large LLCs in the mutant zebrafish liver. However, these cells were not
granulated but had the morphology of a lymphocyte cell. Normal fish non-parenchyma
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liver cells contain NCC-like cells that have little to no cytolytic activity (Evans, JasoFriedmann et al. 1988). NK cells or large granular lymphocytes or “pit cells” have also
been described in the liver of rats (Bouwens, Remels et al. 1987) (Connor, JasoFriedmann et al. 2009) and as such may be an important effector protein of innate
immune responses (Kaur, Kamboj et al. 2005) of phylogenetically diverse vertebrates.
The use of flow cytometry in zebrafish research has increased over the last
decade. However, there are a very few protocols available which describe detailed
procedures for flow cytometry. Most protocols are not clear about the type of buffer (with
or without Ca2+ & Mg2+) they use for the cell preparation. For a successful flow
cytometry experiment, it is essential to attain >90% cell survival for antibody staining
and FACS analysis. We determined that HBSS w/o Ca2+ and Mg2+was the best buffer to
attain zebrafish cell membrane integrity and cell survival for flow cytometry.
There was no statistical difference between the background staining of cells
blocked with zebrafish serum or mouse-Fc block. However, the disadvantage of using
zebrafish serum is 30 wild type zebrafish provide 50 µl of serum. The mouse Fc-block is
commercially available and a small amount is required for blocking cells. Fixing cells in
4% paraformaldehyde is a standard procedure in flow cytometry. However, in zebrafish
cells we noticed a shift in the cell population, although the staining patterns had the same
trend as the first run. Due to the shift in the population, fixing the cells for use within 24h
is acceptable, but it is not advisable to analyze cells that have been fixed for more than a
day.
The putative NK cell activating receptor NITR9 in zebrafish has shown to be
signaling via DAP12 intracellularly (Wei, Zhou et al. 2007) (Fig 2.15). An anti-NITR9
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zebrafish antibody is available (Shah, Rodriguez-Nunez et al. 2012). However, a working
protocol for this antibody was lacking, and extracellular staining did not result in efficient
staining of the NITR9 positive cells in zebrafish (Shah, Rodriguez-Nunez et al. 2012).
The intracellular labeling of zebrafish cells with anti-NITR9 antibody resulted in efficient
staining of NK cells. We hypothesis that NCCs are NCCRP-1+ and NITR9- whereas the
NK cells are NCCRP-1- and NITR9+. But were unable to prove it in this study.
There was a positive staining with in-house and commercial anti-NCCRP-1 (5C6)
mAb. However, the staining with anti-NITR9 mAb was not significantly different
compared to the secondary isotype control antibody. Next, we performed extracellular
and intracellular (non-permeated and permeated) assay to compare the anti-NITR9
labeling patterns between WT and mutant zebrafish. There was a substantial difference in
the staining patterns between intracellular an extracellular staining. However, there was
little extracellular staining involved, which could suggest that the antibody is able to
recognize the NITR9’s extracellular region as well but to a lesser degree.
2.5

Conclusion
We identified LCCs that have characteristic NK cell morphology. Based on size,

two LLC populations were found in the liver, kidney and spleen. Gene expression data
from a previous study (Muire et al 2017) supported the observations of resident LCC
populations in the liver, kidney and spleen. We also optimized flow cytometric
procedures to attain a high percentage of viable cells (>90%) for FACS analysis and also
optimized protocols of anti-NITR9 and anti-NCCRP-1 monoclonal and anti-MPEG
polyclonal antibodies. In order to achieve a reliable result following the use of a
secondary antibody, it is very important to rule out any background staining patterns.
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Here, we compared two blocking agents: mouse Fc block and zebrafish serum. The main
challenge behind using zebrafish serum is use of the several (n=30) wild type fish to
attain a tiny amount of serum. Since there was no significant staining percentage
difference between the cells blocked with the mouse Fc block or zebrafish serum, we
continued further experiment using mouse Fc block. Finally, we confirm that anti-NITR9
mAb labels zebrafish NK cells intracellularly.
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CHAPTER III
DIFFERENTIAL GENE EXPRESSION FOLLOWING TLR STIMULATION IN
RAG1-/- MUTANT ZEBRAFISH TISSUES
Abstract
Rag1-/- mutant zebrafish mediate protective immunity in the absence of T and B
cells. Differential expression of immune response genes suggest how tissue environments
induce changes in innate immune cells that can result in these cells having the capacity to
mediate protective immunity on subsequent pathogen exposures. We determined tissue
expression levels of mx, tnfα, ifnγ, t-bet and nitr9 in response to β glucan (TLR2/6
ligand), Poly I:C (TLR3 ligand) and resiquimod (R848) (TLR7/8 ligand) intra-coelomic
injections. β glucan up-regulated tnfα and ifnγ in liver; tnfα, ifnγ, t-bet in kidney; ifnγ in
spleen tissues and down-regulated nitr9 in kidney tissues. Poly I:C up-regulated mx in
liver; mx, ifnγ, t-bet, nitr9 in kidney; mx in spleen tissues and down-regulated tnfα in
kidney and spleen tissues. R848 up-regulated mx, ifnγ, t-bet, nitr9 in liver and kidney; mx,
ifnγ in spleen tissues. These findings suggest the presence and tissue location of cytotoxic
cells in zebrafish.
3.1

Introduction
In fish, the innate immune system is critical in mediating a protective role against

pathogens during early life stages. At this time, fish have not yet developed adaptive
immunity (Petrie-Hanson and Ainsworth 1999, Mulero, García-Ayala et al. 2007).
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Zebrafish develop adaptive immunity 3 weeks post fertilization (Trede, Langenau et al.
2004). Rag1-/- mutant zebrafish lack T cell receptor (TCR) and immunoglobulin (Ig) but
have non-specific cytotoxic cells (NCCs), NK like cells, monocytes/macrophages and
neutrophils (Petrie-Hanson, Hohn et al. 2009). These fish are a model for studying
immune responses in young fish. Rag1-/- zebrafish demonstrate protective immunity to
bacteria after vaccination that is at least partially specific, unlike typical innate responses
mediated only by PRRs (Hohn and Petrie-Hanson 2012). However, the specific cell
population(s) mediating this protection has not been identified.
TLRs are present on macrophages, B cells, dendritic cells and NK cells. They are
the most widely studied pattern recognition receptors (PRRs) because of their importance
for recognizing conserved pathogen associated molecular patterns (PAMPs) and their
important roles in mediating innate as well as helping initiate adaptive immune responses
mediated by B and T lymphocytes. There are 10 TLRs in humans (Lee, Kok et al. 2014,
Pandey, Kawai et al. 2015), 13 TLRs in mice (Kawai and Akira 2010) and 22 TLRs in
zebrafish (Meijer, Gabby Krens et al. 2004).
β glucan, a yeast cell wall derivative, specifically binds to TLR2/6 (Di Renzo,
Yefenof et al. 1991, Brown and Gordon 2001, Brown and Gordon 2003, Brown, Herre et
al. 2003, Chan, Chan et al. 2009, Vaclav Vetvicka Oct 2013). Recognition of β glucan
requires the TLR2/6 heterodimer and the co-receptor Dectin-1 (Janeway, Murphy et al.
2008). Previous studies have shown that β glucan triggers the activation of macrophages,
neutrophils, monocytes, NK cells and dendritic cells and can enhance the function of
human NK cell cytotoxicity (Di Renzo, Yefenof et al. 1991). Poly I:C, an endosomal
TLR3 ligand, is a dsRNA synthetic molecule and is one of the most commonly used TLR
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ligands (Falco, Miest et al. 2014). It stimulates type I interferon and mx production
(Falco, Miest et al. 2014) and is known to activate mammalian NK cells in the absence of
antigen presenting cells (Dong, Wei et al. 2004, Pisegna, Pirozzi et al. 2004, Schmidt,
Leung et al. 2004, McCartney, Vermi et al. 2009). Poly I:C induced mx expression and
demonstrated anti-viral activity in flatfish (Fernandez-Trujillo, Ferro et al. 2008). Further,
in mice, Poly I:C treatment induced the activation and accumulation of hepatic NK cells
(Dong, Wei et al. 2004, Wang, Xu et al. 2005). R848, an endosomal TLR7/8 ligand, is a
synthetic anti-viral compound that mimics viral ssRNA, and belongs to the family of
imidazoquinolines, that are known to induce ifn genes (Hemmi, Kaisho et al. 2002, Jurk,
Heil et al. 2002, Caron, Duluc et al. 2005, Kileng, Albuquerque et al. 2008), especially
ifnγ expression from activated human NK cells (Hart, Athie-Morales et al. 2005).
Zebrafish mx is a GTPase, and belongs to the dynamin family (Obar, Collins et al.
1990) and includes highly conserved motifs common to mammalian mx (Staeheli, Haller
et al. 1986, Aebi, Fäh et al. 1989). The mx genes in teleost are highly polymorphic and
can vary between species. Seven mx isoforms have been identified in zebrafish (Altmann,
Mellon et al. 2004). Mx is an indirect indicator of type I interferon expression in teleost
(Leong, Fryer et al. 1988, Purcell, Kurath et al. 2004, Overturf and LaPatra 2006,
Robertsen 2006, Fischer, Koppang et al. 2013, Falco, Miest et al. 2014) and can inhibit
viral replication at various stages of the virus life cycle (Fernandez-Trujillo, Ferro et al.
2008).
Tnfα is a pro-inflammatory cytokine critical to the host during bacterial and viral
infections (Phelan, Pressley et al. 2005, Pressley, Phelan et al. 2005), and is an indicator
of NK cell and macrophage stimulation. In teleost, the predominant role of tnfα is
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endothelial cell activation, and it is partly responsible for the expression of type 1
interferons (Roca, Mulero et al. 2008).
In bony fish, ifnγ is one of the pro-inflammatory cytokines (class II cytokines
family) required for protection against bacterial and viral attacks (Zou, Carrington et al.
2005, Milev-Milovanovic, Long et al. 2006, Robertsen 2006, Stolte, Savelkoul et al.
2008, Sieger, Stein et al. 2009). Zebrafish ifnγ has two isoforms, ifnγ-1 and ifnγ-2
(Altmann, Mellon et al. 2003), that are functionally similar to mammalian IFNγ (Stein,
Caccamo et al. 2007). Teleost NK and T cell produce ifnγ (Robertsen 2006).
Tbox-21 (t-bet) is a transcription factor required for development of mammalian
NK and Th1 cells (Szabo, Kim et al. 2000), and has been characterized in ginbuna
crucian carp (Takizawa, Araki et al. 2008), zebrafish (Mitra, Alnabulsi et al. 2010),
rainbow trout (Wang, Holland et al. 2010), grass carp (Wang, Shang et al. 2013) and
Atlantic salmon (Kumari, Zhang et al. 2015). Tissue expression of t-bet following
pathogen exposure has been investigated in several fish species (Takizawa, Araki et al.
2008, (Wang, Shang et al. 2013, Kumari, Zhang et al. 2015).
Novel Immune Type-Receptors (NITRs) are unique to bony fish, and are
homologous to mammalian NK KIRs (killer like immunoglobulin receptors) (Wei, Zhou
et al. 2007). The NITR structure is similar to the TCR variable arm. All nitr genes encode
V domains and some J regions. Part of the nitr gene is very similar to the variable region
genes of antibodies and the T-cell receptor, but it does not undergo genetic
rearrangement. Phylogenetic studies suggest nitrs might represent the primordial gene(s)
that gave rise to adaptive immune receptors (Litman, Hawke et al. 2001, Litman, Rast et
al. 2010). NITR genes have been identified in puffer fish (Rast, Haire et al. 1995),
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zebrafish (Danio rerio) (Yoder, Mueller et al. 2001, Yoder, Litman et al. 2004, Yoder,
Cannon et al. 2008), rainbow trout (Oncorhynchus mykiss) (Yoder, Mueller et al. 2002),
channel catfish (Ictalurus punctatus) (Hawke, Yoder et al. 2001, Evenhuis, Bengtén et al.
2007), Japanese flounder (Paralichthys olivaceus) (Piyaviriyakul, Kondo et al. 2007),
medaka (Oryzias latipes) (Desai, Heffelfinger et al. 2008), Fugu (Takifugu rubripes) and
Tetraodon nigroviridis (Strong, Mueller et al. 1999). Of 39 NITR genes, only nitr9 is a
putative activating receptor with immunoreceptor tyrosine-based activation motifs
(ITAMs). Similar to mammalian activating NK receptors (KIRs and Ly49s), NITR9L
(NITR9 isoform) signals via Dap12 adaptor protein (Wei, Zhou et al. 2007). The
remaining nitrs are inhibitory receptors, and possess cytoplasmic immunoreceptor
tyrosine-based inhibition motifs (ITIM) (Wei, Zhou et al. 2007).
T and B cell deficient zebrafish exhibit a specific memory-like response when reexposed to bacteria (Hohn and Petrie-Hanson 2012). Adoptive transfer of leukocytes
from vaccinated T and B cell deficient mutants demonstrated that one or more of the cells
present in the kidney tissue mediated the protection. The cells present in the kidney are
macrophages, neutrophils, NCCs and NK cells (Petrie-Hanson et al 2009).
Microarray analysis of kidney tissue following secondary exposure suggested
increased cell receptor activation and expansion of a cell population (Krishnavajhala et al
2017). These changes followed exposure to attenuated bacteria. Targeted activation of
specific TLRs could suggest the cell population(s) mediating the protective response in
our model.
Few tools are available for immune cell studies in zebrafish. In this study,
TLR2/6, TLR 3 and TLR 7/8 ligands were administered. Tissue specific expression of
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immune cell specific genes mx, tnfα, ifnγ, t-bet and nitr9 were evaluated to gain a better
understanding of the responsive cell population underlying protective immunity in rag1-/mutant zebrafish. Data presented in this chapter were included in Muire et al. 2017.
3.2
3.2.1

Materials and methods
Zebrafish care
Zebrafish were mated, raised and maintained at 28°C in the specific pathogen free

hatchery in the College of Veterinary Medicine, Mississippi State University (MSU)
following standard lab protocols. Experimental protocols were approved by the MSU
Institutional Animal Care and Use Committee (IACUC). A homozygous breeding colony
of rag1-/- mutant zebrafish was previously established (Petrie-Hanson, Hohn et al. 2009)
and bred at the CVM-SPF hatchery and the experimental fish are progeny from that
colony.
3.2.2

TLR ligand injection rates
Rag1-/- zebrafish were intra-coelomically (IC) injected with β glucan (50µg/0.5g

of fish), Poly I:C (50µg/0.5g of fish) and R848 (0.08µl/0.5g of fish) or endotoxin free
PBS (10µl/fish).
3.2.3

RNA extraction and cDNA preparation
Fish were euthanized in buffered 0.02% Tricaine Methanesulfonate solution

(Finquel MS-222; Argent Chemical Laboratories, Redmond, WA) and liver, kidney and
spleen tissues from fish were surgically removed at 0h (non-injected fish (n=5) for basal
expression), 1, 6, 12 and 24 hours post injection (hpi) (n=3) for each TLR ligand. Whole
tissues were immediately transferred to 400µl Trizol reagent (Zymo Research, USA) and
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homogenized following standard procedures in our lab (Elibol-Fleming 2006). Total
RNA was extracted individually from each liver, kidney and spleen homogenized sample
according to manufacturer’s protocol using RNA extraction kit (Zymo Research, USA).
The quantity of extracted total RNA was determined by NanoDrop ND-1000 and ND8000 8-Sample Spectrophotometer and stored at -80°C until used. 100ng cDNA was
prepared from RNA by using Super script III VILOTM cDNA Synthesis Kit (Invitrogen).
3.2.4

Quantifying gene expression
Mx, tnfα, ifnγ, t-bet and nitr9 were measured using real time quantitative PCR

(Takara). The mx and t-bet primers and probes (Table 3.1) were designed by Beacon
Design software (BioRad) and Primer3 plus (GraphPad) software, respectively. All
primers and probes were purchased from Eurofins MWG, Operon, Huntsville, Alabama,
USA. Amplification of the ubiquitously expressed acidic ribosomal phosphoprotein (arp)
gene was used for the internal control (Ju, Xu et al. 1999). The amplification was
performed in a 25µl volume containing 10 µl target cDNA and 15 µl master mix
containing: 8.8 µl Nuclease free water (GIBCO, Ultra PureTM), 1.5 µl MgCl2 (5mM), 2.5
µl 10x buffer, 0.5 µl dNTPs, 0.2µl Taq Polymerase HS enzyme (Hot Start PCR Kit,
TAKARA, Japan), 0.5 µl forward primer (20µM), 0.5 µl reverse primer (20µM) and 0.5
µl probe (10µM). Thermal cycler parameters for the qPCR program were set as follows:
50°C for 2 minutes, 95°C for 10 minutes, 45 cycles of 95°C for 15 seconds and 61°C for
1 minute. All samples (biological reps) were run in triplicates i.e., 3 technical
reps/sample.
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Table 3.1

Oligonucleotide primers and probes used for qRT-PCR to quantify gene
expression levels of mx, tnfα, ifnγ, t-bet and nitr9.

Gene

Oligonucleotide sequences (5’–3’)

arp

Fwd: CTGCAAAGATGCCCAGGGA
Rev: TTGGAGCCGACATTGTCTGC
Probe:[6~FAM]TTCTGAAAATCATCCAACTGCTGGATGACTACC
[BHQ1a~ Q] (Vojtech, Sanders et al. 2009)
Fwd:GCATCATTAGTTCAGACAGTCG
Rev:AAATTATCGATAGTGTCGATACAAG
Probe:[6~FAM]TGCTGACTGAACGTGTAACTCAACT [BHQ1a~ Q] *
Fwd:TCGCATTTCACAAGGCAATTT
Rev: GGCCTGGTCCTGGTCATCTC
Probe:[6~FAM]AGGCTGCCATCCATTTAACAGG[BHQ1a~Q]
(Vojtech, Sanders et al. 2009)
Fwd: CTTTCCAGGCAAGAGTGCAGA
Rev: TCAGCTCAAACAAAGCCTTTCG
Probe:[6~FAM]AACGCTATGGGCGATCAAGGAAAACGAC[BHQ1a~
Q] (Vojtech, Sanders et al. 2009)
Fwd:GATCAAGCTCTCTCTGTGATAG
Rev:GCTAAAGTCACACAGGTCT
Probe:[6~FAM]TTCTGAAGGTCACGGTCACA[BHQ1a~Q] *
Fwd: GTCAAAGGGACAAGGCTGATAGTT
Rev:GTTCAAAACAGTGCATGTAAGACTCA
Probe: [6~FAM]CAAGGTTTGGAAAAGCAC[BHQ1a~Q] (Shah,
Rodriguez-Nunez et al. 2012)

mx
tnfα

ifnγ

t-bet
nitr9

GenBank
Accession No.
NM_131580

NM_182942.4
NM_212859

NM_212864

NM_00117059
9.1
AY570237.1

Housekeeping gene arp was used as a reference gene*. The mx and t-bet primers and
probes were designed by Beacon Design software (BioRad) and Primer3 plus (GraphPad)
software, respectively.
3.2.5

Data analysis and statistical evaluation
Relative gene expression was determined using the Pfaffl method (Pfaffl 2004).

Data obtained from qRT-PCR were expressed as fold change and were converted to log2
values. Data were analyzed by two-way analysis of variance using PROC MIXED (SAS
for Windows 9.4, SAS Institute, Inc., Cary, NC). Separate models were used for each
gene and tissue combination. The explanatory variables for all models were treatment,
time post injection, and the treatment x time interaction. The effect of treatment was
reported only if the treatment and treatment x time interaction was significant. If the
interaction was significant, treatment to control comparisons were made at each time
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point with p values corrected for multiple comparisons using the SIMULATE option in a
LSMESTIMATE statement. Similarly, the 0 hour (non injected fish) data were
transformed to log2 values and analyzed by analysis of variance using PROC MIXED
(SAS for Windows 9.4, SAS Institute, Inc., Cary, NC). Separate models were used for
mx, tnfα, ifnγ, t-bet and nitr9 to compare their basal expression within the liver, kidney
and spleen. An alpha level of 0.05 was used to determine the significance of all analyses.
3.3
3.3.1

Results
Gene expression in control tissues
No significant differences were observed in the gene expressions of mx, tnfα, ifnγ,

t-bet and nitr9 between different tissues prior to injecting rag1-/- mutant zebrafish with
TLR ligands (Fig. A1).
3.3.2

Effect of β glucan on mx, tnfα, ifnγ, t-bet and nitr9 expression in liver,
kidney and spleen

Mx expression in liver, kidney and spleen
β glucan did not affect mx expression in the liver, kidney or spleen. Statistical
values for tissue gene expression studies were summarized (Table A2).
Tnfα expression in liver, kidney and spleen
Liver tnfα expression was affected by β glucan and expression was significantly
different between time points (Fig. 3.1 A). β glucan significantly increased the expression
of tnfα at 1 hpi and 12 hpi. However, β glucan did not affect tnfα expression at 6 hpi and
24 hpi. In the kidney, tnfα expression was significantly different between time points
(Fig. 3.1 B). β glucan caused significantly greater tnfα expression at 1 hpi and 6 hpi. β
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glucan did not affect 12 hpi or 24 hpi tnfα expression. In the spleen, tnfα expression was
not significantly affected.
Ifnγ expression in liver, kidney and spleen
In the liver, ifnγ expression was significantly affected by β glucan at 1 hpi, 6 hpi,
12 hpi and 24 hpi (Fig. 3.1 C). In the kidney, expression was significantly different
between time points (Fig. 3.1 D). Kidney ifnγ expression was significantly greater at 1
hpi, 6 hpi and 12 hpi. β glucan did not significantly effect ifnγ expression at 24 hpi. In the
spleen, ifnγ expression was significantly affected by β glucan at 1 hpi, 6 hpi, 12 hpi and
24 hpi (Fig. 3.1 E).
T-bet expression in liver, kidney and spleen
T-bet expression in the liver was not significantly affected by β glucan. In the
kidney, expression was significantly different between time points (Fig. 3.1 F), with t-bet
expression significantly greater only at 6 hpi. β glucan did not significantly affect t-bet
expression at 1 hpi, 12 hpi or 24 hpi. In the spleen, expression of t-bet was not
significantly affected by β glucan.
Nitr9 expression in liver, kidney and spleen
β glucan had no effect on nitr9 expression in the liver. In the kidney, expression
of nitr9 was significantly different between time points (Fig. 3.1 G), with nitr9
expression significantly down-regulated at 12 hpi and 24 hpi. β glucan had no effect on
nitr9 expression when compared to PBS treatment in the spleen.
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Figure 3.1

Graphs depicting changes in mRNA expression over time of tnfα, ifnγ, t-bet
and nitr9 in liver, kidney and spleen after treatment with β glucan.

Only tissues and genes that demonstrated significant changes in expression compared to
PBS injected controls are presented. Fold changes in tnfα in liver (A) and kidney (B),
ifnγ in liver (C), kidney (D) and spleen (E), t-bet in kidney (F) and nitr9 in kidney (G) are
presented as mean fold change relative to the time zero group ± standard deviation as
measured by quantitative RT-PCR. Arp was used as a housekeeping gene. hpi= hours
post injection; control= PBS (endotoxin-free); Treated= β glucan. *Significant (p<0.05)
difference in expression of treated compared to control. No significant changes in
expression were observed in tnfα in spleen, in t-bet in liver and spleen and in nitr9 in
liver and spleen (Table A1).
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3.3.3

Effect of Poly I:C on mx, tnfα, ifnγ, t-bet and nitr9 in liver, kidney and
spleen.

Mx expression in liver, kidney and spleen
Poly I:C significantly affected mx expression in liver at 1 hpi, 6 hpi, 12 hpi and 24
hpi (Fig. 3.2 A). In the kidney, expression was significantly different between time points
(Fig. 3.2 B). There was increased mx expression at 6 hpi, 12 hpi and 24 hpi. The
expression of kidney mx was not significantly affected by Poly I:C at 1 hpi. In the spleen,
expression was significantly different between time points (Fig. 3.2 C). The expression of
mx was significantly greater at 6 hpi and 12 hpi. Poly I:C did not significantly affect mx
expression at 1 hpi and 24 hpi.
Tnfα expression in liver, kidney and spleen
Liver tnfα expression was not significantly affected by Poly I:C. In the kidney,
expression was significantly different between time points (Fig. 3.2 D). The expression of
tnfα was significantly down-regulated at 24 hpi. In the spleen, the expression between
different time points was significantly different, and tnfα expression was significantly
down-regulated at 24 hpi (Fig. 3.2 E).
Ifnγ expression in liver, kidney and spleen
Poly I:C did not affect ifnγ expression in the liver. In the kidney, expression was
significantly different between time points (Fig. 3.2 F), and ifnγ expression was
significantly greater at 12 hpi. Poly I:C did not significantly affect kidney ifnγ expression
at 1 hpi, 6 hpi and 24 hpi. Poly I:C did not significantly affect splenic expression of ifnγ
(Data not shown).
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T-bet expression in liver, kidney and spleen
Poly I:C had no effect on t-bet expression in the liver. In the kidney, expression
was significantly different between time points (Fig. 3.2 G), and Poly I:C significantly
increased t-bet expression at 6 hpi. However, Poly I:C did not affect t-bet expression at 1
hpi, 12 hpi and 24 hpi. Poly I:C had no effect on t-bet expression in the spleen.
Nitr9 expression in liver, kidney and spleen
Poly I:C did not significantly effect nitr9 expression in liver. In the kidney, nirt9
expression was significantly different between time points (Fig. 3.2 H), and nitr9
expression was significantly greater at 1 hpi. Poly I:C had no effect on nitr9 expression at
6 hpi, 12 hpi and 24 hpi. Poly I:C did not significantly affect splenic nitr9 expression.
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Figure 3.2

Graphs depicting changes in mRNA expression over time of mx, tnfα, ifnγ,
t-bet and nitr9 in liver, kidney and spleen after treatment with Poly I:C.

Only tissues and genes that demonstrated significant changes in expression compared to
PBS injected controls are presented. Fold changes in mx in liver (A), kidney (B) and
spleen (C), tnfα in kidney (D) and spleen (E), ifnγ in kidney (F), t-bet in kidney (G) and
nitr9 in kidney (H) are presented as mean fold change relative to the time zero group ±
standard deviation as measured by quantitative RT-PCR. Arp was used as a housekeeping
gene. hpi= hours post injection; control= PBS (endotoxin-free); Treated= Poly I:C.
*Significant (p<0.05) difference in expression of treated compared to control. No
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significant changes in expression were observed in tnfα in liver, in ifnγ, t-bet and in nitr9
in liver and spleen (Table A1).
3.3.4

Effect of R-848 on mx, tnfα, ifnγ, t-bet and nitr9 in liver, kidney and spleen

Mx expression in liver, kidney and spleen
Mx expression was significantly affected by R848 in liver at 1 hpi, 6 hpi, 12 hpi
and 24 hpi (Fig. 3.3 A). Mx expression was significantly affected by R848 in kidney at 1
hpi, 6 hpi, 12 hpi and 24 hpi (Fig. 3.3 B). Splenic mx expression was affected by R848
and expression was significantly different between time points (Fig.3.3 C). R848
significantly increased the splenic mx expression at 6 hpi and 12 hpi. R848 did not affect
mx expression at 1 hpi and 24 hpi.
Tnfα expression in liver, kidney and spleen
R848 did not affect tnfα expression in the liver, kidney or spleen.
Ifnγ expression in liver, kidney and spleen
Liver ifnγ expression was effected by R848, and expression was significantly
different between time points (Fig. 3.3 D). R848 significantly increased the expression of
ifnγ at 6 hpi, 12 hpi and 24 hpi. However, R848 did not affect ifnγ expression at 1 hpi. In
the kidney, ifnγ expression was effected by R848 at 1 hpi, 6 hpi, 12 hpi and 24 hpi (Fig.
3.3 E). Splenic ifnγ expression was effected by R848 and expression was significantly
different between time points (Fig. 3.3 F). R848 significantly increased the expression of
ifnγ at 6 hpi, 12 hpi and 24 hpi. However, R848 did not affect ifnγ expression at 1 hpi.
T-bet expression in liver, kidney and spleen
Liver t-bet expression was significantly different between time points (Fig. 3.3 G)
and was increased at 1 hpi, 6 hpi and 24 hpi. R848 did not affect t-bet expression at 12
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hpi. Kidney t-bet expression was significantly different between time points (Fig. 3.3 H)
and was increased at 1 hpi and 6 hpi. R848 did not affect t-bet expression at 12 hpi and
24 hpi. In the spleen, expression of t-bet was not significantly affected by R848.
Nitr9 expression in liver, kidney and spleen
Liver nitr9 expression was significantly different between time points (Fig. 3.3 I).
R848 significantly increased nitr9 expression at 1 hpi and 6 hpi. R848 did not affect nitr9
expression at 12 hpi or 24 hpi. In the kidney, nitr9 expression was significantly different
between time points (Fig. 3.3 J), and was increased at 6 hpi. R848 did not affect nitr9
expression at 1 hpi, 12 hpi and 24 hpi. In the spleen, nitr9 expression was not
significantly affected by R848.
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Figure 3.3

Graphs depicting changes in mRNA expression over time of mx, tnfα, ifnγ,
t-bet, and nitr9 in liver, kidney and spleen after treatment with R848.

Only tissues and genes that demonstrated significant changes in expression compared to
PBS injected controls are presented. Fold changes in mx in liver (A), kidney (B), and
spleen (C), ifnγ in liver (D), kidney (E) and spleen, (F), t-bet in liver (G), and kidney (H)
and nitr9 in liver (I) and kidney (J) are presented as mean fold change relative to the time
zero group ± standard deviations measured by quantitative RT-PCR. Arp was used as a
housekeeping gene. hpi= hours post injection; control= PBS (endotoxin-free); Treated=
R848. *Significant (p<0.05) difference in expression of treated compared to control. No
significant changes in expression were observed in t-bet and nitr9 in spleen (Table A1).
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Table 3.2

Summary of expression changes of significantly up-regulated and downregulated genes following immune stimulation

Treatment

Tissues

<10 fold
change

β glucan

Liver

tnfα (1 hpi)
tnfα (12 hpi)

β glucan

Kidney

tnfα (1 hpi)
tnfα (6 hpi)
t-bet (6 hpi)

β glucan

Spleen

Poly I:C

Liver

Poly I:C

Kidney

Poly I:C

Spleen

mx (6 hpi)

R848

Liver

nitr9 (6 hpi)

R848

Kidney

t-bet (1 hpi)
t-bet (6 hpi)

R848

Spleen

mx (6 hpi)
mx (12 hpi)
ifnγ (6 hpi)
ifnγ (12 hpi)
ifnγ (24 hpi)

10-100 fold
change

ifnγ (1 hpi)
ifnγ (12 hpi)
ifnγ (1 hpi)
ifnγ (12 hpi)

mx (1 hpi)
mx (6 hpi)
mx (12 hpi)
mx (24 hpi)
ifnγ (12 hpi)
t-bet (6 hpi)

>100 fold
change
ifnγ (1 hpi)
ifnγ (6 hpi)
ifnγ (12 hpi)
ifnγ (24 hpi)
ifnγ (6 hpi)
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nitr9 (12 hpi)
nitr9 (24 hpi)

ifnγ (6 hpi)
ifnγ (24 hpi)

mx (6 hpi)
mx (12 hpi)
mx (24 hpi)
nitr9 (1 hpi)
mx (12 hpi)
ifnγ (12 hpi)
ifnγ (24 hpi)
nitr9 (1 hpi)
t-bet (6 hpi)
mx (1 hpi)
mx (6 hpi)
mx (12 hpi)
mx (24 hpi)
ifnγ (1 hpi)
ifnγ (12 hpi)
ifnγ (24 hpi)
nitr9 (6 hpi)
mx (1 hpi)
mx (6 hpi)
mx (12 hpi)
mx (24 hpi)

Down
regulated
genes

tnfα (24 hpi)

tnfα (24 hpi)
ifnγ (6 hpi)
t-bet (1 hpi)
t-bet (24
hpi)

ifnγ (6 hpi)

3.4

Discussion
In this study, targeted activation of specific TLRs could suggest the cell

population(s) mediating the protective response in our model. Fold changes of
significantly up-regulated or down-regulated genes are summarized in Table 3.2.
Mx is produced by many leukocyte types and increased expression suggests
immune system stimulation. Tnf is produced by NK cells and macrophages, and
increased tnfα expression suggests NK cell and macrophage stimulation. Ifnγ is produced
by NK cells and macrophages, but primarily by NK cells, and up-regulated ifnγ suggests
NK cell stimulation in our lymphocyte deficient fish. T-bet is a transcription factor of NK
cells and T cells and up regulation suggests NK cell expansion in a T cell deficient
model. Increased nitr9 suggests increased NK cell activity.
β glucan did not affect mx expression in any rag1-/- mutant zebrafish tissues. In
contrast, β glucan + Poly I:C co-administration up-regulated mx expression in kidney and
spleen tissue of common carp (Falco, Miest et al. 2014).
β glucan down-regulated tnfα expression in common carp (Falco, Miest et al.
2014). β glucan induced less than 10 fold increases (4 and 8 fold change) in kidney tnfα
expression at 1 and 6 hpi in our rag1-/- mutant zebrafish. β glucan administered with A.
hydrophila up-regulated tnfα expression in zebrafish kidney cells (Rodríguez, Chamorro
et al. 2009), while zebrafish infected with live A. hydrophila had increased kidney tnfα
expression that later declined (Rodríguez, Novoa et al. 2008). However, in fish injected
with heat killed A. hydrophila there was a low but consistent expression of kidney tnfα.
Following E. tarda infection of zebrafish, there was a 14 fold increase of tnfα in pooled
liver and spleen tissues, and these levels later declined (Pressley, Phelan et al. 2005).
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Elevated expression of tnfα in zebrafish larvae followed exposures of Listonella
anguillarum (Rojo, de Ilárduya et al. 2007) and Vibrio anguillarum (Oyarbide, Rainieri et
al. 2012).
These cumulative responses resulted in a 1500 fold increase of liver ifnγ
expression at 1, 6, 12 and 24 hpi in our mutant zebrafish. The overall greatest change was
in ifnγ expression following β glucan exposure. β glucan stimulates all immune cells and
this resulted in increased production of a broad range of cytokines that further stimulated
immune cells, resulting in an expanding immune response and accumulation of
cytokines. Stimulated accessory immune cells such as macrophages and dendritic cells
further stimulate NK cells (Adib-Conquy, Scott-Algara et al. 2014). In mice treated with
soluble β glucan, changes in cytokine expression correlated with changes in cell
populations (Hida, Ishibashi et al. 2009). At 6 hpi, rag1-/- kidney ifnγ expression
increased to 193 fold change, while 10 to 100 fold increases (68 and 63 fold change) in
kidney ifnγ expression occurred at 1 and 12 hpi. Similarly increased ifnγ expression levels
were found in WT zebrafish kidney tissue at 6 hpi following β glucan treatment
(Rodríguez, Chamorro et al. 2009). In the rag1-/- mutant zebrafish spleen, β glucan
induced greater than 100 fold increases in ifnγ expression at 6 and 24 hpi (111 and 116
fold change respectively) and between 10 and 100 fold increase in splenic ifnγ expression
at 1 and 12 hpi (70.24 and 95 fold change respectively). Ifnγ was also up-regulated in
Atlantic salmon kidney, spleen, skin and intestine following Aeromonas salmonicida
infection (Kumari, Zhang et al. 2015). In contrast, administration of β glucan alone
induced ifnγ expression only at 6 hpi in kidney, and when injected with A. hydrophila,
induced kidney ifnγ expression at 4 hpi and later declined (Rodríguez, Novoa et al. 2008).
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In our rag1-/- mutant zebrafish, β glucan induced a <10 fold increase (0.6 fold
change) in kidney t-bet expression at 6 hpi, but did not induce changes in t-bet expression
in any other tissues. In healthy grass carp, t-bet expression was higher in head kidney and
spleen than in gill, kidney, intestine and liver. Further, following infection with grass carp
reovirus, elevated expression of ifnγ co-related with elevated t-bet expression in kidney
tissue (Wang, Shang et al. 2013). In Atlantic salmon infected with A. salmonicida, there
was an increased expression of t-bet in kidney tissue and moderate to low expression in
spleen tissue (Kumari, Zhang et al. 2015). T-bet is a transcription factor for T cells and
NK cells, and these findings suggest that in rag1-/- mutant zebrafish, β glucan stimulated
NK cell development in the kidney hematopoietic tissue, resulting in t-bet up-regulation
at 6 hpi. The decrease in t-bet expression after 6 hpi in our study could result from NK
cells trafficking out of the kidney hematopoietic tissue at that time.
In our study rag1-/- mutant zebrafish kidney tissue, β glucan treatment resulted in
down-regulated nitr9 expression at 12 and 24 hpi. After WT zebrafish were infected with
Listonella anguillarum, there was a 2 fold and 2.6 fold increased nitr9 expression at 4 hpi
and 6 hpi, respectively, followed by a decline in expression at 22 hpi (Rojo, de Ilárduya
et al. 2007). However, in that study, nitr9 expression was quantified from individual
whole fish, and we analyzed individual tissues from separate fish. The downregulation of
nitr9 expression in the rag1-/- mutant kidney tissue (Table 2.2) probably resulted from
nitr9 positive NK cells trafficking out of the kidney and into other tissues in the
zebrafish, similar to how changes in tissue cytokine expression were correlated to
changes in cell populations following β glucan exposure in mice (Falco, Miest et al.
2014). A. salmonicida infection strongly induced t-bet expression in Atlantic salmon
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kidney (Kumari, Zhang et al. 2015). The trends of up and down regulation of gene
expression of NK cell specific t-bet and nitr9 (in our T and B cell deficient zebrafish)
suggest the stimulation of NK cells by TLR 2/6 and the resulting production of ifns, and
the development of NK cells reflected by the up-regulation of the t-bet transcription
factor at 6 hpi. At 12 and 24 hpi, NK cells trafficked out of the kidney, and nitr9
expression decreased below control levels.
Poly I:C induced ifn and ifn-inducible genes (Robertsen 2006), and mx expression
is an indicator of increased type I interferon in fish (Saint-Jean and Pérez-Prieto 2007)
and mice (Roers, Hochkeppel et al. 1994). In the liver, Poly I:C induced a <10 fold upregulation of mx at 1, 6, 12 and 24 hpi in our rag1-/- mutant zebrafish. Liver mx
expression was also up-regulated in yellow perch and directly correlated to viral load of
viral hemorrhagic septicemia virus (Olson, Emmenegger et al. 2013). Mx expression was
elevated 10 fold in liver of Atlantic salmon one week following treatment with Poly I:C
(Das, Ellis et al. 2009). Following Poly I:C treatment, there was a <10 fold increased
expression of ifna and ifnc (type 1 interferon) in the liver of Atlantic salmon, suggesting
mx up-regulation (Svingerud, Solstad et al. 2012).
In the kidney, we saw the greatest fold increases (10 to 100 fold) in mx expression
at 6, 12 and 24 hpi following Poly I:C treatment in rag1-/- mutant zebrafish. Type 1
interferon was up-regulated in rainbow trout head kidney tissue following treatment with
Poly I:C (Palti, Gahr et al. 2010), suggesting subsequent up-regulation of mx expression.
Mx expression was elevated 35 fold and 10 fold in head kidney of Atlantic salmon at 2
and 5 days, respectively, following treatment with Poly I:C (Das, Ellis et al. 2009). When
WT zebrafish kidney cells were exposed to Poly I:C, mx expression was up-regulated
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(Mitra, Alnabulsi et al. 2010). In another study, Poly I:C induced mx expression in
zebrafish within 48 hours after injection (Kavaliauskis, Arnemo et al. 2015). Following
Poly I:C treatment in Atlantic salmon hepatic mx expression was elevated 10 fold (Das,
Ellis et al. 2009) and a <10 fold increased hepatic mx expression of type I interferon
(Svingerud, Solstad et al. 2012) and an up-regulation of type 1 and 2 interferon in
rainbow trout head kidney tissue (Palti, Gahr et al. 2010), suggesting mx up-regulation in
these fish.
Rag1-/- mutant zebrafish splenic mx expression was up-regulated <10 fold at 6 hpi
and 10 to 100 fold at 12 hpi. Poly I:C treatment also induced mx up-regulation in WT
zebrafish spleen cells (Mitra, Alnabulsi et al. 2010), and rainbow trout spleen (Purcell,
Kurath et al. 2004). Poly I:C induced a <10 fold increased expression of ifna and ifnc,
suggesting mx expression (Svingerud, Solstad et al. 2012) and 30 and 10 fold mx
expression at day 2 and 5, respectively, (Strandskog, Skjæveland et al. 2008) in the
spleen of Atlantic salmon. Further, following Poly I:C treatment in rock bream, mx
expression increased and peaked at day 2 (4.2 fold) and then gradually decreased (Kim,
Oh et al. 2012). In contrast to these findings, Poly I:C did not increase mx expression in
carp spleen tissues (Falco, Miest et al. 2014).
In our study, Poly I:C did not affect liver tnfα in rag1-/- mutant zebrafish, and this
agreed with findings in common carp (Falco, Miest et al. 2014). Poly I:C down-regulated
tnfα in rag1-/- mutant kidney tissues. In gilthead seabream, at 0.5 and 1.5 hpi, Poly I:C
significantly up-regulated tnfa in acidophilic granulocytes and macrophages (Sepulcre,
López-Castejón et al. 2007), in the head kidney (García-Castillo, Pelegrín et al. 2002,
Roca, Mulero et al. 2008) and rainbow trout anterior kidney leukocytes (Purcell, Smith et
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al. 2006). Interestingly, we found kidney tnfα was down-regulated following Poly I:C
treatment. These decreases in our mutant zebrafish could result from macrophages and/or
NK cells trafficking out of the kidney hematopoietic tissue. Another study reported that
Poly I:C did not have an effect on tnfα1 and tnfα2 in common carp kidney tissue (Falco,
Miest et al. 2014). Poly I:C also down-regulated splenic tnfα in our mutant zebrafish.
Poly I:C had no effect on splenic tnfα expression in rainbow trout (Purcell, Kurath et al.
2004) and common carp (Falco, Miest et al. 2014).
In rag1-/- mutant zebrafish, Poly I:C treatment had no effect on liver ifnγ
expression. Kidney ifnγ expression was up-regulated less than 10 fold at 12 hpi in rag1-/zebrafish kidney. In Atlantic salmon following Poly I:C treatment, there was 10 fold
increased expression of ifnγ on day 2 and no effect on day 5 (Strandskog, Skjæveland et
al. 2008). Ifnγ was up-regulated following Poly I:C treated kidney tissues in rainbow trout
(Zou, Carrington et al. 2005), in grass carp (Wang, Shang et al. 2013) and in kidney cells
of Labeo rohita (Parhi, Sahoo et al. 2015). Poly I:C exposure up-regulated ifnγ expression
in WT zebrafish kidney cells (Mitra, Alnabulsi et al. 2010) and in head kidney tissue of
grass carp (Wang, Shang et al. 2013). In rag1-/- mutant zebrafish, Poly I:C treatment had
no effect on splenic ifnγ expression. Similarly, in Atlantic salmon following Poly I:C
treatment, there was no effect on ifnγ expression in the spleen on day 2 and 5
(Strandskog, Skjæveland et al. 2008). In contrast, ifnγ was up-regulated in Poly I:C
treated spleen tissues in rainbow trout (Zou, Carrington et al. 2005).
Poly I:C did not affect liver t-bet expression of rag1-/- mutant zebrafish. T-bet
expression was up-regulated 1.2 fold at 6 hpi in kidney tissue suggesting Poly I:C
induced NCC and NK cell development. Poly I:C exposure also up-regulated kidney t-bet
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in WT zebrafish (Mitra, Alnabulsi et al. 2010) and grass carp (Wang, Shang et al. 2013).
Poly I:C did not affect splenic t-bet expression in rag1-/- mutant zebrafish, but upregulated splenic t-bet in WT zebrafish (Mitra, Alnabulsi et al. 2010).
At 1 hpi of Poly I:C, mutant zebrafish kidney tissue demonstrated a 19 fold
increase in nitr9 expression suggesting stimulation of NK cells. This was the only Poly
I:C induced up-regulation of nitr9 in our study. Following SHRV infection, there was no
change in nitr9 expression between rag1-/- and WT zebrafish kidney and spleen (Shah
2009). Since nitr9 is a putative receptor of zebrafish NK cells (Wei, Zhou et al. 2007,
Shah, Rodriguez-Nunez et al. 2012), our findings suggest that Poly I:C induced kidney
NK cell stimulation, followed by an expansion of NK cells (demonstrated by kidney t-bet
up-regulation at 6 hpi).
R848 has immune modulating roles in mammals (Tomai, Imbertson et al. 2000,
Wu, Huang et al. 2004, Gorski, Waller et al. 2006), Japanese flounder (Zhou and Sun
2015), Atlantic salmon (Svingerud, Solstad et al. 2012), and rainbow trout (Purcell,
Kurath et al. 2004, Purcell, Smith et al. 2006). The TLR7/8 NF-κB–My-d88 signaling
pathway has been demonstrated in Japanese flounder (Zhou and Sun 2015). R848
significantly up-regulated hepatic mx expression at 1, 6, 12 and 24 hpi (50 fold increase),
suggesting a steady rise in type I interferon expression in our mutant zebrafish, and we
also saw a 35 fold up-regulation of mx in kidney tissue. Increases in type 1 interferon
were observed in rainbow trout (Palti, Luo et al. 2009) and Atlantic salmon kidney
(Svingerud, Solstad et al. 2012), and fluorescent in situ hybridization further
demonstrated that a small population of head kidney cells produced type 1 interferon
(Svingerud, Solstad et al. 2012). We also saw a 6 fold increase in splenic mx gene
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expression at 6 hpi and 8 fold increase at 12 hpi. In Atlantic salmon, type 1 interferon
was significantly up-regulated by a small population of splenic cells (Svingerud, Solstad
et al. 2012).
In our study, R848 did not induce differential tnfα expression in any tissues at any
time. R848 induced up-regulation of tnfα in rainbow trout kidney (Purcell, Kurath et al.
2004), when used higher at levels than in our study.
In rag1-/- mutant zebrafish, we noted that liver ifnγ gene expression increased 100
fold at 6 hpi, 70 fold at 12 hpi and 40 fold at 24 hpi. Kidney ifnγ increased 10 to 100 fold
at 1, 12 and 24 hpi (13, 31 and 24, respectively). The highest expression for kidney ifnγ
following R848 treatment was 153 fold change at 6 hpi. Splenic ifnγ gene expression
increased 7 fold at 6 hpi, 8 fold at 12 hpi and 6 fold at 24 hpi. The effects of R848 on ifnγ
expression are not documented in other fish.
In our mutant zebrafish, R848 induced increased t-bet expression in the liver, (100
fold at 1 hpi, 12 fold at 6 hpi and 200 fold at 24 hpi), and kidney (1 hpi and a 7 fold
increase at 6 hpi). Hepatic nitr9 expression increased (50 fold at 1 hpi, and 6 fold at 6
hpi), as did kidney nitr9 gene expression (increased 10 fold at 6 hpi). The effects of R848
on t-bet or nitr9 tissue expression in other fish are not documented. Gene expression of
transcription factors does not necessarily correlate to protein expression. However, we
feel the significant increases seen in t-bet following TLR ligand treatments suggests an
increased number of non-specific cytotoxic cells (NCCs) and NK cells, while nitr9
expression more specifically represents an NK cell population.
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3.5

Conclusion
Our findings reveal important insight into the way fish that have limited

lymphocyte based immunity can respond to infections. T and B cell deficient rag1-/mutant zebrafish demonstrate specific protection (Hohn and Petrie-Hanson 2012), and
our current study was performed to elucidate the cell population(s) involved in that
response by interpreting transcript level changes in immune tissues. Differential
expressions of immune response genes suggest how tissue environments induce changes
in innate immune cells that can result in these cells having the capacity to mediate
protective immunity at subsequent pathogen exposure.
Following β glucan treatment the up-regulated tnfα predominately resulted from
stimulated macrophages. The lack of NK cell specific nitr9 up-regulation suggests that
the hepatic NK cell population is small, and below detectable levels in the liver, or that
there is a hepatic population of nitr- NK cells. β glucan induced hepatic ifnγ expression
could have resulted from stimulated macrophages and dendritic cells, or nitr9- cytotoxic
cells. Up-regulation of kidney t-bet expression at 6 hpi suggests NK cells are developing.
Down-regulation of kidney nitr9 expression at 12 hpi and 24 hpi suggests nitr9
expressing NK cells may be trafficking out of the kidney at those times. The finding that
β glucan did not stimulate nitr9 expression and induced stimulation of tnfα expression,
suggests a potential monocyte/macrophage role as well as possibly NK cells during
protective immunity in rag1-/- mutant zebrafish. This protective response could involve
‘trained’ monocytes/macrophages, using functions previously described (Bowdish,
Loffredo et al. 2007, Quintin, Saeed et al. 2012).
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Poly I:C induced significant mx up-regulation, which is indicative of type 1
interferons. Type 1 interferons induce multiple immune changes, and undoubtedly
induced the kidney tissue tnfα down-regulation observed in our fish. Significant increases
in t-bet and nitr9 indicate NK cell development and stimulation. In lymphocyte deficient
animals, ifnγ is primarily produced by stimulated NK cells and by macrophages to a
lesser extent.
Following R848 treatment the greatest up-regulation of nitr9 and t-bet occurred in
the liver, but the expression profiles indicate that R848 also induces NK cell development
and stimulation in the kidney. Our studies suggest R848 stimulates NK cells better than
Poly I:C, inducing t-bet, nitr9 and ifnγ. R848 is a better NK cell inducer than Poly I:C in
humans as well (Hart, Athie-Morales et al. 2005). It is interesting to note that the strong
induction of liver NK cell gene expression occurred with R848 and studies with
lymphocyte deficient mice demonstrated that protection against cytomegalovirus
infection involved a population of Ly49H+ NK cells in the liver (Sun et al. 2009) and this
population demonstrated proliferation and contraction, forming a memory NK cell pool
that can respond rapidly and provide protection following secondary exposure.
Down-regulated gene expression levels did not occur in the liver, suggesting cells
do not exit from this tissue. In the kidney, down-regulated expression of nitr9 may be the
result of NK cells exiting the kidney, and indicative of the bone-marrow equivalent role
of this tissue. The spleen has largely antigen presentation and processing roles, and in our
mutant zebrafish, changes in splenic immune gene expressions are not predictable and are
much lower than in the liver and kidney. T-bet and nitr9 levels did not change, suggesting
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that under the conditions of this study, splenic NK cells were not stimulated to
differentiate, respond immunologically, or proliferate.
We saw a pattern of NK cell associated gene expression. T-bet up-regulation
either preceded or occurred simultaneously with nitr9, and nitr9 expression changes
never preceded those of t-bet, suggesting NK cell development and differentiation occur
before nitr9 expression. Another possibility is t-bet up-regulation represents nitr9- NK
cells and nitr9+ NK cells. Our findings of strong ifnγ up-regulation and a small t-bet upregulation with no nitr9 up-regulation (in the β glucan/vaccine group) suggest that there
may be a nitr9- NK cell subpopulation and this population was stimulated. Intracoelomic
injection of β glucan and R848 caused >100 fold increase in ifnγ expression in liver and
kidney. Rag1-/- mutant zebrafish can develop protective immunity (Hohn and PetrieHanson 2012) and these findings suggest protective immunity can be induced and/or
enhanced by NK cells when lymphocyte based immunity is compromised.
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CHAPTER IV
DIFFERENTIAL EXPRESSION OF NK CELL SPECIFIC MARKERS FOLLOWING
R848 AND VTX TREATMENTS IN RAG1-/- MUTANT ZEBRAFISH
Abstract
Previously we used targeted activation of specific TLRs to determine the presence
and tissue location of Natural Killer (NK) cells in rag1-/- mutant zebrafish. We also
identified the NK cell genes associated with protection and enhanced protection from
bacterial infection. In this study, we analyzed differential expression of NK cell specific
genes ifnγ, nitr9, t-bet, Nk-lysin(nkl)a, nklb, nklc and nkld in liver, kidney and spleen
tissues after treatment with two mammalian NK cell stimulators. The expression level of
the genes was tissue specific and varied between the two concentrations of R848 and
VTX that are TLR7/8 and TLR8 ligands, respectively. Overall, the highest responses
were from R848, and predominant Nk-lysins were nklc in the liver and spleen, and nkld
in the kidney. The Nk-lysins most affected by VTX were nklc in the spleen and nkld in
the kidney. VTX did not significantly increase NK-lysins in hepatic NK cells. We also
evaluated novel immune type receptor 9 (NITR9) protein expression in liver and kidney
tissues, and by flow cytometry. Results generated from the selected NK cell genes
support the role of NK cells during immune stimulation in teleosts.

98

4.1

Introduction
Teleost have a well-developed innate and adaptive immune system with cells

morphologically similar to their mammalian counterparts. These features provide the fish
with a capacity to mediate immune responses to infections similar to mammals. In
teleost, the adaptive immune system is developed between two to eight weeks post hatch.
Fish larvae and young survivors depend mostly on their innate immune defense system
for protection against pathogens. Zebrafish innate immune cells include monocytes,
macrophages, basophils, eosinophils, mast cells, neutrophils, non-specific cytotoxic cells
(NCCs) (Moss, Monette et al. 2009) and natural killer (NK) cells (Muire, Hanson et al.
2017). The NK cells were recently identified as large granular lymphocyte like cells
(LLCs) in zebrafish (Muire, Hanson et al. 2017). Cytokine release is a by-product of a
cellular encounter with infected cells, tumor induced cells or indirect activation by
cytokines produced by toll like receptor (TLR) activation on other innate immune cells.
Zebrafish NK cells are morphologically similar to mammalian NK cells.
Zebrafish NK cells contain granules that resemble the cytotoxic granules of mammalian
NK cells. NK cells contain Nk-lysins that are anti-microbial peptides (AMPs) present in
the cytotoxic granules. The primary function of Nk-lysins is to provide defense against
pathogens. Nk-lysins are the largest AMPs with 74-78 amino acids (Liepinsh, Andersson
et al. 1997). They were first identified as anti-bacterial peptides in porcine NK cells and
cytotoxic T lymphocytes (Andersson, Gunne et al. 1996). Four Nk-lysins paralogs have
been characterized in zebrafish (nkla, nklb, nklc and nkld) (Pereiro, Varela et al. 2015).
Nk-lysins are mainly found in T cells and NK cells. They mediate antimicrobial
activity in three ways (i) by activating dendritic cells, monocytes and macrophages via
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chemotaxis and triggering the release of IL-1, IL-8, cytokines and other proinflammatory
cytokines (Zhang, Long et al. 2013) (ii) by binding to intracellular and (iii) extracellular
bacterial membranes and causing lysis. Junfeng Chen et al in 2016 have shown pore
formation and lysis of bacterial cells by NK1, a hydrophobic domain containing Nk-lysin
(Chen, Yang et al. 2016).
Until now, Nk-lysin genes have been identified in mammalian species such as
cow (Endsley, Furrer et al. 2004), pig (Andersson, Gunne et al. 1996), horse (Davis, Sang
et al. 2005), water buffalo (Kandasamy and Mitra 2009), in birds such as chicken (Lee,
Jang et al. 2014) and quail (Ishige, Hara et al. 2016). In fish, eight NK-lysin genes have
been identified from five species, i.e. Japanese flounder (Paralichthys olivaceus) (Hirono,
Kondo et al. 2007), pufferfish (Takifugu rubripes) (GenBank accession number
XP_003962755), Atlantic salmon (Salmo salar) (GenBank accession number
NP_001134582), zebrafish (Danio rerio) (GenBank accession number AY184216),
channel catfish (Ictalurus punctatus) (Wang, Wang et al. 2006) and Cynoglossus
semilaevis (Zhang, Li et al. 2014). In 2004, Yoder et al 2004 sequenced nkld cDNA from
zebrafish (Yoder 2004). Recently, Pereiro et al 2015 identified 4 paralogs of NK lysins
(nkla, nklb, nklc and nkld) in tandem on chromosome 17 in zebrafish (Pereiro, Varela et
al. 2015). Zebrafish have two tripled clusters of Nk-lysin genes on chromosome 17 and
one on chromosome 5 (Wang, Wang et al. 2006). The reason for these multiple repeats
on the same gene is due to the fact that in fish, during evolution, the Nk-lysin gene
underwent a teleost-specific duplication event. There is 44.6% similarity between the Nklysin genes in channel catfish and zebrafish (Wang, Wang et al. 2006). NK lysins’
highest synteny was found between zebrafish and cave fish (A. mexicanus) (Pereiro,
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Varela et al. 2015). Zebrafish nkla and nklb were found to be more homologous to catfish
Nkl3, while nklc and nkld were more related to Nkl2 catfish (Pereiro, Varela et al. 2015).
The zebrafish nkld showed the highest scores with regard to synteny with Nk-lysins from
teleost species (Pereiro, Varela et al. 2015). So far three distinct Nk-lysin transcripts have
been identified in channel catfish respectively Nk-lysin 1, Nk-lysin 2, Nk-lysin 3 (Wang,
Wang et al. 2006), (Chen, Yang et al. 2016). The catfish NK-lysin shared less than 25%
amino acid identity with any mammalian sequence. Catfish NK-lysin exhibits a
conserved expression pattern with mammalian orthologues suggesting conservation of
gene function (Wang, Wang et al. 2006).
Granulysin and Nk-lysins are intracellularly synthesized and are stored in the
cytoplasmic granules of NK cells and cytotoxic T lymphocytes (Andersson, Curstedt et
al. 1995), (Jongstra, Schall et al. 1987) , (Yabe, Mcsherry et al. 1990).
R848 and VTX enhance NK cell function in mammals (Hart, Athie-Morales et al.
2005) (Lu, Dietsch et al. 2012). R848 is a synthetic TLR7/8 ligand that mimics ssRNA.
VTX is a novel, highly potent and selective TLR8 ligand and an immunetherapeutic
chemical. NK cells are major producers of interferon gamma (ifnγ) (Arase, Arase et al.
1996). Both these ligands are known to induce ifnγ expression through activation of NK
cells, increase NK cell lytic activity and enhance NK cell ability to lyse tumor cells
through antibody-dependent cell-mediated cytotoxicity (ADCC) (Lu, Dietsch et al. 2012).
TLR7 and 8 when activated by their ligands, have the ability to upregulate other TLRs
and further modulate the immune response to bacterial pathogens. VTX activates
monocytes, DCs and NK cells and increase ifnγ production, cytolytic activity, and
enhance rituximab-mediated ADCC (Lu, Dietsch et al. 2012). The use of R848
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(Resiquimod) is effective at activating local immune responses and NK cells (Tomai,
Miller et al. 2007). Yet, Hart et al 2012 report that despite the presence of TLR8 in NK
cells, most of the time NK cell cytotoxicity and cytokine production is primarily
mediated through accessory cells. However, Hailing Lu 2012 et al in their study have
demonstrated that purified NK cells were directly activated by VTX. They reported an
increased ADCC activity of NK cell as well as increase in ifnγ production (Lu, Dietsch et
al. 2012).
TLR 7 and 8 are phylogenetically similar and are expressed on intracellular
vesicles. They are capable of sensing different viral pathogens by recognizing ssRNA and
short dsRNA that are released from phagosomes to the endolysosomal compartments
(Gringhuis, Van Der Vlist et al. 2010). TLR-mediated recognition of PAMPS in the
phagosome promotes selection of antigens for optimal presentation on MHC class II.
TLR8 responds not only to viral pathogens but also gets activated upon binding of
bacterial RNA (in humans) which leads to the production of a variety of nuclear factor
(NF)-kB-mediated cytokines (i.e. tumor necrosis factor) and type I IFNs necessary for
activation and differentiation of lymphocytes (Davila, Hibberd et al. 2008) (Davila,
Hibberd et al. 2008, Cervantes, Dunham-Ems et al. 2011, Kawai and Akira 2011). Recent
studies have shown that stimulation of TLR 7 and 8 can play a role in mediating NK cell
activation (Jurk, Heil et al. 2002, Hart, Athie-Morales et al. 2005).
NK cells are major producers of interferon gamma (ifnγ) (Arase, Arase et al.
1996). The novel type immune receptor 9 (nitr9) has been characterized in zebrafish
(Wei, Zhou et al. 2007). Nitr9 is a putative activating receptor present on NK cells similar
to human KIRs and murine Ly49 (activating NK cell receptors) and it mediates its signal
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via the adaptor molecule DAP12 (Wei, Zhou et al. 2007) similar to mammalian activating
receptors. T-bet is a NK cell and T cell transcription factor (Gordon, Chaix et al. 2012)
and has been characterized in zebrafish (Mitra, Alnabulsi et al. 2010). T-bet or Tbox-21 is
a transcription factor for NK cells and Th1 cells and is required for cellular development.
T-bet gene was recently characterized in zebrafish (Mitra, Alnabulsi et al. 2010).
A few reports are available on the anti-bacterial and anti-viral activity of Nklysins from aquatic species but no work has been published showing the different
expression levels of the Nk-lysins following exposure to different NK cell specific TLR
ligands. The rag1-/- mutant zebrafish are devoid of mature T and B cells (Tokunaga,
Shirouzu et al. 2017), (Petrie-Hanson, Hohn et al. 2009) and is a suitable model to study
the functions and characteristics of NK cells.
In our study, we use the rag1-/- mutant zebrafish model and TLR ligands R848
(TLR7/8 ligand) and VTX (TLR8 ligand) to discern NK cell subpopulations in zebrafish
tissues. We used genes that are expressed in T call and NK cells: nkla, nklb, nklc, nkld,
ifnγ, nitr9 and t-bet as bio-markers for NK cells (in rag1-/- mutant zebrafish). We
compared the differential effect of the TLR ligands on the expression of NK cell
expressed genes and estimated NITR9 protein expression. We also used flow cytometry
to identify cell populations positive for NITR9.
4.2
4.2.1

Materials and methods
Zebrafish care
Zebrafish were raised and maintained at 28°C in the specific pathogen free

hatchery in the College of Veterinary Medicine, Mississippi State University (MSU)
following standard lab protocols. The MSU Institutional Animal Care and Use
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Committee (IACUC) approved experimental protocols. A homozygous breeding colony
of rag1-/- mutant zebrafish was previously established (Petrie-Hanson, Hohn et al. 2009)
and bred at the CVM-SPF hatchery and the experimental fish are progeny from that
colony. Both adult males and females of 6 months age and weighing on an average 0.5g,
were used in this study.
4.2.2

TLR ligand injection rates
Rag1-/- zebrafish were IC injected with VTX (0.25l or 2.5l/0.5g of fish) and

R848 (0.08l or 0.8l)/0.5g of fish) or endotoxin free saline. TLR ligands were
reconstituted in endotoxin free saline and a final volume of 10µl was injected per fish.
4.2.3

RNA extraction and cDNA preparation
Fish were euthanized in buffered 0.02% Tricaine Methanesulfonate solution

(Finquel MS-222; Argent Chemical Laboratories, Redmond, WA) and liver, kidney and
spleen tissues were surgically removed at 0h (non-injected fish (n=5) for basal
expression), 6, 12 and 24 hours post injection (hpi) (n=5) for each TLR ligand. Whole
tissues were immediately transferred to 400µl Trizol reagent (Zymo Research, USA) and
homogenized following standard procedures in our lab (Elibol-Fleming 2006). Total
RNA was extracted individually from each liver, kidney and spleen homogenized sample
according to manufacturer’s protocol using RNA extraction kit (Zymo Research, USA).
The quantity of extracted total RNA was determined by NanoDrop ND-1000
spectrophotometer and stored at -80°C until use. cDNA (100ng) was prepared from RNA
by using Super script III VILOTM cDNA Synthesis Kit (Invitrogen).
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4.2.4

Quantifying gene expression
Ifnγ, t-bet, nitr9, nk lysin a, b, c and d were measured using real time quantitative

PCR (Takara). The t-bet, nk lysin a, b, c and d primers and probes (Table 1) were
designed by Primer3 plus (GraphPad) software and primers and probes of ifnγ, nitr9
(Table 1) were adopted from previous publications. All primers and probes were
purchased from Eurofins MWG, Operon, Huntsville, Alabama, USA. Amplification of
the ubiquitously expressed acidic ribosomal phosphoprotein (arp) gene was used for the
internal control (Ju, Xu et al. 1999). The amplification was performed in a 25µl volume
containing 10 µl target cDNA and 15 µl master mix containing: 8.8 µl Nuclease free
water (GIBCO, Ultra PureTM), 1.5 µl MgCl2 (5mM), 2.5 µl 10x buffer, 0.5 µl dNTPs,
0.2µl Taq Polymerase HS enzyme (Hot Start PCR Kit, TAKARA, Japan), 0.5 µl forward
primer (20µM), 0.5 µl reverse primer (20µM) and 0.5 µl probe (10µM). Thermal cycler
parameters for the PRC program were set as follows: 50°C for 2 minutes, 95°C for 10
minutes, 45 cycles of 95°C for 15 seconds and 61°C for 1 minute. All samples (biological
reps) were run in triplicate.
Table 4.1

Oligonucleotide primers and probes used for qRT-PCR to quantify gene
expression levels of mx, tnfα, ifnγ, t-bet and nitr9.

Gene

Oligonucleotide sequences (5’–3’)

arp

Fwd: CTGCAAAGATGCCCAGGGA
Rev: TTGGAGCCGACATTGTCTGC
Probe:[6~FAM]TTCTGAAAATCATCCAACTGCTGGATGA
CTACC [BHQ1a~ Q] (Vojtech, Sanders et al. 2009)
Fwd: CTTTCCAGGCAAGAGTGCAGA
Rev: TCAGCTCAAACAAAGCCTTTCG
Probe:[6~FAM]AACGCTATGGGCGATCAAGGAAAACGAC
[BHQ1a~ Q] (Vojtech, Sanders et al. 2009)
Fwd:GATCAAGCTCTCTCTGTGATAG
Rev:GCTAAAGTCACACAGGTCT
Probe:[6~FAM]TTCTGAAGGTCACGGTCACA[BHQ1a~Q] *

ifnγ

t-bet
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GenBank
Accession No.
NM_131580

NM_212864

NM_001170599.1

Table 4.1 (continued)
nitr9

nkla

nklb

nklc

nkld

Fwd: GTCAAAGGGACAAGGCTGATAGTT
Rev:GTTCAAAACAGTGCATGTAAGACTCA
Probe:
[6~FAM]CAAGGTTTGGAAAAGCAC[BHQ1a~Q]
(Shah, Rodriguez-Nunez et al. 2012)
Fwd: TTTCTGGTCGGCTTGCTCAT
Rev: TTCTCATTCACAGCCCGGTC
Probe:[6~FAM]TCTGCAGCTCACTGGGAGGTTCGTGA[BH
Q1a~Q]
Fwd: TCCGCAACATCTTTCTGGTCA
Rev: AGCCTGCTCATGAATGAAAATGA
Probe:[6~FAM]CACGCCTGCAAATCTGAACCACCCA[BHQ
1a~Q]
Fwd: CTGCTTGTGCTGCTCACTTG
Rev: AGCACACATGGAGATGAGAACA
Probe:
[6~FAM]GGGCTTGCAAGTGGGCCATGGGAA[BHQ1a~Q]

AY570237.1

Fwd: ACCCTGCTCATCTCCTCTGT
Rev: CCCCAGCTAAAGCAAAACCC
Probe:[6~FAM]TGCCTGGGATGTGCTGGGCTTGCAA[BHQ
1a~Q]

NM_212741.1

NM_001311794

NM_001311792

NM_001311793.1

Housekeeping gene arp (house-keeping gene) was used as a reference gene. * The nkla,
nklb, nklc, nkld and t-bet primers and probes were designed by Primer3 plus (GraphPad)
software.
4.2.5

Protein expression
Rag1-/- mutant zebrafish were injected with R848 (0.08µl/fish) and the liver,

kidney and spleen were sampled at 6 hpi. Tissues were homogenized in tissue protein
extraction buffer (T-PER) (ThermoScientific) and supernatant was collected. Protein
concentration was estimated in the supernatant by Bradford’s assay (Sigma-Aldrich).
30g of protein from liver, kidney and spleen cell lysate was resolved on 12% SDSpolyacrylamide gels and transferred to polyvinylidene difluoride (PVDF) membranes
(BioRad) for western blot analysis. PVDF membranes were incubated in blocking buffer
(3% milk in Tris-buffered saline with 0.1% Tween 20 (TBS-T)) overnight. Membranes
were washed in TBS-T and TBS twice for 5 minutes and once for 5 minutes respectively
and were incubated with primary antibody: IgG mouse anti zebrafish Nitr990.10.5 mono106

clonal antibody (1:500), a gift from J. Yoder (Shah, Rodriguez-Nunez et al. 2012). The
membrane was washed in TBST and TBS twice for 5 minutes and once for 5 minutes
respectively and incubated with secondary antibody: goat anti-mouse IgG/HRP
conjugated (1:4000) (ThermoScientific) for 1h at 4°C. The PVDF blot was stripped for 7
minutes at room temperature by RestoreTM PLUS Western Blot Stripping buffer
(ThermoScientific) followed by one wash in TBS for 5 minutes. Membrane was
incubated in blocking buffer overnight at 4°C followed by incubation with anti-GAPDH
rabbit polyclonal antibody (1:500) (AnaSpec, Fremont, CA) overnight at 4°C. Membrane
was washed in TBST and TBS twice for 5 minutes and once for 5 minutes respectively
and incubated with secondary antibody goat anti-rabbit IgG-HRP conjugated (1:2000)
(ThermoScientific) for 1h at 4°C. To visualize the bands, PVDF membrane was washed
in TBST and stained with Pierce ECL western blotting substrate (ThermoScientific) and
developed by using clear blue X-Ray Film (ThermoScientific). Band densities were
determined using Studio Lite Software (Li-Cor).
4.2.6

Flow cytometry
Rag1-/- mutant zebrafish were IP injected with Saline (control), R848 (0.08l) and

VTX (2.5 mM). Kidney and liver cells were sampled 12 hours post injections (hpi).
Tissues were macerated and strained through a 40micron filter in HBSS buffer w/o Ca2 +
and Mg2+ (Sigma, H4891-10x1L). Cells were washed and separated on a histopaque
1119 gradient (11191). The layer at the interface between the cell suspension and the
gradient was aspirated and washed, fixed with 4% paraformaldehyde and permeablized in
BD Perm/Wash buffer (BD, 51-2091KZ). Cells were incubated with IgG mouse AntiNITR990.10.1 monoclonal antibody for 1 hour at 4C. This was followed by incubation
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with goat anti-mouse IgG-PE (Biolegend, 405307) for 30 minutes at 4C. Cells were
washed after each step twice with 1ml FACS buffer at 500 x g. Labelled cells were
analysed on the FACS NovoCyte with NovoExpress software.
4.2.7

Data analysis and statistical evaluation
Relative gene expression was determined using the Pfaffl method (Pfaffl 2004).

Data obtained from qRT-PCR were expressed as fold change and were converted to log2
values. Two-way ANOVA followed by Dunnett’s multiple comparisons test was
performed to TLR ligand with PBS control. Tukey’s test was performed to compare R848
to VTX treatments. Flow cytometry data was analyzed by two way ANOVA multiple
comparison test. Statistics software used was GraphPad Prism version 7 for Mac,
GraphPad Software, La Jolla California USA, www.graphpad.com. An alpha level of
0.05 was used to determine the significance of all analyses.
4.3
4.3.1

Results
Gene expression of ifnγ
In liver tissues, 0.8l R848 caused significantly increased ifnγ at 6 hpi. There was

no difference in expression at any time points in 2.5l VTX treated fish. In kidney
tissues, ifnγ expression was up-regulated at 12 hpi after treatment with 0.8l R848. Ifnγ
significantly increased at 6 hpi and 12 hpi in spleen tissues (Table 4.2).
In liver, there was no increase of ifnγ at any time points after 0.08l of R848 or
0.25l of VTX exposure (Table 4.2). In kidney and spleen tissues, ifnγ expression
increased at 12 hpi following R848 injections. There was no difference in ifnγ expression
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at any time points after VTX exposure in kidney or spleen tissues at either concentration
(Table 4.2).
4.3.2

Gene expression of t-bet
There were no increases of t-bet at any time point in liver tissues after 0.8l R848

or 2.5l VTX. In kidney tissues, t-bet expression increased 24 hpi of 2.5l VTX. In
spleen tissues, t-bet increased 12 hpi of 2.5lR848 (Table 4.2).
After 0.08l R848 injection, t-bet increased at 24 hpi in the liver. VTX had no
effect on t-bet in the liver. 0.08l R848 caused increased kidney t-bet at 12 and 24 hpi.
0.25l VTX increased kidney t-bet at 6 and 12 hpi. Injection of 0.08l R848 increased
spleen t-bet at 12 hpi (Table 4.2).
4.3.3

Gene expression of nitr9
In liver, there was a significant increase of nitr9 expression on fish treated with

0.8l R848 at 6 hpi (p=0.0001) and 24 hpi (p=0.0453). There was no difference in the
level of expression for 2.5l VTX (Table 2). In kidney, the expression level of nitr9 upregulated at 6 hpi (p=0.0046) and 24 hpi (p=0.0001) following VTX injections and at 24
hpi (p=0.0001) following R848 treatment. In spleen, there was no difference in the level
of expression of nitr9 at any time points after R848 and VTX injections (Table 4.2).
In liver, there was a significant increase of nitr9 when treated with 0.08l R848 at
24 hpi (p=0.0453). There was no difference in the level of expression at any other time
points (Table 4.2). In kidney, the expression level of nitr9 up-regulated at 6 hpi
(p=0.0099) and 24 hpi (p=0.0064) following 0.25l VTX injections. In spleen, the
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expression level of nitr9 up-regulated at 12 hpi (p=0.0003) and 24 hpi (p=0.0001)
following R848 injections (Table 4.3).
4.3.4

Gene expression of nkla
In liver and kidney tissues, there were no difference in the levels of nkla at any

time points after 0.8l R848 and 2.5l VTX injections (Table 4.2). In spleen tissues, the
only increase in nkla was at 12 hpi, following 2.5 mM R848.
In liver tissues, there were no difference in the levels of nkla at any time points
after 0.08l R848 and 0.25l VTX injections (Table 4.2). In kidney tissues, the only
increase was at 24 hpi R848. In spleen, the expression level of nkla up-regulated at 12 hpi
and 24 hpi after 0.08l R848.
4.3.5

Gene expression of nklb
In liver, there was a significant increase of nklb when treated with 0.8l R848 at 6

hpi (p=0.0001). There was no difference in liver nklb at any other time points, or any
treatment of VTX (Table 4.2). In kidney, there was a significant nklb increase at 24 hpi
0.8l R848. In spleen, there was no difference in the level of expression of nklb between
PBS treated with R848 and VTX at 6 hpi, 12 hpi and 24 hpi (Table 4.2). In spleen tissues
there were no changes in nklb at any time point for any treatment.
In liver tissue there were no changes in nklb at any time point for any 0.08l R848
or 0.25l VTX treatments (Table 4.2). In kidney, there was a significant increase of nklb
at 24 hpi when treated with 0.25l VTX. There were no differences in spleen nklb
expression any other time points or 0.08l R848 treatments. In spleen, there were
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significant increases of nklb when treated with 0.08l R848 at 12 hpi (p=0.004) and 24
hpi (p=0.0107). There were no differences for the VTX treatments (Table 4.2).
4.3.6

Gene expression of nklc
In liver, there was a significant increase of nklc when treated with 0.8l R848 at

12 hpi. There was no difference in the level of expression of liver nklc for any other time
points or treatments (Table 4.2). In kidney, there was a significant increase of nklc at 6
hpi and 24 hpi when treated with 0.8l R848. There was no difference in the level of
expression of kidney nklc for any other time points or treatments. In spleen, there were
significant increases of nklc at 24 hpi following administration of 0.8l R848 and 2.5l
VTX. There were no differences in nklc expression at any other time points or treatments
in spleen tissues (Table 4.2).
In liver, there was a significant increase of nklc when treated with 0.08l R848 at
12 hpi. There were no other differences in nklc expression in liver tissues for 0.08l R848
or 0.25l VTX (Table 4.3). In kidney, there were significant increases of nklc at 6 hpi
and 12 hpi when treated with 0.25l VTX, and at 12 hpi when treated with 0.08l R848.
In spleen, there was a significant increase of nklc at 12 hpi when treated with 0.08l
R848. There were no other differences in splenic nklc for 0.08l R848 and 0.25l VTX
(Table 4.3).
4.3.7

Gene expression of nkld
In liver, there was a significant increase of nkld when treated with 2.5l VTX at

12 hpi. There were no other differences in liver tissue (Table 4.2). In kidney, there was a
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significant increase of nkld when treated with 2.5l VTX at 6 hpi. There were no other
differences in kidney tissues (Table 4.2). In spleen, there were significant increases of
nkld at 24 hpi following administration of 0.8l R848 and VTX. There were no
differences in nkld expression at any other time points or treatments in spleen tissues
(Table 4.2).
In liver, there were no differences in nkld expression after 0.08l R848 and 0.8l
R848 for any time points (Table 4.3). In kidney tissues, there were significant increases
of nkld at 6 hpi and 12 hpi when treated with 0.25l VTX, and at 12 hpi and 24 hpi when
treated with 0.08l R848. There were no other differences for kidney tissues (Table 4.3).
In spleen tissues, there were significant increases of nkld at 12 hpi and 24 hpi when
treated with 0.08l R848. There were no other differences in splenic nkld (Table 4.3).
Table 4.2

Liver
ifnγ
t-bet
nitr9
nkla
nklb
nklc

ANOVA of gene expression data comparing 0.8l R84 with 2.5l VTX
treatments in liver, kidney and spleen tissues at 6 hpi, 12 hpi and 24 hpi.
6 hpi
MeanSD (p values)
2.5l VTX
0.8l R848
234.9820 713.37681.
6.65
31
(0.5261)
(0.0001)
2.921.99
2.971.01
(0.9999)
(0.9999)

12 hpi
MeanSD (p values)
2.5l VTX
0.8l R848
97.0249.3 177.11173.7
4 (0.9990)
1
(0.8689)
5.253.85
2.241.25
(0.6645)
(0.2510)

24 hpi
MeanSD (p values)
2.5l VTX
0.8l R848
54.5815.80 110.9595.
(0.9995)
03
(0.9909)
4.731.88
7.8510.73
(0.9996)
(0.9995)

16.3511.1
2
(0.9997)
15.5810.9
2
(0.7336)
2.271.71
(0.9999)
16.9010.0
7
(0.9999)

280.971271
.8
(0.0001)
25.2414.47
(0.9904)

47.6237.4
1
(0.9991)
9.516.42
(0.9999)

40.8439.20
(0.9993)

11.087.20
(0.9958)

6.748.12
(0.9998)

85.0174.98
(0.9999)

44.9332.82
(0.0001)
21.1918.41
(0.9999)

1.551.40
(0.9997)
5.148.20
(0.9999)

5.223.95
(0.9916)
2415.03239
6
(0.0001)

1.630.19
(0.9991)
6.321.87
(0.9999)
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68.2143.2
6
(0.0453)
16.0526.2
4
(0.9993)
7.644.48
(0.9995)
62.1261.9
3
(0.9998)

Table 4.2 (continued)
nkld
Kidney
ifnγ

64.3832.8
5
(0.1353)
2.5l VTX

5.952.69
(0.9999)

1.440.92
(0.0002)

0.8l R848

2.5l VTX

500.8624
3.47
(0.9790)
2392.143
57.6
(0.7275)
1.040.40
(0.0046)
682.8612
6.80
(0.9999)
76.5045.8
3 (0.9994)

1515.2686.
09
(0.0598)
1821.51138
.8
(0.9815)
0.230.17
(0.9897)
19001712.4
7 (0.9996)

383.51187
.2
(0.9958)
1517.8791
.1
(0.9954)
0.330.28
(0.9131)
204.74120
.4
(0.9999)
9.5512.84
(0.9990)

88.2516.9
1
(0.9858)
3068568.
47
(0.0001)
2.5l VTX

276.28203.
20
(0.0101)
18.5119.78
(0.9999)

118.61109.4
8
(0.9999)
0.8l R848

43.8589.67
(0.6587)

7.804.88
(0.9999)

2.5l VTX

0.8l R848

1598.51344.
1
(0.0414)
3390.11622.
5
(0.1333)
0.3210.55
(0.9276)
1207.7211.4
9
(0.9997)
630.30432.8
5
(0.9997)
1.431.34
(0.9996)

555.9950
6.81
(0.9993)
1152.458
8.64
(0.9993)
0.110.07
(0.0001)
263.9822
0.98
(0.9999)
188.3591.
04
(0.0295)
169.2511
8.20((0.001
7)
764.0155
8.6
(0.9995)
0.8l R848
19.8517.6
5
(0.9973)
3.643.09
(0.9995)
0.230.16
(0.9997)

36.1332.63
(0.9997)

0.8l R848

218.42109
.4
(0.9998)
2.5l VTX

0.8l R848

1105.3157.
01
(0.6941)
5027.6262
7.3
(0.0270)
0.050.03
(0.0001)
209.73119.
59
(0.9999)
978.63486.
72
(0.7209)
350.65192.
18
(0.6362)
1091.9349
4.8
(0.9668)
2.5l VTX

51.4023.9
0
(0.1728)
0.750.42
(0.9999)
0.120.22
(0.9998)

72.9856.07
(0.0261)

7.453.42
(0.9963)

106.4990.69
(0.0006)

99.4762.76
(0.0678)

2.001.39
(0.9999)
0.551.05
(0.9306)

29.4039.29
(0.0001)
0.070.10
(0.9998)

17.0010.48
(0.5286)
0.520.55
(0.9994)

nkla

5.866.64
0.9994

18.206.45
(0.8475)

0.690.56
(0.9999)
0.0040.00
2
(0.9999)
3.555.78
(0.9997)

49.4638.38
(0.0103)

10.423.25
(0.9996)

nklb

4.308.27
(0.9991)

19.3616.74
(0.1124)

1.591.54
(0.9997)

12.2017.24
(0.6057)

25.1128.77
(0.9993)

nklc

50.9769.4
8
(0.9998)
8.106.67
(0.9959)

156.80126.
7
(0.9993)
5.853.96
(0.9994)

15.76
15.99
(0.9999)
1.261.55
(0.9999)

262.17198.0
7
(0.9882)
40.8226.42
(0.0706)

928.32309.
32
(0.0001)
55.8223.50
(0.0395)

t-bet
nitr9
nkla
nklb
nklc
nkld
Spleen
ifnγ
t-bet
nitr9

nkld

508.26420.
65 (0.0518)

20.468.09
(0.9999)
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32.2026.0
5
(0.3604)
28.8316.1
9
(0.1724)
2067.861
695
(0.0001)
62.3833.1
6
(0.0006)

4.3.8

Comparative effect of TLR ligands
The effect of immune stimulation was compared between 0.08l R848 and 0.25l

VTX; and 0.8l R848 and 2.5l VTX using Tukey’s multiple comparison test (Table
4.3). 0.08l R848 concentration up-regulated at 6 hpi: t-bet in liver and kidney; at 12 hpi:
ifnγ, t-bet, nklc and nkld in kidney; ifnγ, nitr9, nkla, nklb and nklc in spleen; at 24 hpi:
nkla, nklb, nkld in kidney; nitr9, nklb in spleen. 0.25l VTX up-regulated at 6 hpi: nklc
and nkld in kidney. 0.8l R848 up-regulated at 6 hpi: ifnγ, nitr9, nklb in liver; nitr9 in
kidney; at 12 hpi: nklc, nkld in liver; nklb in kidney; ifnγ, t-bet, nkla and nkld in spleen; at
24 hpi: nklc in spleen. 2.5l VTX up-regulated at 6 hpi: nkld in kidney and at 24 hpi: nklb
in kidney.
Table 4.3

Summary of significant differences between treatments R848 vs VTX.

Tissue
Liver

Kidney

Spleen

0.08l
t-bet (24 hpi)

ifnγ (12 hpi),
t-bet (6 hpi),
t-bet (12 hpi),
nkla (24 hpi),
nklb (24 hpi),
nklc (12 hpi),
nkld (12 hpi),
nkld (24 hpi)
ifnγ (12 hpi),
nitr9 (12 hpi),
nitr9 (24 hpi),
nkla (12 hpi),
nklb (12 hpi),
nklb (24 hpi),
nklc (12 hpi),
nkld (12 hpi),
nkld (24 hpi)

R848
0.8l
ifnγ (6 hpi),
nitr9 (6 hpi),
nklb (6 hpi),
nklc (12 hpi)
nkld (12 hpi)
nitr9 (6 hpi),
nklb (12 hpi)

ifnγ (12 hpi),
t-bet (12 hpi),
nkla (12 hpi),
nklc (24 hpi),
nkld (12 hpi)
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VTX
0.25l

2.5l

nklc (6 hpi),
nkld (6 hpi)

nklb (24 hpi),
nkld (6 hpi)

4.3.9

Protein expression by Western blots
The NITR9 expression levels increased in R848 and VTX treated tissue protein

samples from liver and spleen when compared to saline treated samples at 6 hpi (Fig 4.1).
In the case of liver, there was no difference in the expression of NITR9 between R848
and VTX. NITR9 was down-regulated in kidney with R848 and VTX compared to PBS
treatment. Splenic NITR9 increase following R848 treatment when compared with PBS
treatment. In the case of VTX treatment in spleen, NITR9 protein up-regulated when
compared to PBS, but not as much as R848 treatment (Fig 4.1).

Figure 4.1
4.3.10

NITR9 protein expression in liver, kidney and spleen of rag1-/- mutant
zebrafish treated with PBS (control), 0.08l R848 and 2.5l VTX.

Flow cytometry
NITR9 expression was evaluated in rag1-/- mutant zebrafish gated lymphocyte

like cells (LLCs) following 0.8l R848, 2.5l VTX and saline (control) treatments at 12
hpi. In liver, the NITR9+ cells decreased as a percentage of total cells following VTX
(p=0.0311) treatment. However, there was no significant difference between control and
R848 (p=0.3908) or R848 vs VTX (p=0.1824) treatment (Fig 4.2). There was no
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statistical difference in kidney NITR9+ cells between the R848 (p=0.3790) and VTX
(p=0.9705) compared to control treatments as well as R848 compared to VTX
(p=0.4898) treatment (Fig 4.3).

Figure 4.2

NITR9 expression in rag1-/- mutant zebrafish liver lymphocyte like cells
(LLCs).

(A) Graphical representation of NITR9 labeled liver LLCs from fish IP injected
with Saline (control), R848 and VTX. (B) Intracellular NITR9 expression of
lymphocyte cell population from R848 injected fish, analyzed by flow cytometry
at 12 hpi. (C) Intracellular NITR9 expression of lymphocyte cell population from
VTX injected fish, analyzed by flow cytometry at 12 hpi. NITR9 expression was
compared between treatments and control by one-way ANOVA. *Significant
(p<0.05) difference in expression of treated compared to control. The green peak
represents anti-mouse IgG: PE conjugated secondary antibody (control) (NITR9 cells); the blue peak represents anti-NITR9 monoclonal antibody + anti-mouse
IgG: PE conjugated secondary antibody (NITR9+ cells following saline
treatment), and the red peak represents anti-NITR9 monoclonal antibody + antimouse IgG: PE conjugated secondary antibody (NITR9+ cells following R848 (B)
or VTX (C) treatments).
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Figure 4.3

NITR9 expression in rag1-/- mutant zebrafish kidney lymphocyte like cells
(LLCs).

(A) Graphical representation of NITR9 labeled kidney LLCs from fish IP injected with
Saline (control), R848 and VTX. (B) Intracellular NITR9 expression of lymphocyte cell
population from R848 injected fish, analyzed by flow cytometry at 12 hpi. (C) Intracellular
NITR9 expression of lymphocyte cell population from VTX injected fish, analyzed by flow
cytometry 12 hpi. NITR9 expression was compared between treatments and control by
one-way ANOVA. *Significant (p<0.05) difference in expression of treated compared to
control. The green peak represents anti-mouse IgG: PE conjugated secondary antibody
(control) (NITR9- cells); the blue peak represents anti-NITR9 monoconal antibody + antimouse IgG: PE conjugated secondary antibody (NITR9 + cells following saline treatment),
and the red peak represents anti-NITR9 monoclonal antibody + anti-mouse IgG: PE
conjugated secondary antibody (NITR9+ cells following R848 (B) or VTX (C) treatments).
4.4

Discussion
Nk-lysins are important agents in the fish immune response against pathogens.

The response can vary by pathogen, but generally Nk-lysins increase significantly as an
initial immune response (Pridgeon, Mu et al. 2012) (Zhou, Wang et al. 2016) (Pereiro,
Varela et al. 2015) (Murji 2015) (Hirono, Kondo et al. 2007) (Liang, Ji et al. 2013,
Zhang, Li et al. 2014). In chickens, Nk-lysin transcript levels coincide with parasite
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oocyst production, suggesting that transcription levels increase when more pathogens are
present (Hong, Lillehoj et al. 2006).
In our study, the overall greatest response was from R848, a TLR7 and TLR8
ligand. Generally, there was less response to VTX, a TLR8 ligand. Our findings suggest
that TLR7 may be more specific to NK cell activation than TLR8 in zebrafish, or TLR7
and 8 are both required for NK activation. Following R848 administration, predominate
responses were from nklc in the liver and spleen, and nkld in the kidney. Specifically, in
the liver, the greatest increase was 2415 fold in nklc at 12 hpi of 0.8l R848. In the
spleen, the greatest increase was 2067 fold in nklc at 24 hpi of 0.8l R848, and 1553 fold
increase in nklc at 12 hpi of 0.08l R848. In the kidney, the greatest fold increase was
4368 fold in nkld at 12 hpi 0.08l R848 and 3517 fold increase of nkld at 24 hpi 0.08l
R848. In the kidney, nklc increases were much lower and ranged from 169 to 525 fold
following R848 administration. With VTX administration and TLR8 stimulation, the only
significant fold increase in the liver was 1.44 fold in nkld. In the spleen, VTX caused a
928 fold increase of nklc at 24 hpi and a 55.8 fold increase of nkld at 24 hpi. In the
kidney, 2.5l VTX caused a 3068 fold increase in in nkld at 6 hpi, and 2583 and 2130
fold increases in nkld at 6 and 12 hpi (0.25 mM VTX), respectively.
Spring Viremia of Carp virus caused predominant nkla and nkld responses in
zebrafish kidney tissues, but the highest expressions were from nklc and nkld in the
spleen (Pereiro, Varela et al. 2015). Expression profiles of Lc-Nk-lysin also varied
significantly in gill, head kidney, spleen and liver tissues of Larimichthys crocea (Zhou,
Wang et al. 2016). Lc-Nk-lysin was differentially expressed in tissues from Cynoglossus
semilaevis (Zhang, Long et al. 2013). The catfish Nk-lysin gene exhibited strong tissue118

specific expression in tissues with lymphocyte populations. In another study, expression
profiles of Channel catfish NK lysins showed that these AMPs are highly, but
differentially expressed in gill, spleen, anterior and posterior kidney (Kocabas, Li et al.
2002). A different catfish study showed high levels of NK-lysin expression was detected
in gill, head kidney, intestine, and spleen, and no expression was detected in muscle
(Wang, Wang et al. 2006). Nkla was mainly expressed in muscle, whereas nklb and nklc
showed highest expression in intestine and spleen, respectively. High differential
expressions of Nk-lysins was limited to lymphoid tissues that house immune cell
populations. This was also observed with porcine Nk-lysin that was predominately found
in spleen, bone marrow, colon, and small intestine (Andersson, Gunne et al. 1995),
(Bonetto, Andersson et al. 1999).
In a study that compared total Nk-lysin amounts between wild-type (WT) and
rag1-/- mutant zebrafish, there was a higher absolute expression of the Nk-lysins in the
rag1-/- when compared to the WT zebrafish. This is understandable, because in the
absence of the T and B cells, the NK cells tend to fill in the void and would lead to higher
expression of NK cell specific Nk-lysins (Pereiro, Varela et al. 2015). This same study
also showed tissue specific differential expression of Nk-lysin in WT and rag1-/- mutant
zebrafish.
It has been suggested that nkla could be primarily produced by CTLs and the NK
cells mainly express nklb, nklc and nkld (Pereiro, Varela et al. 2015). In another study,
zebrafish nkl4+(nkld+) cell types were reported and were suggested to represent putative
CTLs. This same population declined in the T cells in a rag2 mutant zebrafish, and nkld+
expressing cells and myeloid cells substantially increased (Moore, Garcia et al. 2016).
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Nklc and nkld have been shown to have a closer synteny between other Nk-lysins
and mammalian Nk-lysins/granulysin, indicating a higher evolutionary conservation of
nklc and nkld (Pereiro, Varela et al. 2015). The precursor cell population in whole kidney
marrow was the highest producer of the 4 NK lysins in general and mainly showed
expression of nkla and nkld mRNA, followed by next highest in lymphoid and least in
myeloid populations showed highest expression of nklb and nkld mRNA (Pereiro, Varela
et al. 2015).
Data detailing the transcriptional responses of zebrafish Nk-lysins to viral and
bacterial infections are now available. Therefore, it will be important to conduct further
studies testing the natural functions of NK-lysins in immune responses and their potential
therapeutic value. In order to provide a more comprehensive survey of which TLR ligand
leads to changes in transcript levels of zebrafish NK-lysins, similar studies could evaluate
the transcriptional responses of NK-lysins to additional bacteria, viruses, parasites and
fungi. These observations could lead to findings of new NK cell markers and also study
NK cell biology in zebrafish to use it as a potential host model for infectious diseases.
Our flow cytometry and protein expression analyses were inconclusive. It is
important to note that unlike the qPCR where we estimated the gene expression in tissues
from individual fish, for western blot and flow cytometry we pooled tissues from fish in
order to get an optimal amount of protein or cells for our analysis. For this reason, it is
not easy to correlate gene expression with protein expression in tissue. Individual fish
mount responses in varying levels that make interpretation challenging.
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CHAPTER V
THE EFFECT OF IMMUNOMODULATION BY TLR LIGANDS UPON
EDWARDSIELLA ICTALURI EXPOSURE IN IMMUNOCOMPROMISED RAG1-/MUTANT ZEBRAFISH (Danio rerio)
Abstract
Rag1-/- mutant zebrafish were intra coelomically injected with RE-33®, (a live
attenuated Edwardsiella ictaluri vaccine), or one of the TLR ligands β glucan, Poly I:C
or R848. The TLR ligands were also co-administered with RE-33®. Fish were challenged
with WT E. ictaluri 4 weeks later and survival evaluated. RE-33® alone significantly
increased survival. β glucan alone significantly increased survival more than above that
of RE-33®. Survival after co-administration of β glucan and RE-33® was significantly
higher than observed after treatment with RE-33®. Survival from administration of R848
alone was not significantly higher than with RE33® alone. Co-administration of R848
and RE-33® resulted in survival significantly higher than RE-33® or R848 alone.
Treatment with R848 potentiated the protective effect of RE-33®. Poly I:C did not
significantly increase survival more than RE-33®, but co-administration of Poly I:C and
RE-33® resulted in survival significantly higher than observed with RE-33® or Poly I:C
alone. Poly I:C potentiated RE-33®. Treatment with Poly I:C potentiated the protective
effect of RE33®. Tissue specific gene expression of ifnγ, t-bet, nitr9, nkla, nklb, nklc and
nkld were determined and correlated to survival. After the primary exposure in the liver,
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all of these genes were up regulated over 100 fold in fish with enhanced protection 4
weeks later. After the WT E. ictaluri exposure, all of the genes evaluated were up
regulated including ifnγ in the fish group was associated with the highest survival rates.
After primary exposure in kidney tissue, the greatest differentially expressed genes were
ifnγ, t-bet, nkla, nklc, and nkld. After the WT E. ictaluri exposure, up-regulated gene
expressions of kidney ifnγ, nklb, and nkld was associated with the highest survival.
5.1

Introduction
Rag1-/- mutant zebrafish lack T cells and B cells but still exhibit specific

protection and a memory-like response (Hohn and Petrie-Hanson 2012). The cellular
basis for this protection has not been determined, but NK cells have been identified and
characterized in this fish model (Muire, Hanson et al. 2017), and NK cells have been
implicated in specific immunity in mammalian models (reference).. Immune stimulants
are agents that stimulate an immune response. Such a response could be beneficial during
the outbreak of a disease. Toll like receptors (TLRs) are pattern recognition receptors and
are activated by specific pathogen associated molecular patterns (PAMPs). PAMPs
facilitate the role of NK cells as effector cells and are also involved in NK cell mediated
adaptive immune responses (Guo and Zhang 2012). TLRs activate NK cells to trigger an
induction of interferons (IFNs), tumor necrosis factor (TNF) and several interleukins, at
variable levels of expression, via different signaling pathways (Hart, Athie-Morales et al.
2005, Gorski, Waller et al. 2006).
The use of immune stimulants in aquaculture has increased over the past decades,
to protect fish from several pathogenic infections. Petit et al. 2016 have reviewed the
long-lived effects of one such immune stimulant, β glucan in different species of fish,
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including zebrafish. T and B cell deficient zebrafish exhibit mount specific protection
when re-exposed to bacteria (Hohn and Petrie-Hanson 2012). The cellular basis for this
protection has not been determined in fish. In this study, TLR ligands were coadministered with vaccination, and their ability to enhance survival evaluated. After
enhanced survival was demonstrated, the TLR ligands were administered alone to
determine their effect on innate immune cells in rag1-/- zebrafish. Tissue specific
macrophage and NK cell gene expression were evaluated to determine the potential
contribution of these cells in initiating protective immunity in rag1-/- mutant zebrafish.
Leukocytes are generally categorized as being involved in either innate or
adaptive immunity. Innate immune responses were believed to not be modified by
repeated exposure to the same pathogen. Over the past decade that definition has
dramatically changed. Natural Killer (NK) cells are innate immune cells but are now
known to mediate adaptive immune responses to chemical haptens and cytomegalovirus
in lymphocyte deficient mice (Sun and Lanier 2011). T and B cell deficient zebrafish
(rag1-/- mutants) can mediate specific protection from bacteria, and NK cells are believed
to mediate that response (Hohn and Petrie-Hanson 2012). The use of rag1-/- mutant
zebrafish in immunological analyses has provided new insights into our understanding of
teleost immunity. However, a limited availability of monoclonal antibodies for zebrafish
immune cells has made it very challenging. We believe that a population of zebrafish NK
cells mediates a protective memory response, and that these cells have a mechanism for
enhanced discrimination of specific bacterial targets following primary exposure. This
study was performed to determine if specific TLR ligands could enhance protective
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memory and which NK cell specific genes were differentially regulated during this
protective response.
5.2
5.2.1

Material and methods
Zebrafish care
Zebrafish were raised and maintained at 28°C in the specific pathogen free

hatchery in the College of Veterinary Medicine, Mississippi State University (MSU)
following standard lab protocols. Experimental protocols were approved by the MSU
Institutional Animal Care and Use Committee (IACUC). A homozygous breeding colony
of rag1-/- mutant zebrafish was previously established (Petrie-Hanson, Hohn et al. 2009)
and bred at the CVM-SPF hatchery and the experimental fish are progeny from that
colony.
5.2.2

Survival trials
Rag1-/- adult zebrafish (n=10) were intra-coelomically (IC) injected with either a

TLR ligand alone or a combination of 1x104 CFU live attenuated vaccine strain of
Edwardsiella ictaluri (RE-33®) (Klesius and Shoemaker 2000) and each ligand (β glucan
50µg/0.5g of fish; Poly I:C 50µg/0.5g of fish and R848 0.08µl/0.5g of fish or endotoxin
free PBS 10µl/fish). The following treatments were administered: RE-33® only; β glucan
only; Poly I:C only; R848 only; β glucan + RE-33®; Poly I:C + RE-33®; R848 + RE33®; and control (PBS injected). Two tanks were used per treatment, and the experiment
was repeated three times. After 4 weeks, the vaccinated rag1-/- zebrafish were challenged
by 1×104 CFU/fish IC injections of a virulent E. ictaluri strain (#93146). When
challenged, naïve fish (n=20) were injected with virulent WT E. ictaluri. Fish were
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observed and deaths recorded for 20 days. All moribund fish demonstrated signs of
Enteric Septicemia of Catfish (ESC) infection in zebrafish (Petrie-Hanson, Romano et al.
2007) and E. ictaluri was recovered from randomly sampled fish.
5.2.3

Quantifying gene expression
Treatments were administered as described above except for the omission of Poly

I:C due to the limitation in number of samples that could be processed within the
sampling time frame. Fish were euthanized in buffered 0.02% MS222 and liver, kidney
and spleen tissues from fish were surgically removed at 0h (non-injected fish, n=5) for
basal expression), 1, 6, 12 and 24 hours post injection (hpi) (n=3) for each TLR ligand.
Whole tissues were immediately transferred to 400µl Trizol reagent (Zymo Research,
USA) and homogenized following standard procedures in our lab (Elibol-Fleming 2006).
Total RNA was extracted from each liver, kidney and spleen sample using RNA
extraction kits (Zymo Research, USA) according to the manufacturer’s protocol. The
quantity of extracted total RNA was determined by NanoDrop ND-1000 and ND-8000 8Sample Spectrophotometer and stored at -80°C until used. 100ng cDNA was prepared
from RNA by using Super script III VILOTM cDNA Synthesis Kit (Invitrogen).
Arp, Ifnγ, t-bet, nitr9, nkla, nklb, nklc and nkld cDNA were measured using real
time quantitative PCR. The t-bet primer and probe (Table 1) were designed by Beacon
Design software (BioRad) and Primer3 plus (GraphPad) software, respectively. The
source of the other primers and probes are included in Table 1. All primers and probes
were purchased from Eurofins MWG, Operon, Huntsville, Alabama, USA. Amplification
of the ubiquitously expressed acidic ribosomal phosphoprotein (arp) gene was used for
the internal control (Ju, Xu et al. 1999). The amplification was performed in a 25µl
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volume containing 10 µl target cDNA and 15 µl master mix containing: 8.8 µl Nuclease
free water (GIBCO, Ultra PureTM), 1.5 µl MgCl2 (5mM), 2.5 µl 10x buffer, 0.5 µl dNTPs,
0.2µl Taq Polymerase HS enzyme (Hot Start PCR Kit, TAKARA, Japan), 0.5 µl forward
primer (20µM), 0.5 µl reverse primer (20µM) and 0.5 µl probe (10µM). Thermal cycler
parameters for the PCR program were set as follows: 50°C for 2 minutes, 95°C for 10
minutes, 45 cycles of 95°C for 15 seconds and 61°C for 1 minute. All samples (biological
reps) were run in triplicates i.e., 3 technical reps/sample.
Table 5.1

Oligonucleotide primers and probes used for qRT-PCR to quantify gene
expression levels of ifnγ, t-bet, nitr9, nkla, nklb, nklc and nkld.

Gene

Oligonucleotide sequences (5’–3’)

Arp

Fwd: CTGCAAAGATGCCCAGGGA
Rev: TTGGAGCCGACATTGTCTGC
Probe:[6~FAM]TTCTGAAAATCATCCAACTGCTGGATGACTACC
[BHQ1a~ Q] (Vojtech, Sanders et al. 2009)
Fwd: CTTTCCAGGCAAGAGTGCAGA
Rev: TCAGCTCAAACAAAGCCTTTCG
Probe:[6~FAM]AACGCTATGGGCGATCAAGGAAAACGAC[BHQ1
a~ Q] (Vojtech, Sanders et al. 2009)
Fwd:GATCAAGCTCTCTCTGTGATAG
Rev:GCTAAAGTCACACAGGTCT
Probe:[6~FAM]TTCTGAAGGTCACGGTCACA[BHQ1a~Q] *
Fwd: GTCAAAGGGACAAGGCTGATAGTT
Rev:GTTCAAAACAGTGCATGTAAGACTCA
Probe: [6~FAM]CAAGGTTTGGAAAAGCAC[BHQ1a~Q] (Shah,
Rodriguez-Nunez et al. 2012)
Fwd: TTTCTGGTCGGCTTGCTCAT
Rev: TTCTCATTCACAGCCCGGTC
Probe:[6~FAM]TCTGCAGCTCACTGGGAGGTTCGTGA[BHQ1a~Q]
Fwd: TCCGCAACATCTTTCTGGTCA
Rev: AGCCTGCTCATGAATGAAAATGA
Probe:[6~FAM]CACGCCTGCAAATCTGAACCACCCA[BHQ1a~Q]
Fwd: CTGCTTGTGCTGCTCACTTG
Rev: AGCACACATGGAGATGAGAACA
Probe: [6~FAM]GGGCTTGCAAGTGGGCCATGGGAA[BHQ1a~Q]

Ifnγ

t-bet
nitr9

nkla
nklb
nklc

nkld

Fwd: ACCCTGCTCATCTCCTCTGT
Rev: CCCCAGCTAAAGCAAAACCC
Probe:[6~FAM]TGCCTGGGATGTGCTGGGCTTGCAA[BHQ1a~Q]

GenBank
Accession No.
NM_131580

NM_212864

NM_001170599.
1
AY570237.1

NM_001311794
NM_001311792
NM_001311793.
1
NM_212741.1

Housekeeping gene arp (house-keeping gene) was used as a reference gene. *The nkla,
nklb, nklc, nkld and t-bet primers and probes were designed by Primer3 plus (GraphPad)
software.
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5.2.4

Data analysis and statistical evaluation
Survival curves analysis were performed by the Kaplan-Meier survival plot using

GraphPad Prism version 6.00 for Windows, GraphPad Software, La Jolla California
USA, www.graphpad.com. The non-parametric statistic tests Gehan-Breslow-Wilcoxon
test and Log ranked (Mantel-Cox) test were used to estimate the statistical significance
between the survival curves of RE-33® only, TLR ligand groups only and RE-33® plus
TLR ligand groups. The Gehan-Breslow-Wilcoxon method gives more weight to
mortalities at early time points. The Log-rank (Mantel-Cox) test gives equal weight to all
time points and is more preferred. Relative gene expression was determined using the
Pfaffl method (Pfaffl 2004). Data obtained from qRT-PCR were expressed as fold change
and were converted to log2 values. Data were analyzed by two-way analysis of variance
using PROC MIXED (SAS for Windows 9.4, SAS Institute, Inc., Cary, NC). Separate
models were used for each gene and tissue combination. The explanatory variables for all
models were treatment, time post injection, and the treatment x time interaction. The
effect of treatment was reported only if the treatment and treatment x time interaction was
significant. An alpha level of 0.05 was used to determine the significance of all analyses.
5.3
5.3.1

Results
Survival Trials
RE-33® vaccinated rag1-/- zebrafish demonstrated significantly higher survival

than non-vaccinated fish when injected with a field isolate of WT E. ictaluri 4 weeks
after vaccination (Fig. 5.1 and Table 5.2). β glucan was the only TLR ligand that when
administered by itself, provided significantly higher survival than RE-33® (Fig. 5.2).
When β glucan was co-administered with RE-33®, survival was significantly higher than
132

RE-33® alone. Survival after the administration of β glucan+RE-33® was not
significantly greater than survival after the administration of β glucan alone (Fig. 5.2 and
Table 5.2).

Figure 5.1

Comparison of survival of non-vaccinated rag1-/- mutant zebrafish and
RE33® vaccinated fish after E.ictaluri challenge group.

There was significantly higher survival in the rag1-/- mutant zebrafish that was vaccinated
compared to the group that was not. All control fish died by day 7. Treatment groups:
WT E. ictaluri (dotted line) and RE-33® (dashed line)

Figure 5.2

Comparison of survival of rag1-/- mutant zebrafish groups that were pre
exposed to RE-33®, β glucan + RE-33® or β glucan and then challenged
with WT E. ictaluri 4 weeks later.

The rag1-/- mutant zebrafish that received β glucan alone had significantly higher survival
than the group that received RE-33® alone. β glucan + RE-33® demonstrated
significantly higher survival than the group that received RE-33® alone. Survival in
treatments that received β glucan and β glucan + RE-33® were not significantly different.
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Treatment groups: RE-33® (dashed line), β glucan + RE-33® (solid line) and β glucan
(dotted line).
Survival resulting from the administration of Poly I:C alone was not significantly
greater than survival in fish that received RE-33® alone (Fig. 5.3 and Table 5.2). The coadministration of Poly I:C+RE-33® resulted in survival that was significantly higher than
RE-33® for the first ten days of the study, but not for the last ten days. Survival after the
administration of Poly I:C+RE-33® was not significantly greater than survival after the
administration of Poly I:C alone.

Figure 5.3

Comparison of survival of rag1-/- mutant zebrafish groups that were pre
exposed to RE-33®, Poly I:C + RE-33® or Poly I:C and then challenged
with WT E. ictaluri 4 weeks later.

The group that received the Poly I:C alone demonstrated no significant difference for
survival from the vaccinated (RE-33®) group There was no difference in survival
between the group that received Poly I:C + RE-33® and the group that was vaccinated
(RE-33®) alone. Treatment groups: RE-33® (dashed line), Poly I:C + RE-33® (solid
line) and Poly I:C (dotted line).
Survival resulting from the administration of R848 alone was not significantly
higher than survival from survival in fish that RE-33® alone (Fig. 5.4 and Table 5.2).
R848+RE-33® treated rag1-/- zebrafish demonstrated significantly higher survival than
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RE-33® only treated fish after challenge. R848 alone provided the same protection as
R848+RE-33® treated fish.
When the co-administered treatments were compared to each other, there were no
significant difference between the survival for β glucan+RE-33® and R848+RE-33®
treated fish. Both treatments demonstrated higher survival than fish that received Poly
I:C+RE-33®.

Figure 5.4

Comparison of survival of rag1-/- mutant zebrafish groups that were pre
exposed to RE-33®, R848 + RE-33® and R848 and then challenged with
WT E. ictaluri 4 weeks later.

The group that received R848 alone demonstrated no significant difference in survival
from the RE-33® alone group. The group that received the R848 + RE-33®
demonstrated significantly higher survival than the group that received RE-33® alone.
Treatment groups: RE-33® (dashed line), R848 + RE-33® (solid line) and R848 (dotted
line).
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Table 5.2

Comparison of survival of fish administered TLR ligands or RE-33® alone,
or combinations of TLR ligands and/or RE-33®. Rag1-/- mutant zebrafish
were challenged with wild type E. ictaluri 4 weeks following TLR ligands
and/or RE-33® administration.
Treatment
RE-33® v control
β glucan v RE-33®
β glucan+RE-33® v RE-33®
β glucan+RE-33® v β glucan
Poly I:C v RE-33®
Poly I:C+RE-33® v RE-33®
Poly I:C+RE-33® v Poly I:C
R848 v RE-33®
R848+RE-33® v RE-33®
R848+RE-33® v R848

5.3.2

Breslow-Wilcoxon
p<0.0001
p=0.0246
p=0.0096
p=0.7392
p=0.3536
p=0.0329
p=0.0843
p=0.1740
p=0.0189
p=0.4519

Mantel-Cox
p<0.0001
p=0.0135
p=0.0116
p=0.6265
p=0.2511
p=0.0544
p=0.1575
p=0.1879
P=0.0285
p=0.4728

Quantitative Gene Expression

WT E. ictaluri exposure (bacterial challenge)
In rag1-/- mutant zebrafish, the effects of WT E. ictaluri exposure were
significantly up-regulated liver nitr9 at 6 hpi, liver ifnγ at 12 hpi, liver ifnγ and liver nkla
at 48 hpi, and kidney nitr9 and nklb at 6 hpi, kidney nitr9 and nklb at 12 hpi, kidney ifnγ
at 24 hpi and nitr9, nkla and kidney nklc at 48 hpi (Table 5.3 Summary and Table A3).
Liver nkla was significantly down-regulated at 48 hpi.
RE-33® exposure
RE-33® caused significantly up-regulated liver ifnγ and nklb at 48 hpi and
significantly up-regulated kidney nklc at 12 hpi and ifnγ at 48 hpi. Following the WT E.
ictaluri exposure 4 weeks after RE-33®, there was significantly increased liver nitr9 at 6
hpi, nkla at 12 hpi and ifnγ and nkla at 48 hpi. Whereas in kidney tissue, there was
significantly increased levels of t-bet at 6 hpi, nkld at 12 hpi and nkla at 48 hpi (Table 5.3
Summary and Table A3).
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β glucan treatment
The primary exposure of β glucan caused significantly increased liver t-bet
expression at 6 hpi and decreased nkld at 48 hpi. In kidney tissue, the primary β glucan
exposure caused significantly increased t-bet at 6 hpi. Following challenge with WT E.
ictaluri, there was significantly increased ifnγ, nkla, nklb, nklc, and nkld at 6hpi in the
liver and significantly increased nklb at 6 hpi, ifnγ and nkld at 12 hpi, ifnγ at 24 hpi and
nkla at 48 hpi in kidney tissue (Table 5.3 Summary and Table A3).
β glucan + RE-33® treatment
The effect of the primary exposure of β glucan + RE-33® in liver caused an
increase in t-bet at 6 hpi, nkla at 12 hpi, nitr9 at 24 hpi and 48 hpi. Nkld was downregulated at 48 hpi. Following challenge with bacteria, expression was significantly upregulated in nkld at 12 hpi, ifnγ, nitr9, t-bet, nkla, nklb, nklc and nkld at 24 hpi and nkla
was significantly down-regulated at 48 hpi. The effect of primary exposure to β glucan +
RE-3c® in kidney caused an increase in t-bet at 6 hpi, and nkla and nklc at 12 hpi.
Following challenge with bacteria, there was an up-regulation in nkld at 12 hpi, nklb and
nkld at 24 hpi and ifnγ at 48 hpi (Table 5.3 Summary and Table A3).
R848 treatment
The effect of primary R848 exposure in liver caused an increase of ifnγ at 24 hpi,
and nkla, nklb, nklc, nkld at 48 hpi. T-bet was down-regulated at 48 hpi. Following
challenge with bacteria, there was an increase in nitr9 at 12 hpi. T-bet and nkla
expressions were down-regulated at 48 hpi. R848 exposure in the kidney caused
increases in ifnγ, nkla, nklc and nkld at 24 hpi, and nklc and nkld at 48 hpi. T-bet was
down-regulated at 6 hpi. Following challenge with bacteria, there was an increase in nkla
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at 48 hpi. T-bet and nkld were down-regulated at 6 hpi and ifnγ was down-regulated at 12
hpi (Table 5.3 Summary and Table A3).
R848 + RE-33® treatment
The effect of R848 + RE-33® in liver caused an increase in nitr9 at 24 hpi and
nkla, nklb, nklc, and nkld at 48 hpi. Following challenge with bacteria, there was in
increase in nitr9 at 24 hpi and ifnγ at 48 hpi. The primary exposure in kidney caused an
upregulation of ifnγ, nkla, nklc, and nkld at 48 hpi. Following bacterial exposure in the
kidney, there was an up-regulation of nkld at 24 hpi and nkla at 48 hpi (Table 5.3
Summary and Table A3).
5.4

Discussion
T and B cell deficient rag1-/- zebrafish develop protective immunity against E.

ictaluri (Hohn and Petrie-Hanson 2012). In this study we demonstrated that exposure to
TLR ligands provide long term protection similar to vaccination. We also used coadministration of TLR ligands and live attenuated bacteria to define the role of NK cells
in protective responses of these fish and found enhanced protection in some cases. Our
study demonstrates that β glucan provides protection when administered alone and
increases protection when co-administered with an attenuated live vaccine in mutant
zebrafish. Most studies that evaluated the effect of β glucan on immune responses in fish
have not evaluated co-administration of β glucan with a vaccine using a parenteral route,
and no other studies have investigated these administrations in T and B cell deficient fish.
In a study on furunculosis using immune competent Atlantic salmon, β glucan coadministered with a vaccine improved vaccine efficacy against Aeromonas salmonicida
(Rørstad, Aasjord et al. 1993). Dalmo and Jarl Bogwald suggested that efficacy of using
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β glucan with vaccines could vary by the host species and the pathogen (Dalmo and
Bøgwald 2008).
Similar findings were reported in a study involving Candida albicans and β
glucan in murine monocytes, in which functional re-programming of monocytes via
dectin-1 was associated with protection (Quintin, Saeed et al. 2012). Inspite of the several
studies that have documented the enhanced effects of β glucan on fish immunity
(reviewed in Vaclav Vetvicka 2013) (Petit and Wiegertjes 2016), there is limited
knowledge of the mechanisms in which β glucan and other TLR ligands modulate fish
immunity. The effect of β glucan on the modulation of gene expression leading to
stimulation of fish immunity is not clear. Earlier studies using β glucan showed that β
glucan application significantly stimulated the phagocytic system and also played a role
in general defense against tumors and infections (Novak and Vetvicka 2008) (Novak and
Vetvicka 2009).
In teleosts, the mechanism of action of R848 is mediated by the TLR7/8 signaling
pathway, in which MyD88 and NK-B are essential players (Zhou and Sun 2015). R848
is known to enhance humoral and cellular Th1 immune responses (Vasilakos, Smith et al.
2000, Quiniou, Boudinot et al. 2013). R848 has been successfully used as an anti-viral
agent in humans (Miller, Meng et al. 2008) and Japanese flounder (Zhou and Sun 2015).
The use of R848 demonstrated the induction of anti-bacterial activity in tongue sole (Li
and Sun 2015). In our study, administration of R848 alone did not result in significantly
higher survival compared to RE33®. However, co-administration of R848+RE-33®
significantly increased survival compared to R848 alone (Fig. 3.4). Zhou and Sun
reported several functions of R848 in Japanese flounder including stimulating
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proliferation of peripheral blood leukocytes (PBL), reduced apoptosis of PBL, replication
inhibition of megalocytivirus and enhanced mRNA expression of tlr7, il-6, Myd88, ifnγ
and irf3 and down-regulation il-1β (Zhou and Sun 2015). The effect of R848 on immune
responses of T and B cell deficient animals has not been investigated.
When Poly I:C was administered alone or co-administered with RE-33® 1 month
prior to E. ictaluri challenge, it improved survival in our rag1-/- mutant zebrafish, but not
as much as β glucan and R848. This suggests that induction of protection to E. ictaluri in
lymphocyte deficient fish requires the stimulation of TLRs other than TLR3. However,
TLR3 is involved in recognizing bacteria and viruses (Schmidt, Leung et al. 2004). Poly
I:C is known to strongly induce type 1 interferon and this can suppress viral replication
and dissemination in the host. It also causes macrophages to direct type 1 response
focusing on intracellular pathogens. This suppression enhances survival when live virus
is administered, allowing the fish to survive the primary infection long enough to develop
acquired immunity (Takami, Kwon et al. 2010, Oh, Takami et al. 2012). Used in this
manner, it may not enhance acquired immunity, but protection can ultimately develop. In
Chapter 2, we saw that mx was substantially up-regulated indicating that a strong
induction of type 1 interferon had occurred. Alternatively, the benefit of using Poly I:C in
vaccines may relate to enhance T and B lymphocyte based immune responses. Poly I:C
has been shown to be beneficial when used in vaccine studies with immune competent
aquaculture species (Strandskog, Skjæveland et al. 2008, Nishizawa, Takami et al. 2009,
Takami, Kwon et al. 2010, Nishizawa, Takami et al. 2011, Oh, Takami et al. 2012). Poly
I:C is successfully used as a cancer vaccine adjuvant in humans (Ammi, De Waele et al.
2015).
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In the current study, β glucan and β glucan + RE-33® treated fish and R848 +
RE-33® treated fish demonstrated higher survival than fish that received Poly I:C + RE33®, Poly I:C, R848 or RE-33® alone when challenged with WT E. ictaluri four weeks
after these treatments were administered (Figs. 3.1, 3.2 and 3.3). The molecular and
cellular mechanisms mediating this enhanced survival have not been determined. Other
studies have shown that macrophages and NK cells can undergo epigenetic changes,
causing a phenomenon known as “trained immunity”, following a primary stimulus
(vaccination). In mammals, these cells are capable of mounting adaptive cellular
mechanisms in the absence of T and B cells upon reinfection (Quintin, Saeed et al. 2012).
The concept of trained immunity has not been explored in fish.
Table 5.3

Treatment

Summary of expression changes of significantly up-regulated and downregulated genes at different hours post injection (hpi) following primary or
secondary immune stimulation in rag1-/- mutant zebrafish.
Tissues

Up regulated
<10 fold change
Pri

E. ictaluri

Kidney

RE33

Sec

Liver

Liver

Up regulated
10-100 fold change
Pri
Ifnγ
(12hpi)
Nklc
(48hpi)

Sec

Nitr9
(6hpi)
Nitr9
(12hpi)
Nitr9
48hpi)
Nkla
(48hpi)
Nkla
(48hpi)

Up regulated
>100 fold change
Pri
Ifnγ
(6hpi)
Ifnγ
(48hpi)
Ifnγ
(24hpi)

Ifnγ
(48hpi)
Nklb
(48hpi)
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Sec

Ifnγ
(48hpi)
Nitr9
(6hpi)
Nkla
(12 hpi)

Down regulated genes

Pri
Nkla
(48hpi)

Sec

Table 5.3 (continued)
Kidney

B glucan

Liver

Kidney

B glucan
+ RE33

Nkla
(48hpi)

Nkla
(48hpi)

Liver

Kidney

Ifnγ
(24hpi)

Nitr9
(48hpi)

Nkla
(48hpi)

Ifnγ
(48hpi)
Nklc
(12hpi)
Tbet
(6hpi)

Tbet
(6hpi)
Nkld
(12hpi)
Ifnγ
(6hpi)
Nkla
(6 hpi)
Nklb
(6hpi)
Nklc
(6hpi)
Nkld
(6hpi)

Tbet
(6hpi)

Ifnγ
(12hpi)
Nklb
(6hpi)
Nkld
(12 hpi)

Tbet
(6hpi)
Nitr9
(24hpi)
Nkla
(12hpi)

Ifnγ
(24hpi)
Tbet
(24hpi)
Nitr9
(24hpi)
Nkla
(24hpi)
Nklb
(24hpi)
Nklc
(24hpi)
Nkld
(12hpi)
Nkld
(24hpi)
Ifnγ
(48hpi)
Nklb
(24hpi)
Nkld
(12hpi)
Nkld
(24hpi)

Tbet
(6hpi)
Nkla
(12hpi)
Nklc
(12hpi)
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Nkld
(48hpi)

Nkla
(48hpi)

Nkld
(48hpi)

Nkla
(48hpi)

Table 5.3 (continued)
R848

Liver

Kidney

R848 +
RE33

Nkla
(48hpi)

Liver

Kidney

Nkla
(48hpi)

Ifnγ
(24hpi)
Nkla
(48hpi)
Nklb
(48hpi)
Nklc
(48hpi)
Nkld
(48hpi)
Ifnγ
(24hpi)
Nkla
(24hpi)
Nklc
(24hpi)
Nklc
(48hpi)
Nkld
(24hpi)
Nkld
(48hpi)

Nitr9
(12hpi)

Nitr9
(24hpi)
Nkla
(48hpi)
Nklb
(48hpi)
Nklc
(48hpi)
Nkld
(48hpi)
Ifnγ
(48hpi)
Nkla
(48hpi)
Nklc
(48hpi)
Nkld
(48hpi)

Ifnγ
(48hpi)
Nitr9
(24hpi)

Tbet
(48hpi)

Tbet
(48hpi)
Nkla
(48hpi)

Tbet
(6hpi)

Tbet
(6hpi)
Nkld
(6hpi)
Ifnγ
(12hpi)

Ifnγ
(12hpi)
Nkla
(48hpi)

Nkld
(24hpi)

Rag1-/- mutant zebrafish were intra coelomically injected with RE33® or one of
The TLR ligands β glucan, Poly I:C or R848. The TLR ligands were also co-administered
with RE33®. Fish were challenged with WT E. ictaluri 4 weeks later and gene
expressions determined in liver and kidney tissues. Table 3.3 is the summary of
expression changes of significantly up-regulated and down-regulated genes after the
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administration of these treatments. Zebrafish have NK cells and non-specific cytotoxic
cells (NCCs) (Petrie-Hanson, Hohn et al. 2009). NCCs are small agranular lymphocytes.
They have been isolated and described, and reported to be NK cell precursors (Moss,
Monette et al. 2009). NCCs are unique to teleosts and are small and large agranular
lymphocytes. In Chapter 5, we reported the presence of NK cells in zebrafish kidney,
liver and spleen that ranged in sizes from 4um (small) to 9.5um (large) (Muire, Hanson et
al. 2017). Other than these two reports, zebrafish NK cells and NCCs have not been
explored. A zebrafish NK cell line is not available and this makes it challenging to study
the cells’ activation and dynamics during infection. It is a challenge to isolate a pure NK
cell population based on a size and granularity on a forward/side scatter dot-plot due to
the interference of NCCs (reported as mammalian NK cells equivalents) (Yoder 2004).
The rag1-/- mutant zebrafish T and B cells (Petrie-Hanson, Hohn et al. 2009) and the
advantage of using this model is to rule out the contribution of T and B cells in immune
responses. The tissue locations of NK cells and NCCS are not clear at present. In Chapter
5, we show that a large granular nitr9+ NK cell population is within the myeloid
population. A similar cell population was recently reported that corroborates this cell
population (Pereiro, Varela et al. 2015).
Zebrafish have four Nk-lysin genes: nkla, nklb, nklc and nkld. A recent study of
Nk-lysins in the NK cells and NCCs of wild type and rag1-/- mutant zebrafish reported
that the kidney precursor cell population was the highest producer of the 4 Nk-lysins.
Differential expression patterns of NK lysins suggests specialization of the cell types in
the production of these proteins (Pereiro, Varela et al. 2015). Since rag1-/- fish lack T and
B cells, the NK cells are the major producers of the Nk-lysins (Petrie-Hanson, Hohn et al.
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2009, Pereiro, Varela et al. 2015). Zebrafish have the highest repertoire of Nk-lysin genes
described (Pereiro, Varela et al. 2015). Such a diversity could indicate a specialization of
the different proteins into different functions and as consequence the preferential
expression of these genes by different cell types (Pereiro, Varela et al. 2015). The
morphology of different NK cell populations in the liver, kidney and spleen of rag1-/mutant zebrafish is discussed in Chapter 2.
Transcript of Nklc represents 71% of the total Nk-lysin expression in the rag1-/mutant zebrafish kidney. Transcript of Nkla, nklb and nkld are 18%, 11% and <1% of the
total, respectively (Pereiro 2015). In our study, when naïve fish were challenged with E.
ictaluri, nklc was significantly up-regulated in the liver. Ifnγ was significantly upregulated at 6, 12 and 48 hpi in liver. Ifnγ was up-regulated at 24 hpi in kidney. Nitr9 was
up-regulated in the kidney at 6hpi, 12hpi and 48hpi. Indicating that nitr9 expression was
up-regulated until 12hpi and decreased, but again up-regulated at 48hpi, the time when E.
ictaluri pathogenesis sets in, suggesting an anti-bacterial role of nitr9. Following RE33® injection (live attenuated vaccine) and after challenging the fish 4 weeks post
vaccination at 48 hpi ifnγ was up regulated in liver and kidney (only E. ictaluri control).
However, there was no over expression of ifnγ in the kidney of the challenged fish, but
there was an expression of t-bet (NK cell transcriptional factor) in the kidney of
vaccinated-challenged fish, indicating a proliferation of NK cells at 6hpi. T-bet was
downregulated in primary and secondary infection following R848, which could be due
to a feed-back mechanism during an active immune response. In the R848 treated nonchallenged fish, ifnγ was up-regulated at 24 hpi in liver and kidney unlike β glucan,
where ifnγ was not up-regulated during primary infection. Ifnγ was also up-regulated in
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the liver and kidney of β glucan and β glucan + RE-33® administered challenged-fish,
indicating the importance of ifnγ in killing the bacteria and mediating an immune
response. In β glucan and β glucan + RE-33® administered fish, t-bet expression was
mainly in liver and kidney at 6hpi. In the case of R848 and R848 + RE-33® administered
fish, the level of t-bet expression was not statistically different from PBS but was
downregulated at 48 hpi during primary and secondary stimuli.
A set of four Nk-lysin paralogs were described in zebrafish and their
transcriptional response to viral infection was characterized (Pereiro, Varela et al. 2015).
Although all Nk-lysin genes were expressed at mRNA level in all the tissues,
proportionally, nkla is the most expressed gene in liver, kidney, tail, head and muscle;
nkla and nklb genes were expressed equally in gills; nklb was predominantly expressed in
intestine; nklc was expressed in spleen and nkld was highly prevalent in gills, kidney and
spleen (Pereiro, Varela et al. 2015). Pereiro et al 2015 observed that there was a higher
absolute expression of the Nk-lysins in the rag1-/- when compared to the WT zebrafish
(Pereiro, Varela et al. 2015). This could support the theory that in the absence of the T
and B cells, the NK cells tend to fill in the vacuum and hence could lead to higher
expression of NK cell specific Nk-lysins. Nkla was expressed in the rag1-/- mutants but to
a lesser extent when compared to the WT zebrafish, whereas, nklb, nklc and nkld were
highly expressed in rag1-/- mutant zebrafish. Therefore, the results from Pereiro et al
suggest that CTLs are the major producers of nkla and the NK cells mainly express nklb,
nklc and nkld. All the 4 Nk-lysins were expressed in the rag1-/- mutants and the WT
zebrafish. Therefore, the Nk-lysins serve as good candidate genes for tracking down NK
cells in zebrafish. Zang et al found that NK-lysins exhibit tissue specific expression and,
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when overexpressed in fish, regulate immune gene expression (Zhang, Long et al. 2013).
In our study, the expression of the NK-lysin paralogs were differentially expressed in the
liver and kidney at different time points. Nk-lysins serve as molecular markers for NK
cells identification/detection in zebrafish systems.
In both vaccination (RE33®) and WT challenge nkla was up-regulated only in the
kidney but at a very low expression level at 48hpi, but nkla was downregulated in the
liver at 48hpi post challenge in naïve (non-vaccinated) fish. We report that following
challenge (secondary infection) with E. ictaluri in all treatment groups, nkla was the most
expressed gene at 48 hpi. E. ictaluri pathogenesis sets in at 48h post infection and the
ESC symptoms are evident in the fish. We have shown in our survival curves that all
control fish that were injected with WT E. ictaluri died at day 7 in the trial. Interestingly,
downregulation of liver nkla (secondary infection) at 48hpi was noted in both TLR ligand
administered groups only after bacterial challenge. But the mRNA levels of nkla were
reported to be up-regulated at earlier time points (6hpi and 24hpi) only in β glucan and β
glucan +RE33® groups. In the β glucan and β glucan + RE-33® groups downregulation
of liver nkld (primary infection) was noted. In flounder, constitutive expression of Nklysin was detected mainly in gills, heart, head kidney, intestines, peripheral blood
leukocytes, and spleen, and no expression was detected in brain, skin and stomach
(Hirono, Kondo et al. 2007). In channel catfish, high levels of Nk-lysin expression were
detected in gill, head kidney, intestine, and spleen, and no expression was detected in
muscle (Wang, Wang et al. 2006). E. ictaluri challenge in channel catfish, induced NKlysin type1 and type 2 expression in head kidney (Wang, Wang et al. 2006, Pridgeon, Mu
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et al. 2012) which correlate with our observation with nkla, nklb, nklc and nkld
expression in kidney influenced by TLR ligand exposures.
Moore et al 2016, analysed the expression level of Nk-lysin 4 in rag2 mutant
zebrafish and reported a 10-fold increase (i.e.,6%) in expansion of nkl.4+ cells in the
WKM. This cell population corresponds to a unique cytotoxic lymphocyte like cell
population. Moreover, these nkl.4+ populations expressed the lck gene, suggesting that
they are likely related to cytotoxic T cells, NK cells, or NKT cells. Additionally, an
expansion of the myeloid cell population was reported, suggesting that an influx of
leukocytes is a compensation mechanism in the impaired T and B cell zebrafish to protect
it from infection (Moore, Garcia et al. 2016) and these cells could represent trained
macrophages (reviewed in (Petit and Wiegertjes 2016) and the large granular
lymphocytes (NK cells), respectively (Muire, Hanson et al. 2017). In another study, when
adult WT zebrafish were intraperitoneally injected with SVCV, they observed that the
transcript levels of zebrafish NK-lysins sometimes decreased after viral infection. There
was a significant expression of nkla and nkld observed in kidney at 3, 6 and 24hp
challenge. Nklb and nklc did not have any effect. Whereas nkla and nkld in kidney
displayed the greatest increase after infection with SVCV (Pereiro, Varela et al. 2015),
these NK-lysins displayed differing responses to S. iniae infection (Murji 2015). This
may reflect NK-lysin specialization for different pathogens. The observed variations in
post-infection transcript levels may also be explained by the number of bacteria injected
into the zebrafish. Basal level mRNA expression of Japanese flounder Nk-lysin was
reported in gills, heart, head kidney, intestine, peripheral blood leukocytes (PBLs), spleen
and trunk kidney at higher levels and in liver, muscle and ovary at lower levels. However,
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null expression of Nk-lysin was noted in the brain, skin and stomach of SPF Japanese
flounders (Hirono, Kondo et al. 2007).
Nkla gene expression reached the highest expression at 24h (FC=4.85) with
respect to the control challenge (Pereiro, Varela et al. 2015). In the case of nkld
expression, there was a significantly high expression at 6h (FC=4.05) and returned to its
basal levels after 24h (Pereiro, Varela et al. 2015). In our study, β glucan treated fish,
following secondary infection, liver nkla was up-regulated at 6hpi (>100fold) and then
gradually downregulated at 48 hpi in liver but was still up-regulated in kidney at 48 hpi
(<10 fold) although at a very small fold change. Similar observations were noted for liver
nkla expression in fish treated with β glucan + RE-33® where the nkla mRNA was upregulated at 24 hpi (>100 fold) and then down regulated at 48 hpi in liver. Although the
nkla expression was up-regulated in kidney at 48 hpi (<10 fold) but a lower level. This
observation suggests that administration of β glucan alone or in co-administration with
RE-33® does not involve nkla and nkld in the bacterial lysis activity. In the case of R848
exposure (primary stimulation), liver nkla was up-regulated at 48 hpi (>100hpi) and
kidney nkla was up-regulated at 24 hpi (>100 fold). Following secondary stimulation,
liver nkla was downregulated at 48 hpi and kidney nkla was up-regulated at 48 hpi (>100
fold). There was no up/down-regulation of nklb in the control fish treated with E. ictaluri.
Nklb was up-regulated in liver at 48 hpi in RE-33® vaccinated fish. Nklb was up
regulated at 6hpi in liver and 24hpi in liver and kidney post challenge in β glucan and β
glucan + RE-33® treated fish, respectively. Liver Nklb was up-regulated in liver at 48 hpi
in R848 and in R848 + RE-33® treated fish. Interestingly, nkla was downregulated in
liver in both TLR ligand administered groups only after bacterial challenge. Septic shock
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causes an influx of cytokines that can mediate a negative effect on the host. During this
time, the host adapts to this “cytokine storm” by becoming immunocompromised and are
more susceptible to infections that often leads to fatal outcomes (Słotwiński, Sarnecka et
al. 2015) (Wiersinga, Leopold et al. 2014). This could be the reason for downregulation
of the Nk-lysins. Another reason for downregulation could be due to a feed-back
mechanism, occurring during NK cell stimulation and pathogenesis. Other studies in fish
treated with R848 have reported up-regulated expression of genes associated with TLR
signaling, notably IFN I, IFN-γ, IL-1β, IL-8, TNF-α, and interferon regulatory factor 3
(IRF3) (Palti 2011) (Purcell, Kurath et al. 2004) (Svingerud, Solstad et al. 2012). In our
study, up-regulation of the NK-lysins was observed in the liver and kidney of β glucan
and β glucan + RE-33® treated fish groups during the secondary stimulus (E.ictaluri
challenge). In contrast, in R848 and R848 + RE-33® treated fish groups, Nk-lysins were
up-regulated during the primary stimulus (vaccination). These results indicate that R848
induces a greater immune response following primary stimulus comparable to that
observed in secondary stimulus (E. ictaluri challenge), which suggests that R848 has a
lasting protective effect but not as robust as β glucan, β glucan + RE-33 or R848 + RE33®. This observation infers that R848 provides only a primary protection but β glucan
provided a longer secondary immune memory protection.
According to Hong et al. 2006, the kinetics leading to increases and decreases of
chicken Nk-lysin transcript levels coincide with parasite oocyst production, thus
suggesting that transcription levels increase when more pathogens are present (Hong,
Lillehoj et al. 2006). Once E. ictaluri was injected intramuscularly in zebrafish, the
pathogen may have travelled to surrounding tissues and induced transcription of the Nk150

lysin genes. This could have led to variations in NK-lysin response, as some tissues may
have been exposed to the pathogen at different times. In chickens, the activity of the
peptide was dependent on intact disulfides, and both the bactericidal effect and the
cytolytic effect of the peptide were inhibited when Nk-lysin was downregulated
(Andersson, Gunne et al. 1996). In channel catfish, all Nk-lysin genes are expressed, but
exhibit distinct expression profiles in various tissues (Wang, Wang et al. 2006). In
channel catfish, it is possible that the appearance of mature CTLs affects the number of
NK cells and/ or the transcription of certain genes and therefore, these changes in the cell
populations could be altering the expression level of Nk-lysin genes. Overall, we observe
that T and B cell deficient zebrafish, ifnγ, Nk-lysins and nitr9 (in co-administered TLR
ligand and vaccine group) were up-regulated mostly following challenge with E. ictaluri,
indicating the response of macrophages and NK cells during the onset of infection. This
could suggest that β glucan promotes memory in the naïve cells which is why we observe
increased expression of the Nk-lysins mRNA following pathogenic challenge.
5.5

Conclusion:
Our findings reveal pathways that are important for the way fish that have limited

lymphocyte based immunity can respond to primary infections or vaccination. T and B
cell deficient rag1-/- mutant zebrafish demonstrate specific protection (Hohn and PetrieHanson 2012), and our current study was performed to better characterize the cell
population(s) involved in that response by interpreting transcript level changes in tissues.
Gene expression profiles and survival (following bacteria challenge) results gave us an
idea about the measure of immune function. Differential expression of immune response
genes suggests how tissue environments induce changes in innate immune cells that can
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result in these cells having the capacity to mediate protective immunity at subsequent
pathogen exposure.
Significant increases in ifnγ expression in Poly I:C treatment did not occur
(Muire, Hanson et al. 2017) and when Poly I:C was co-administered with vaccination,
survival was not increased. Administration of β glucan, β glucan + RE-33® and R848 +
RE-33® 4 weeks prior to bacterial challenge resulted in the greatest survival.
Intracoelomic injection of β glucan and R848 caused >100 fold increase in ifnγ
expression in liver and kidney tissues (Muire, Hanson et al. 2017). Rag1-/- mutant
zebrafish can develop protective immunity, and TLR ligands (β glucan and R848)
stimulate this protective response when administered alone or co-administered with RE33®.
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CHAPTER VI
THE DEVELOPMENT OF LCK:mCherry RAG1-/- MUTANT ZEBRAFISH AND
RAF1A-/- MUTANT ZEBRAFISH MODELS TO INVESTIGATE THE ROLE OF NK
CELLS IN TELEOST IMMUNITY
Abstract
Zebrafish are a powerful model to study the vertebrate immune system. The lack
of availability of monoclonal antibodies for zebrafish immune cell markers has made it
challenging to use zebrafish as a model for several studies. As an alternative, several labs
are working to develop transgenic zebrafish and knock out models to study particular
cells. Transgenic fish that express mCherry protein is driven from the LCK promoter.
Lymphocyte specific tyrosine kinase (lck) is expressed by T cells and NK cells. We
developed the wild type:lck:mCherry as well as rag1-/-:lck:mCherry zebrafish models,
using the Tol2 kit method, to elucidate the functions of lck expressing Natural Killer
(NK) cells in the absence of T cells. At 4 days post fertilization (dpf) lck+ cells were seen
in the head kidney and blood vessels. At 7 dpf lck+ cells were seen in thymus of wild
type:lck:mCherry zebrafish. Lck+ cells were seen only in the head kidney and the blood
vessels in rag1-/-:lck:mCherry zebrafish. No lck+ cells were seen infiltrating the thymus in
rag1-/-:lck:mCherry zebrafish. Our observations suggest the lck+ population at 4 dpf in the
rag1-/- mutant zebrafish comprises the NK cells. To further elucidate the function of NK
cells without the interference of trained macrophages in innate immune protection, we
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developed a raf1-/- mutant zebrafish model using CRISPR-Cas9 gene knock out
technique. Raf1a is a serine/threonine kinase and is activated via the MEK-ERK1/2
pathway and activates monocytes to become trained macrophages.
6.1

Introduction
Zebrafish have proved to be highly advantageous in research due to their small

size, fast generation time, transparent embryos and ease to carry out gene mutations and
knock down studies. The tol2kit is a multisite gate way based construction kit for tol2
transposon transgenesis constructs (Kwan, Fujimoto et al. 2007). The importance of using
transgenic zebrafish in research is that it allows one to study the function of a particular
gene either by inactivating the gene function or by fusing a reporter gene to the promoter
of the gene of interest and tracking its function in vivo. In this study we worked to
differentiate natural killer (NK) cells from macrophages. The CRISPR-cas9 gene knock
out (KO) technology system has been used as a successful tool to target important genes
in many cell lines and organisms, including human (Mali, Yang et al. 2013, Louwen,
Staals et al. 2014), bacteria (Louwen, Staals et al. 2014), zebrafish (Hwang, Fu et al.
2013), pigs (Hai, Teng et al. 2014), goats (Ni, Qiao et al. 2014), plants (Miao, Guo et al.
2013), C. elegans (Waaijers, Portegijs et al. 2013), yeast (Niu, Shen et al. 2014),
Drosophila (Gratz, Ukken et al. 2014), monkeys (Niu, Shen et al. 2014), rabbits, rats and
mice (Mashiko, Young et al. 2014).
Lymphocyte specific tyrosine light chain kinase gene (lck) is a T cell specific
tyrosine kinase which is expressed by immature and mature T cells as well as in NK
cells. The mCherry expression is driven by the lck promoter activation. The lck:mCherry
zebrafish model was used in previous studies to elucidate the functions of T cells
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(Langenau, Ferrando et al. 2004, Trede, Langenau et al. 2004, Brugman, Witte et al.
2014). A recent study used the lck:mCherry zebrafish to study lymphocyte like cells
(LLCs) (Carmona, Teichmann et al. 2017).
Raf1a is a proto oncogene, a serine/threonine kinase and is activated via the
MEK-ERK1/2 pathway. Raf1a functions downstream of p21 Ras (Zhang, X. F. et al 1993
and Ghosh, S. et al 1994) and serves as an upstream regulator of the Ras-Raf1a-MEKMAP kinase signal transduction cascade that is activated in response to a wide variety of
signals, including growth factors, differentiation hormones, tumor promoters,
inflammatory cytokines, calcium mobilization, DNA-damaging agents and oxygen
radicals.
T-bet (also known as Tbox-21) belongs to the T-box family of genes, consisting
of over 20 members characterized in mammals. They contain a conserved sequence,
around 200 amino acids in length, called the ‘T-box’, which, in t-bet, is centrally located,
whereas, in other members, it is located at the amino terminus. T-bet is the transcription
factor required for the differentiation of the naïve T cell to Th1 cell and of innate
lymphoid group 1 cells, which consists of Natural Killer (NK) cells and the innate
lymphoid cells (ILC) in humans and mice. NK cells are prototypical type I (ILC).
Additionally, the T-box transcription factors, eomesodermin (Eomes) (E4BP4) and t-bet
direct the fate and function of cytotoxic cell lineages including NK cells and CD8 + T
cells. Runx3, GATA-3, t-bet and Eomes mediate regulation of NK cells response. The
expression of t-bet suppresses Eomes and results in Eomes-/- NK cells. This means that
the repression of t-bet is essential for the expression of the Eomes +/+ NK cells (Daussy,
Faure et al. 2014). Thus, t-bet controls the developmental stability of immature NK cells,
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while Eomes regulates NK maturation. The zebrafish t-bet/ tbx21I cDNA (EMBL
accession no. AM942761) consists of a 36 bp 5’-untranslated region (UTR), a 419 bp 3’UTR and a single open reading frame of 1830 bp (Mitra, Alnabulsi et al. 2010). The gene
organizations of zebrafish t-bet were also determined and found to be very similar to their
human homologues. Both the human and zebrafish t-bet genes contain the same number
of exons and introns i.e., six exons and five introns.
Here, we present results from our attempt to generate a t-bet transgenic construct;
the preliminary results from rag1-/-:lck:mCherry zebrafish; and the methods and results
from CRISPR-Cas9 mediated raf1a KO zebrafish. We developed these models with an
intent to elucidate the role of NK cells in zebrafish immunity, due to the scarcity of
molecular tools or antibodies to target and study zebrafish NK cells. I would like to
acknowledge the American Association of Immunologist (AAI) for selecting Dr. PetrieHanson’s laboratory as the recipient of a Travel for Techniques Award to learn the
CRISPR/cas9 system for generating knockout zebrafish. This award funded my travel to
Dr. Jeffrey Yoder’s laboratory at North Carolina State University to learn the CRISPRCas9 technique, and I thank Dr. Jeffrey Yoder and Dustin Wcisel for teaching me the
CRISPR-Cas9 technique. I also thank Dr. Matthew Jenny from University of Alabama,
Tuscaloosa for helping with the lck:mCherry transgenic fish project.
6.2
6.2.1

Material and methods
Zebrafish care
Zebrafish were mated, raised and maintained at 28°C in the specific pathogen free

hatchery in the College of Veterinary Medicine, Mississippi State University (MSU)
following standard lab protocols. Experimental protocols were approved by the MSU
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Institutional Animal Care and Use Committee (IACUC). A homozygous breeding colony
of rag1-/- mutant zebrafish was previously established (Petrie-Hanson, Hohn et al. 2009)
and bred at the CVM-SPF hatchery and the experimental fish are progeny from that
colony.
6.2.2

Amplification of desired sequence
This method uses the three-insert multisite gateways system. The three inserts are

the entry vectors: 5’ entry clone (p5E-XX), middle clone (pME-XX) and the 3’ entry
clone (p3E-XX). The 5’ entry clone contains the promoter element of the gene of interest,
with attL4 and attR1 sites flanking the insert. The 5’ entry clone has the t-bet (prepared in
house) (Fig. 6.1) or lck (purchased from: https://www.addgene.org/58890/) gene
promoter elements as inserts. In the middle clone the insert is a reporter: mCherry with
attL1 and attL2 sites flanking the insert. The 3’ entry clone contains a polyA signal or a
3’ tag (myc:EGFP fusions) with attR2 and attL3 sites flanking the insert. The 3’ entry
clone has a polyA signal.
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Figure 6.1

lck:mCherry 5’ entry construct

(A) Overview of lck:mCherry entry construct; (B)5.5Kb lck promoter; (C)Site
specific recombination and transposase mediated cut and paste mechanism of
transposition (animation adapted from (Watson and Watson 2008).
6.2.3

Generation of t-bet 5’ entry clone
Bacterial artificial chromosome (BAC) was extracted using BAC extraction kit

(zymoresearch) from [BAC] CH211-194K22 transformed E.coli cells
(http://zfin.org/action/marker/view/ZDB-BAC-050218-1713). In order to amplify the tbet gene promoter sequence upstream of exon 1, we PCR amplified the target sequence
by using appropriate primer sets designed for ~6.5kb upstream of the first exon and few
base pairs downstream of the start site. Since the start site for t-bet is in the 1st exon.
There is no need to go downstream of the first exon. There is a conserved element ~1kb
upstream of the first exon which could be the non-coding exon. The primers designed for
t-bet amplification were: forward - aaaatcgatTATGTAATATAAGCACTTAGCT and
reverse – aaaggatccCTTCTTACCGTCCTTGTTTCGT. The amplified region of t-bet
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was cloned in the vector 228 (from Dr. Matthew Jenny, University of Alabama,
Tuscaloosa, AL), to generate the “t-bet 5’ entry clone”.
6.2.4

Designing target oligo(s) and primers for Raf-1a KO zebrafish mutants
using CRISPR-Cas9 technique
The target for the CRISPR-cas9 mutation (Fig. 6.2) selected was designed using

http://useast.ensembl.org/index.html and http://zifit.partners.org/ZiFiT/Disclaimer.aspx.
Target sequence was: 5’taatacgactcactataGGAACTTGTAACCACATCTTgttttagagctagaaatagc-3’, this region
was within exon 5 and within the protein kinase domain of RAF1a. The ultramer oligo
for the guide RNA synthesis was
5’AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTA
TTTTAACTTGCTATTTCTAGCTCTAAAAC-3’

Figure 6.2

Target site for CRISPR-Cas9 mutations and protein coding region in raf1a.

RAF1A protein domains. RBD: Ras binding domain; C1: protein kinase domain.
(Animation drawn on www.smart.embl-heidelberg.de).
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6.2.5

GuideRNA (gRNA) synthesis
To align target oligos and guideDNA: dNTPs, target oligo, guideDNA (default)

and taq polymerase were combined. The following thermal cycles were applied:
denaturation at 98C for 2min, annealing at 50C for 10min and extension at 72C for
10min. This was followed by in-vitro RNA transcription using manufacturers protocol
(Ambion Invitrogen - mMESSAGE mMACHINE® T7 Transcription Kit (Catalog
number: AM1344). gRNA sample was DNAse treated followed by a RNA clean up
procedure (RNA Clean & Concentrator™-5 (Catalog number R1015). gRNA was stored
at -80C until use.
6.2.6

Spawning and microinjections
For the lck:mCherry injections we used rag1-/- mutant and WT zebrafish. For the

raf1-/- KO CRISPR-Cas9 mutations, we used NHGRI-1 WT zebrafish strain. Fish were
set up to spawn (males and females mixed at a ratio of 2:1) per holding tank with
spawning nets to get at least 200 healthy eggs per group. Spawning tanks were provided
with air stones and covered all night. After the injection set up was ready, spawning tanks
were brought out to a will lit area to drop eggs. Eggs were microinjected at the 1 to 2
celled stage (i.e. approx. within 1h post fertilization) at both times. Eggs in the tol2kit
experiment were lck:mCherry construct and transposase enzyme. Eggs in the CRISPRCas9 experiment were injected with gRNA and Cas9 enzyme.
6.2.7

Confirming microinjections
Forty-eight hours post microinjections, fry were screened with an OLYMPUS

1X50 stereomicroscope with OLYMPUS U-RFL-T burner and positive fry with the
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lck:mCherry transgene were raised to adult. About 8 of the raf1a gRNA injected embryos
or adults were genotyped for mosaic mutation. Genomic DNA was extracted from
individual embryo or fin clips from adult fish and PCR (Promega GoTaq - GoTaq® DNA
Polymerase) was performed with forward: 5’CAGTCGGGCGTCATCACTGTCTTGACCATCTCTTTTCA-3’ and reverse: 5’AGTCCAGTCTACACACATAGTGG -3’ primers designed upstream and downstream
of the target site. The thermal conditions were as follows: initial denaturing: 95C for 2
minutes, denaturing: 95C for 30 seconds, annealing 54C for 30 seconds, extension: 72C
for 30 seconds, final extension: 72C for 7 min, hold: 4C. Each sample was diluted as
1:50, 1:20 or 1:10 (based on the thickness of the band on the gel) and subjected to
fragment analysis. Data collected from fragment analysis was analysed using Peak
Scanner software by Thermo Fisher-Applied Biosystems.
6.2.8

Genotyping adult zebrafish and mating patterns
The F0 adult zebrafish with a mosaic mutation was crossed with a wild type

zebrafish. The progeny (F1) were raised to adults and were fin clipped and genotyped as
above. Heterozygous mutations were confirmed by TA cloning the PCR product in to a
pCR4 vector (Invitrogen) and sequencing in forward (T3 primer) and reverse (T7 primer)
directions. Sequencing data was analyzed by MEGA M7, Sequencher 5.4.6 and
Lasergene softwares. F1 zebrafish with heterozygous mutation in one of the raf1a alleles
were in-crossed. 1/4th of the F2 progeny are expected to have a homozygous mutation for
raf1a (Fig 6.3).
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Figure 6.3
6.2.9

Schematic of mating patterns.

Microscopic detection and imaging
Images of 4 days post fertilization (dpf) and 7 dpf lck+:mCherry fry were acquired

with a Cytation 5 image reader at 10X and 60X magnification under bright field or texas
red (detects mCherry) or FITC (detects green fluorescence protein) filters. GFP
fluorescence was excited at 488 nm detected between 415 and 570 nm. mCherry
fluorescence was excited at 561 nm and detected between 570 and 655 nm. Fry were
anesthetized in 0.4% MS-222 (Tricaine) solution and immobilized for a short time in 3%
methyl cellulose during the image capture period and were revived minutes after placing
them back in fresh water.
6.3
6.3.1

Results
T-bet amplification of 6.5 kb upstream of exon 1
We were able to amplify a ~3.9 kb, instead of a 6.5 kb fragment, upstream

element of the t-bet gene (Fig 6.4).
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Figure 6.4

Construction of t-bet entry clone.

(A)T-bet gene with exons 1- 6; (B)Schematics of the amplifying region of t-bet exon 1
and putative promoter; (C)3.9Kb amplified product from BAC; (D)3.9Kb cloned product
from colony PCR.
6.3.2

NK cells distribution in wild type and rag1-/-lck:mCherry zebrafish
At 24 hpf (hours post fertilization), expression of the myocardial gene (positive

control for transgenic insert) was noted in embryos. At 2 days post fertilization (dpf),
expression of lck:mCherry+ cells were noted in the embryos, mainly in the circulatory
system in wild type embryos. At 4 days lck:mCherry+ cells were noted in the circulatory
system in wild type and rag1-/- mutant zebrafish embryos (Fig 6.5). At 7 dpf
lck:mCherry+ T lymphocytes were homing in the thymus in the wild type zebrafish.
Interestingly, at 7 dpf, there was no T lymphocyte homing in the rag1-/- mutant zebrafish.
(Fig 6.6) This suggests that the lck:mCherry + cells in the rag1-/- mutant zebrafish are NK
cells. However, the F0 generation always has mosaic expression that is not as strong and
consistent as an F1. Not all blood cells expressed mCherry. Only a small fraction of
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individual circulating cells expressed mCherry indicating the occurrence of NK cells at 4
dpf.

Figure 6.5

Lck:mCherry expression in Wild type and rag1-/- mutant zebrafish at 4 days
post fertilization (dpf). Blue arrows indicate the myocardial gene
expression (positive control for transgene insert). White arrows indicate
lck+ cells via mCherry expression.
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Figure 6.6

6.3.3

Lck:mCherry expression in Wild type and rag1-/- mutant zebrafish at 7 days
post fertilization (dpf). Blue arrows indicate the myocardial gene
expression (positive control for transgene insert). White arrows indicate
lck+ cells via mCherry expression.

Genotyping F0 for raf1a mosaic mutations
Results from fragment analysis suggested a 25% mutation rate of raf1a (Fig 6.7).

Following screening by fragment analysis, the samples with multiple short peaks were
considered positive for mosaic mutation and were subjected to sequencing from further
analysis (Fig 6.8).
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Figure 6.7

Fragment analysis to screen for raf1a mosaic mutation in F0 generation.

Figure 6.8

Screening F0 generation for raf1a mosaic mutation

(A)Chromatograms showing the difference between wild type alleles and heterozygous
mutant alleles; (B)Wild type and mosaic allele DNA and protein sequences
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6.3.4

Genotyping F1 for raf1a heterozygous mutations
Sequencing data from F1 generation showed WT (Fig 6.9 A) and three types

mutations within the target sequence at the PAM (TGG) site. Mutation 1 is a 3 bp
deletion (Fig 6.9 B). The translation of this mutation did not result in a premature stop
codon but resulted in a frame shift mutation. Mutation 2 is a CTCT insertion (Fig 6.9 C).
The translation of this mutation resulted in a premature stop codon and addition of serine
residues right after the PAM site. Mutation 3 is an 11bp deletion (Fig 6.9 D). The
translation of this mutation resulted in a premature stop codon.

Figure 6.9

Genotyping results of F1 generation for raf1+/- heterozygous mutation

(A)Wild type allele; (B)Mutation with 3 bp deletion. No premature stop codon but
resulted in a frame shift mutation; (C)Mutation with CTCT insertion and a premature
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stop codon and addition of serine residues right after the PAM site; (D)Mutation with
11bp deletion and a premature stop codon.
6.4

Discussion:
Tol2Kit method uses att site specific recombination based cloning (multisite gate

way technology). The use of the Tol2 transposon backbone takes advantage of the
systems transgenesis efficiency (Kawakami 2004). Expression from tol2 constructs seems
sufficiently non-mosaic that it may be possible to carry out many experiments in injected
embryos (i.e. transient transgenics) rather than using stable lines. The tol2kit method
includes a method to visualize transgenes expressing non-target proteins like a
cmlc2:EGFP transgenesis marker included in the vector backbone to drive EGFP
expression. The general requirements for cloning a target gene into a vector are to ideally,
take the 1st exon, the 1st intron and 5Kb upstream of the 1 st exon; the start site should be
in the first or second exon. If the 1st intron is too long (10-20kb), it is difficult to clone it
into a vector. Here in the case of t-bet the exon 1 is 1500 bp.
T-box transcription factor TBX21/t-bet is a protein in humans (Zhang and Yang
2000), mouse (Jenner, Townsend et al. 2009) and zebrafish (Mitra, Alnabulsi et al. 2010).
The TBX21 and other related phylogenetically conserved genes share a common DNAbinding domain called T-box. T-box genes encode transcription factors involved in the
regulation of developmental processes. T-bet has shown to activate T helper 1 (Th1) cells
as well as NK cells in human and mice (Szabo, Kim et al. 2000, Jenner, Townsend et al.
2009). This gene has been cloned and sequenced in zebrafish (Mitra, Alnabulsi et al.
2010). Similar to its role in mice and humans, T-bet stimulates the activation of Th1 cells.
In a study in molecular cloning and expression analysis of t-bet in ginbuna crucian carp,
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kidney cells were sorted by FACS and subjected to RT-PCR analysis, which revealed that
t-bet was highly expressed in surface IgM negative lymphocytes and absent on surface
IgM positive lymphocytes, suggesting the importance of the involvement of t-bet in the
immune system and can serve as an important tool to analyze teleost cell mediated
immunity (Takizawa, Araki et al. 2008). In the case of T cells, the homozygous mutant
mice for t-bet did not differentiate CD4 T cells and showed a marked decrease in IFNγ
synthesis during a primary stimulation. In the case of heterozygous mice for t-bet showed
a slight expression of CD4 T cells and NK cells and a milder defect in IFNγ compared to
the homozygous mutants (Szabo, Sullivan et al. 2002). In the absence of T-bet, CD4 T
cells fail to differentiate into the Th1 lineage and differentiate to the default Th2 state and
NK cells showed markedly reduced cytolytic activity. Hence the role of t-bet is also
known to mediate NK cell cytotoxicity.
We attempted to develop a rag1-/-:t-bet:EGFP transgenic zebrafish to study the
ontogeny of NK cells. The rag1-/- mutant fish do not have the ability to undergo
recombination activation of the T and B cell receptors, thus rendering the T and B
lymphocytes in the inactive state. This makes it feasible to study NK cells activation via
t-bet:EGFP promoter expression. In our study, we aimed to amplify 6.5kb upstream of
exon 1. However, we were not able to amplify 3.9 kb of the fragment even after several
attempts. The reason for the failed DNA amplification could be due to the presence of
microsatellites in the region upstream of the t-bet exon 1. Microsatellites are short (16bp), tandem repeats (10-5- copies) in DNA. They are randomly distributed and comprise
of mono to tetra nucleotides (AT)n. Therefore, the polymerase might keep slipping off the
DNA stand hence resulting in failed amplification of PCR product.
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Since we were unable to amplify the t-bet promoter, we chose another NK cell
specific marker, lymphocyte protein tyrosine kinase (lck) to study the zebrafish NK cells.
Fry were screened for cmlc2:EGFP expression 1 dpf in the heart to confirm the insertion
of the lck:mCherry insert in the genome. The zebrafish thymus is completely developed
by 60 hpf and by 68 hpf is colonized by T lymphocyte progenitors, which give rise to
mature T cells at 72 hpf (Langenau, Ferrando et al. 2004). A study by Langenau et al
2004, reported lck-EGFP expression in the thymus at 3 or 4 dpf, indicating T cell homing
to the thymus. Post 4 dpf, the mature T cells migrate in the blood stream which is
indicated by lck-EGFP expression in the tail portion (Langenau, Ferrando et al. 2004). At
7 dpf the T cells in the thymus doubled in number giving a brighter signal. Similar to our
observation, the study by Langenau et al also reported auto-fluorescence in the yolk sac.
In another study, Sylvia Brugman et al used the Tg (lck:mCherry) zebrafish model to
study the influence of T cell mechanisms on chemokine (CxCl8) regulation in zebrafish
intestines (Brugman, Witte et al. 2014).
In our study, we observed an expression of lck:mCherry in the wild type zebrafish
as well as in the rag1-/- mutant zebrafish at 4 dpf and 7 dpf. At 7 dpf, T cell homing in the
thymus was noted in the wild type:lck:mCherry zebrafish. T cell homing in the thymus
was not observed in the rag1-/-:lck:mCherry zebrafish. However, there was lck:mCherry
expression observed in the head kidney and blood circulatory vessels in wild type and
rag1-/- mutant zebrafish. As a negative control, non-transgenic fish were used. The order
of development of lymphoid organs is as follows: the thymus is the first lymphoid organ
to develop and become lymphoid; this is followed by the kidney and lastly the spleen
(reviewed by (Bajoghli, Guo et al. 2011). Kidney is the main site for granulopoiesis in
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zebrafish. Immunocompetence in zebrafish, as measured by humoral response to Tdependent and -independent antigens, is not reached until 4–6 wpf (Lam, Chua et al.
2004). Expression of TCRα was observed throughout the thymus at 6 wpf and rag1
expression was localized to the peripheral cortex (Danilova, Hohman et al. 2004,
Bajoghli, Guo et al. 2011).
The raf1a gene is the homologue of the viral raf (V-raf) gene. Raf1 is known to
regulate the MAP kinase pathway. MAP kinase kinase kinase (MAP3K) functions
downstream of the Ras family of membrane associated GTPases to which it directly
binds and activates itself. This is followed by binding to RAF1 protein. This binding is
associated with phosphorylation to activate dual specificity protein kinase MEK1 and
MEK2, which in turn phosphorylate to activate the serine/threonine specific kinase,
ERK1 and ERK2. Activated ERKs are pleotropic effectors of cell physiology and play an
important role in the control of gene expression involved in cell division, apoptosis, cell
differentiation and cell migration.
In this study, we used the CRISPR-Cas9 technique to knock down a raf1a gene in
zebrafish. The CRISPR-cas9 technology is a recent advance in the field of reverse
genetics and knockout (KO) studies and has proven to be a better method for KO
zebrafish when compared to the zinc finger nucleases (ZFN) and transcription activator
like nucleases (TALENS) methods (Auer and Del Bene 2014).
In 2013, Hwang et al were the first group to successfully demonstrate the use of
the CRISPR/Cas9 gene KO system to mediate site-specific mutagenesis in zebrafish
(Hwang, Fu et al. 2013, Hwang, Fu et al. 2013). In this study, a custom designed sgRNA
had to be created by replacing the 20bp responsible for target recognition with the
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sequence of interest, so that, the sgRNA has atleast 20bp homology with the target DNA.
Following the in-vitro transcription of the customized sgRNA, the Cas9 protein along
with the sgRNA are co-injected into single cell stage zebrafish embryos (Kim, Kim et al.
2014, Sung, Kim et al. 2014). Following injections, the N terminus of the 20bp sequence
in the sgRNA hybridizes to its complementary locus (target DNA) in the genome by
Watson and Crick base pairing fashion. This is followed by the immediate recruitment of
Cas9 nuclease to the target site. Cas9 nuclease introduces double stranded breaks in the
DNA at the target site just upstream of the PAM (TGG) sequence. The PAM is a standard
3 bp codon which includes any one nucleobase with GG (guanine). The PAM sequence
directs the gRNA and cas9 to the target site in the genome to create random double
stranded breaks (DSB). DSBs are usually repaired by homology-directed repair (HDR) or
the NHEJ pathway. HRD pathway is mediated when a single stranded nick is created,
which reduces the occurrence of indel mutations and allows for precise replacement
mutations to be made (Overballe-Petersen, Harms et al. 2013). Whereas, the NHEJ
pathway results in the incorporation of indels at the site of repair. Formation of indels
within the open reading frame causes frame shifts leading to premature stop codon and
results in the loss-of-function alleles. Thus, creating a KO zebrafish. Recent advances
using the CRISPR/Cas9 approach successfully generated DSBs in multiple targets by coinjecting several custom sgRNAs with Cas9 protein into zebrafish embryos (Le 2013).
By using CRISPR/Cas9 we can attain loss-of-function of alleles either by disruption of
the open reading frame by indel mutation or by deletion of whole loci from the genome.
Depending on the duration and magnitude of activation, raf1a kinase plays a
crucial role in several normal and pathological cellular processes including proliferation,
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differentiation, development, senescence, programmed cell death, cell cycle progression,
immune responses and carcinogenesis (Wood, Sarnecki et al. 1992) (Morrison 1990,
Marshall 1995) (Heidecker, Kölch et al. 1992) (Hu, Stites et al. 2013). Raf1a is also
responsible in maintaining normal neurogenesis and a neuroprotective ability (Rössler,
Giehl et al. 2004).
Previous studies in mammals have reported some disorders associated with
defects in raf1 expression. Defects include congestive heart failure and arrhythmia
leading to premature heart failure; leopard syndrome 2 (LPRD2) characterized by
pulmonic senosis, electrocardiograph conduction abnormalities, retardation of growth,
abnormalities of growth and sensorineural deafness; Noonan syndrome 5 characterized
by short stature, facial dysmorphic features such as hypertelorism, congenital heart
defects and hypertrophic cardiomyopathy. Similarly, a mutation in the ATP binding
pocket of Raf (RafK375M) acts as a dominant negative in Xenopus embryos, resulted in
embryos with shortened body axes and defects in the processes by which mesoderm is
formed and specified. Likewise, mice lacking A-Raf, B-Raf, or c-Raf-1 exhibit several
defects in development and organogenesis. Drosophila D-Raf acts downstream of a
number of receptor tyrosine kinases that are required for normal development, including
the EGF, FGF, torso, and sevenless receptor.
In humans, the region between 398 and 401bp is responsible for the activity of the
raf1a gene activity. Activation of the Raf1a serine/threonine protein kinases is tightly
regulated by multiple phosphorylation events. To examine whether the RafAAA mutation
would affect normal development, synthetic RNAs encoding wildtype human Raf1a were
injected into one to two cell zebrafish embryos. The mutation replaces a critical lysine
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residue at the ATP binding pocket of raf1a resulting in an inactive protein. Injection of
wildtype raf1a had no effect on normal zebrafish development, whereas about 30% of
embryos injected with mutated raf1a (replaced lysine residue at ATP binding site) at 24
hpf produced a phenotype in embryos with no tail or severely shortened, and the over- all
length of the anterior-posterior axis is shortened. Examination of injected zebrafish
embryos at 12 hpf frequently revealed that the notochord was bent or shortened. Thus,
injection of Raf1a with a mutation only in the phosphatidate (ATP) binding site is
sufficient to block normal signaling events that are required for the expression of ntl in
the newly formed mesendodermal layer, resulting in developmental defects. To avoid this
lethal mutation, we designed the target site in the protein kinase domain coding region on
exon 5 between 552bp and 571bp. The Ras binding domain (RBD) is between 49 – 124
aa. The protein kinase domain (132 – 177aa) codes for intracellular signal transduction
and hence will not affect the development of zebrafish.
From previous studies, a mutation in the phosphatidate binding site II of raf1a
results in a compromised development program of zebrafish and this leads to embryos
with bent tail trunk structures and a shortened anterior – posterior axis. Such phenotypic
changes were not observed in our study.
Sonja et al 2007 have demonstrated a role for raf1a in controlling adaptive
immune response through the activation of dendritic cells. The binding of microbial
pathogens to C-type lectin type DC-SIGN expressed by dendritic cells activates raf1aacetylation-dependent signaling pathway to modulate toll like receptor (TLR) signaling
pathways and this raf-1 mediated pathway is involved in regulation of adaptive immune
cells mainly T helper cells. Activation of raf1a leads to the acetylation of p65, one of the
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key activating subunits of NF-B transcription factor (Gringhuis, den Dunnen et al.
2007).
Activated  glucan receptor dectin I mediates a non-canonical raf1a pathway to
activate functional reprograming of monocytes to transform into trained macrophages,
leading to enhanced cytokine production in vivo and in vitro (Quintin, Saeed et al. 2012)
(Saeed, Quintin et al. 2014). This reprograming included changes in histone
trimethylation at H3K4, which suggests the involvement of epigenetic mechanisms in this
phenomenon in macrophages and NK cells (Netea, Latz et al. 2015) (Quintin, Cheng et
al. 2014) (Hoving, Wilson et al. 2014) (Netea, Joosten et al. 2015) (van der Meer, Joosten
et al. 2015) (Dambuza and Brown 2015). The raf1a-/- mutant zebrafish will help up
further determine the concept of trained immunity and may be employed to design
improved vaccine strategies.
The occurrence of lck:mCherry expression in rag1-/- mutant zebrafish suggests
that lck is also expressed in zebrafish NK cells and these cells first appear at 4 dpf. We
noticed an equal expression of lck:mCherry in rag1-/- and wild type fish, which could be
because this this the F0 generation and the integration of the construct in the genome
could result in mosaic expression. A clear idea of the expression of lck gene could be
made in the F1 generation (F0 x WT). The rag1-/-:lck:mCherry model could prove
beneficial to eliminate the challenges associated with the lack of NK cell specific
monoclonal antibodies and help researches to sort out the lck+ NK cell population to
further elucidate its role in immune protection.
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Expression analyses of mx, tnfα, ifnγ, t-bet and nitr9 in liver, kidney and
spleen of non-injected (control) adult rag1-/- mutant zebrafish (n=6) were
analyzed by RT-qPCR.

Gene expression levels of mx, tnfα, ifnγ, t-bet and nitr9 were normalized with
housekeeping gene, arp, expression levels. No significant differences were observed in
the gene expressions between tissues prior to injecting rag1-/- mutant zebrafish with TLR
ligands. Data are presented as mean fold change ± standard deviation.
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Table A.2

Differential gene expression following stimulation of toll like receptors
ligands in rag1-/- mutant Zebrafish.
Mean  SD
(Treatment)

Mean  SD
(PBS)

0.0122

9.97±3.09

1.14±0.78

6 hpi

0.0802

4.77±1.33

0.91±0.08

12 hpi

0.0415

13.55±4.41

3.55±1.03

24 hpi

0.9427

4.71±3.03

6.21±1.77

1 hpi

0.0006

4.35±1.15

0.25±0.14

6 hpi

0.0002

8.34±0.53

0.21±0.04

12 hpi

0.0463

1.99±1.38

0.29±0.07

24 hpi

0.7631

3.74±1.36

0.61±0.92

All time
points
1 hpi

0.2386
<0.0001

1502.27±300.76

167.53±122.24

6 hpi

<0.0001

1226.20±518.96

115.95±11.93

12 hpi

<0.0001

1741.50±904.84

207.35±103.17

24 hpi

<0.0001

2232.38±966.22

578.55±225.71

1 hpi

0.0004

68.61±27.67

7.05±3.89

6 hpi

<0.0001

193.93±81.42

9.63 ±4.98

12 hpi

0.0072

62.57±20.94

12.63±4.59

24 hpi

0.4280

96.18±28.98

59.48±49.36

1 hpi

<0.0001

70.24±30.89

13.40±8.90

6 hpi

<0.0001

110.87±18.95

8.38±3.71

12 hpi

<0.0001

94.85±30.77

31.10±26.71

24 hpi

<0.0001

116.27±36.22

44.98±12.16

All time
points
1 hpi

0.4319
0.5820

0.24±0.07

0.35±0.17

6 hpi

0.0332

0.59±0.19

0.28±0.09

12 hpi

0.9899

0.28±0.07

0.31±0.05

24 hpi

0.7258

0.35±0.07

0.47±0.16

Treatment

Gene

Tissue

Time

p value

β glucan

mx

Liver

All time
points
All time
points

0.7871

All time
points
1 hpi

0.2652

Kidney
Spleen
tnfα

Liver

Kidney

Spleen
ifnγ

Liver

Kidney

Spleen

t-bet

Liver
Kidney

0.1386
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Table A2 (continued)

nitr9

Spleen

All time
points

0.1656

Liver

All time
points
1 hpi

0.3400
0.9361

1.31±1.24

1.48±0.40

6 hpi

0.8726

1.30±0.05

1.10±0.36

12 hpi

0.0062

4.17±0.86

5.12±0.84

1.89±1.46

7.1±1.03

Kidney

Poly I:C

mx

24 hpi

<0.0001

Spleen

All time
points

0.1060

Liver

1 hpi

0.0145

3.80±0.98

2.12±1.06

6 hpi

0.0014

17.01±7.64

2.33±1.26

12 hp

<0.0001

23.27±9.71

2.78±1.48

24 hpi

0.0002

14.50±7.93

3.11±1.50

1 hpi

0.9973

3.19±1.52

3.07±2.35

6 hpi

0.0182

19.59±15.54

1.86±1.53

12 hpi

0.0003

40.86±24.64

1.09±0.44

24 hpi

0.0052

13.04±5.56

1.08±0.48

1 hpi

0.9999

3.15±1.22

2.60±0.36

6 hpi

0.0028

8.03±5.67

0.13±0.18

12 hpi

0.0107

19.76±9.02

0.82±0.44

24 hpi

0.3500

5.95±3.46

1.42±1.07

All time
points
1 hpi

0.1843
0.9997

0.97±0.26

1.12±0.36

6 hpi

0.9783

3.51±2.87

1.00±0.75

12 hpi

0.4310

1.77±0.42

0.61±0.37

24 hpi

0.0194

0.17±0.02

0.67±0.24

1 hpi

0.9829

4.01±0.69

3.19±0.19

6 hpi

0.9894

1.59±1.00

1.09±0.48

12 hpi

0.4594

0.59±0.18

2.38±0.98

24 hpi

0.0041

0.17±0.03

2.13±0.55

All time
points
1 hpi

0.3992
0.9090

4.22±1.20

2.81±0.13

6 hpi

0.6046

8.38±4.31

4.59±2.68

12 hpi

0.0025

6.31±2.14

0.99±0.95

Kidney

Spleen

tnfα

Liver
Kidney

Spleen

ifnγ

Liver
Kidney
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Spleen
t-bet

Liver
Kidney

Spleen
nitr9

Liver
Kidney

Spleen
R848

mx

Liver

Kidney

Spleen

tnfα

Liver
Kidney
Spleen

ifnγ

Liver

24 hpi

0.9973

2.76±2.38

2.57±0.64

All time
points
All time
points
1 hpi

0.0521

0.2044

0.58±0.20

0.35±0.17

6 hpi

0.0004

1.21±0.30

0.28±0.09

12 hpi

0.0913

0.64±0.26

0.31±0.05

24 hpi

0.9978

0.44±0.13

0.47±0.16

All time
points
All time
points
1 hpi

0.1470

0.0274

18.77±7.86

1.13±0.52

6 hpi

0.7303

2.09±1.62

0.58±0.19

12 hpi

0.7253

1.23±1.13

2.69±1.49

24 hpi

0.2842

1.09±1.00

3.77±0.54

All time
points
1 hpi

0.1954
0.0003

11.79±3.23

2.12±1.06

6 hpi

0.0002

30.46±12.59

2.33±1.26

12 hpi

<0.0001

26.04±10.29

2.78±1.48

24 hpi

<0.0001

58.25±20.03

3.11±1.50

1 hpi

0.0009

11.41±9.57

3.07±2.35

6 hpi

0.0008

32.60±10.69

1.86±1.53

12 hpi

0.0052

13.74±9.12

1.09±0.44

24 hpi

0.0014

19.03±9.75

1.08±0.48

1 hpi

0.6934

5.67±1.05

2.60±0.36

6 hpi

<0.0001

4.37±1.20

0.06±0.03

12 hpi

0.0137

7.73±2.56

0.82±0.44

24 hpi

0.2371

4.70± 2.43

1.42 ±1.07

All time
points
All time
points
All time
points
1 hpi

0.1815

0.9897

16.27±5.22

29.08±24.58

6 hpi

0.0310

100.37±40.04

8.85±2.37

12 hpi

0.0040

65.41±32.45

2.49±2.24

0.1279

0.5372

0.4432
0.1167
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Table A2 (continued)
Kidney

Spleen

t-bet

Liver

Kidney

Spleen
nitr9

Liver

Kidney

Spleen

24 hpi

0.0007

41.83±21.16

1.10±0.90

1 hpi

<0.0001

12.61±4.14

2.81±0.13

6 hpi

<0.0001

153.23±90.34

4.59±2.68

12 hpi

0.0030

31.45±25.55

0.99±0.95

24 hpi

<0.0001

24.34±15.29

2.57±0.64

1 hpi

0.7600

2.13±1.24

3.46±0.47

6 hpi

0.0229

6.37±2.12

0.90±0.19

12 hpi

0.0179

8.35±3.22

0.70±0.30

24 hpi

0.0055

5.54±1.78

0.87±0.66

1 hpi

<0.0001

106.64±77.90

1.29±0.68

6 hpi

0.0006

11.69±5.48

1.41±0.28

12 hpi

0.9699

2.16±0.88

2.71±1.07

24 hpi

<0.0001

179.29±84.28

3.85±1.56

1 hpi

0.0006

3.80±2.80

0.35±0.17

6 hpi

0.0006

7.15±1.99

0.28±0.09

12 hpi

0.9913

0.68±0.80

0.31±0.05

24 hpi

0.0789

2.47±1.17

0.47±0.16

All time
points
1 hpi

0.0950
<0.0001

49.13±27.15

0.51±0.31

6 hpi

0.0002

6.22±2.76

0.42±0.35

12 hpi

0.6616

0.97±0.12

0.56±0.07

24 hpi

0.9573

3.11±1.64

2.53±1.74

1 hpi

0.2292

0.90±0.56

0.77±0.73

6 hpi

0.0010

10.18±2.59

0.58±0.19

12 hpi

0.0811

0.51±0.15

2.69±1.49

24 hpi

0.1154

0.91±0.30

3.77±0.54

All time
points

0.4584

The numbers highlighted grey denote not significant.
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Table A.3

Differential gene expressions of up-regulated and down-regulated genes at
different hours post injection (hpi) following primary or secondary immune
stimulation in rag1 mutant zebrafish.
Mean  SD
(Challenge)

Mean  SD
(PBS)

101.1510.91
(0.0172)
91.8791.2
(0.0056)

34.16
21.18
1531.352009.4
4

24
hpi
48
hpi
6 hpi

36.8217.08

2.050.75

1961.90303.72
(0.0065)
29.4313.27

543.08502.89

12
hpi

28.051.75

118.0549.41

24
hpi

992.04142.99
(0.0001)

14.727.22

15.8511.27

5.002.07

Liver

48
hpi
6 hpi

344.8594.31

329.56252.22

72.7016.52

38.9850.43

76.3244.75

7.7410.01

147.56179.56

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

Liver

12
hpi
24
hpi
48
hpi
6 hpi

49065.4023728
.97
23551.8513505
.67
42372.5124723
.35
22819.744531.
83
290.43158.53

3479.651030.1
5
113274.49754
65.53
5510.682292.0
1
49539.494620
1.41
37631.196570
6.75
33.3731.31

72.7863.63

28.771.85

36.647.68

2.141.85

82.1248.10

948.39284.44

Treatment

Gene

Tissue

Time

E. ictaluri

Ifnγ

Liver

6 hpi

p value

Mean  SD
(Vaccination)

12hpi

Kidney

t-bet

Nitr9

12
hpi
24
hpi
48
hpi
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Table A3 (continued)

Nkla

nklb

nklc

Kidney

6 hpi

Liver

12
hpi
24
hpi
48
hpi
6 hpi

9.517.45
(0.0134)
12.078.30
(0.0001)
0.570.73

1.410.94

0.350.33
(0.0005)
13.036.80

0.140.14

3.231.52

0.370.40

40.7451.84

6.194.15

11.387.00

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

13.591.53

298.480322.20
(0.0019)
13.149.95

7.412.80

0.010.02

12.281.13

2.141.69

5.993.81
(0.0001)
67.3219.22

3.072.12

Liver

12
hpi
24
hpi
48
hpi
6 hpi

0.200.17

0.520.90

22.2311.09

22.5124.92

27.455.29

227.03200.91

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

20.364.91

21.9710.06

2.821.23

1.381.41

1463.84441.32
761.72714.97

2335.703036.0
7
234.37211.06

Liver

12
hpi
24
hpi
48
hpi
6 hpi

200.9864.57

168.99183.16

12
hpi
24 hp

36.088.60

1.942.18

84.6374.10

5.573.58

48
hpi
6 hpi

71.0331.95
(0.0006)
179.1273.53

9.954.84

Kidney
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0.080.03
1.121.56

10.755.98

17.1113.14

283.95161.04

Table A3 (continued)

nkld

RE33

Ifnγ

t-bet

12
hpi
24
hpi
48
hpi

58.2124.66

0.020.02

78.2337.45

40.856.03

49.2326.49

104.7229.51

Liver

6 hpi

52.8324.31

32.2810.54

11.268.83

1.220.88

20.4814.36

6.374.04

13.226.74

612.19176.53

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

116.8040.62

155.2280.33

12
hpi
24
hpi
48
hpi

35.3721.81

0.850.31

49.759.56

6.901.90

31.7220.90

52.7620.32

Liver

6 hpi

5.591.97

160.27153.07

34.16
21.18

12hpi

334.8078.58

579.04413.99

1531.352009.4
4

24
hpi

424.72241.17

246.1195.84

2.050.75

48
hpi

2786.473229.8
7
(0.0479)
6.522.79

2132.95774.88
(0.0019)

543.08502.89

104.1039.13

29.1311.36

Kidney

6 hpi

188.68206.82

50.2234.05

118.0549.41

119.744.53

25.529.37

14.727.22

1678.42244.57
(0.0001)
5.522.34

328.19161.69

5.002.07

Liver

12
hpi
24
hpi
48
hpi
6 hpi

329.56252.22

12
hpi

368.05233.92

1649.271507.7
4
21.4017.95
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Table A3 (continued)
24
hpi
48
hpi
6 hpi

1399.45482.59

218.6029.45

7.7410.01

1396.93664.59

446.78179.79

119752.56459
300.59

12
hpi

114340.63515
19.94

280549.852751
27.30
(0.0141)
4937.972163.9
6

3479.651030.1
5
113274.49754
65.53

Liver

24
hpi
48
hpi
6 hpi

41419.451337
3.78
114575.38745
31.83
14.718.13

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

Kidney

Nitr9

Nkla

nklb

5510.682292.0
1
49539.494620
1.41
37631.196570
6.75
33.3731.31

151.03123.42

35912.4710420
.89
39919.684531.
83
284.22198.34
(0.0210)
174.05137.81

214.6336.68

78.8856.57

2.141.85

460.90421.22

96.874.23

948.39284.44

0.130.11

1.320.54

1.410.94

12
hpi
24
hpi

0.390.36

0.190.18

0.080.03

0.150.04

0.540.43

1.121.56

1.380.85

0.210.21

0.140.14

Liver

48
hpi
6 hpi

2.080.77

59.3945.37

10.755.98

207.90190.35

0.370.40

165.4332.86

234.09197.54
(0.0153)
74.2322.38

310.64355.32

173.17138.55

298.480322.20

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

5.342.51

46.7137.14

13.149.95

58.3654.30

98.6858.01

0.010.02

5.351.69

2.001.71

2.141.69

36.4735.25

4.311.68
(0.0001)
75.6269.43

3.072.12

Liver

12
hpi
24
hpi
48
hpi
6 hpi

4.581.47

196

28.771.85

6.194.15

17.1113.14

Table A3 (continued)

nklc

nkld

B glucan

Ifnγ

235.43148.21

297.35230.11

0.520.90

1.490.91

34.416.09

22.5124.92

962.57779.90
(0.0002)
559.15154.85

304.65279.99

227.03200.91

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

1585.371052.5
5

21.9710.06

7389.264622.0
3
17.172.03

2296.84897.65

1.381.41

347.9912.87

11885.267915.
68
26.2713.27

1641.891423.7
3
303.95212.73

2335.703036.0
7
234.37211.06

Liver

12
hpi
24
hpi
48
hpi
6 hpi
12
hpi
24 hp

151.3246.71

155.90104.01

1.942.18

179.9522.19

71.3713.17

5.573.58

667.80334.72

173.15103.17

9.954.84

Kidney

48
hpi
6 hpi

97.4055.68

221.14103.08

283.95161.04

594.25418.49
(0.0301)
53.126.03

114.8780.51

0.020.02

30.263.09

40.856.03

91.0149.35

34.5933.05

104.7229.51

Liver

12
hpi
24
hpi
48
hpi
6 hpi

8.843.81

60.6233.67

32.2810.54

144.3350.78

1.220.88

50.791.17

117.2241.32
(0.0107)
21.896.99

321.13201.98

82.95118.05

612.19176.53

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

53.5124.34

125.1663.21

155.2280.33

66.4329.87

49.2137.11

0.850.31

28.073.11

17.459.77

6.901.90

74.525.49

26.4316.51

52.7620.32

Liver

12
hpi
24
hpi
48
hpi
6 hpi

523.57399.49

1369.23985.77
(0.0116)

34.16
21.18

197

168.99183.16

6.374.04

Table A3 (continued)

t-bet

Nitr9

12hpi

47.1642.80

580833.21

1531.352009.4
4

62.9116.02

208.38183.73

2.050.75

139.16127.82

238.60135.71

543.08502.89

Kidney

24
hpi
48
hpi
6 hpi

14.4710.66

100.9480.85

29.1311.36

15.8713.99

575.15299.31
(0.0276)
92.6648.02
(0.0001)
39.8628.72

118.0549.41

Liver

12
hpi
24
hpi
48
hpi
6 hpi

1954.90710.20

329.56252.22

298.29199.05

38.9850.43

1914.98443.83

66.8557.53

7.7410.01

1372.79664.59

179.49179.79

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

7290.573349.8
8
(0.0001)
233.90143.78

200692.209446
0.04

Liver

12
hpi
24
hpi
48
hpi
6 hpi

1064737.2160
7786.55
(0.0011)
26190.548181.
75
77970.246907
6.64
120924169

3479.651030.1
5
113274.49754
65.53

216.42125.46

117300.994116
2.87
20607.2815163
.86
65882.084531.
83
591.12239.39

5510.682292.0
1
49539.494620
1.41
37631.196570
6.75
33.3731.31

59.5944.26

63.0039.99

28.771.85

203.5067.25

50.3344.41

2.141.85

287.70172.20

62.1560.98

948.39284.44

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

0.750.26

1.800.79

1.410.94

12
hpi
24
hpi

0.200.07

1.801.41

0.080.03

1.691.11

1.621.18

1.121.56

5.922.51
27.425.98

198

14.727.22
5.002.07

Table A3 (continued)

Nkla

nklb

nklc

0.490.31

0.560.26

0.140.14

Liver

48
hpi
6 hpi

37.2117.18

10.755.98

10.0510.29
35.1831.92

8.237.50

6.194.15

56.9231.32

5.252.85

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

249.51208.10
(0.0127)
24.0116.93

22.3214.95

23.927.16

298.480322.20
(0.0015)
13.149.95

11.083.23

31.7311.21

0.010.02

1.771.50

7.472.08

2.141.69

15.549.63

12.634.83
45.4124.46

58.0050.72

22.5124.92

103.18123.01

62.0647.68

227.03200.91

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

2.191.50
(0.0001)
734.20430.87
(0.0244)
17.527.59

3.072.12

Liver

12
hpi
24
hpi
48
hpi
6 hpi

760.30202.16

21.9710.06

720.01272.52

Liver

12
hpi
24
hpi
48
hpi
6 hpi

5536.222044.3
7
(0.0244)
9866.4711062.
12
719.5997.27

12
hpi
24 hp

Kidney

52.4421.51

113.2630.46
2068.871012.3
7
449.66346.55

836.02513.59

0.370.40

17.1113.14
0.520.90

1.381.41
2335.703036.0
7
234.37211.06
168.99183.16

171.7884.55

2134.91896.55
(0.0001)
40.4724.94

386.37154.04

44.2133.94

5.573.58

48
hpi
6 hpi

940.16641.58

60.5926.64

9.954.84

404.05154.75

279.9459.11

283.95161.04

12
hpi

180.33134.85

311.62108.45

0.020.02

199

1.942.18

Table A3 (continued)

Nkld

B glucan
+RE33

Ifnγ

t-bet

572.19446.40

50.0635.28

40.856.03

619.41157.78

49.4939.27

104.7229.51

Liver

24
hpi
48
hpi
6 hpi

103.4264.37

32.2810.54

29.5027.83
94.0236.81

5.173.92

6.374.04

123.1473.52

18.9710.26

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

588.7381.86
(0.0001)
14.7413.28

289.61189.40

194.2964.14

612.19176.53
(0.0107)
155.2280.33

89.2820.36

0.850.31

373.3120.34

147.1144.21
(0.0008)
34.5815.46

193.9335.16

34.2125.26

52.7620.32

Liver

12
hpi
24
hpi
48
hpi
6 hpi

20.507.35

237.1664.05

34.16
21.18

12hpi

348.1752.59

1539.20273.06

1531.352009.4
4

172.93102.33

2.050.75

293.04176.36

1400.53214.21
(0.0075)
322.9688.11

Kidney

24
hpi
48
hpi
6 hpi

13.886

62.5432.10

29.1311.36

300.38104.17

357.19174.53

118.0549.41

36.0915.07

46.2519.48

14.727.22

53.3335.06

954.75859.15
(0.0001)
505.14130.43

5.002.07

Liver

12
hpi
24
hpi
48
hpi
6 hpi

948.25455.48

38.9850.43

3103.952467.4
2
(0.0001)
80.60179.79

7.7410.01

12
hpi
24
hpi
48
hpi

4503.40810.75
(0.0010)
2587.183131.1
9
1.870.44
97.9934.40

200

1.220.88

6.901.90

543.08502.89

329.56252.22

3479.651030.1
5

Table A3 (continued)
Kidney

Nitr9

29171.1120790
.32

113274.49754
65.53

12
hpi
24
hpi
48
hpi

790148.22775
649.65
(0.0011)
312618.13171
006.95
237970.06596
19.65
37455.344531.
83

112173.388711
2.28
60893.416130.
78
51462.464531.
83

5510.682292.0
1
49539.494620
1.41
37631.196570
6.75

6 hpi

232.07171.01

142.4918.28

33.3731.31

12
hpi
24
hpi
48
hpi

99.7231.97

150.9418.58

28.771.85

2312.75839.75
(0.0001)
67.4920.62
(0.0058)

576.44200.12
(0.0001)
45.9319.60

2.141.85

6 hpi

0.250.12

0.430.32

1.410.94

12
hpi

0.790.69

4.113.25

0.080.03

1.160.77

1.890.16

1.121.56

3.455.07

0.970.68

0.140.14

Liver

24
hpi
48
hpi
6 hpi

22.2814.04

17.052.89

10.755.98

328.4558.15
(0.0435)
19.354.00

83.4734.86

0.370.40
6.194.15

61.1219.45

332.07142.16
(0.0004)
51.5446.31

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

5.812.74

2.762.39

298.480322.20
(0.0015)
13.149.95

105.2267.28
(0.0089)
34.9530.08

53.0138.13

0.010.02

6.421.93

2.141.69

15.757.86
23.9615.82

2.160.96
(0.0001)
88.2936.06

3.072.12

Liver

12
hpi
24
hpi
48
hpi
6 hpi
12
hpi
24
hpi

188.9146.78

80.678.05

0.520.90

12.952.69

597.75537.69
(0.0002)

22.5124.92

Liver

Kidney

Nkla

nklb

6 hpi

201

948.39284.44

17.1113.14

Table A3 (continued)

nklc

nkld

R848

Ifnγ

39.2612.50

115.4751.41

227.03200.91

Kidney

48
hpi
6 hpi

429.17632.42

950.50442.02

21.9710.06

11304.883781.
58
675.10212.04

41.4617.56

1.381.41

236.61179.50

2568.971566.3
6
167.9963.12

2086.55474.26

2335.703036.0
7
234.37211.06

Liver

12
hpi
24
hpi
48
hpi
6 hpi

249.35134.88

168.99183.16

12
hpi
24 hp

266.18133.14

320.6341.23

1.942.18

73.3843.38

5.573.58

42.1826.20

Kidney

48
hpi
6 hpi

809.95551.60
(0.0002)
89.7844.71

233.05110.76

64.0637.23

283.95161.04

1148.01389.95
(0.0001)
145.8437.56

88.8635.78

0.020.02

122.0593.18

40.856.03

94.8849.96

209.49131.08

104.7229.51

Liver

12
hpi
24
hpi
48
hpi
6 hpi

46.4713.88

41.284.17

32.2810.54

183.83136.32

1.220.88

19.064.82

108.031.63
(0.0216)
246.20119.84
(0.0001)
26.6015.38

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

84.8424.48

79.1735.66

289.29171.12

0.850.31

14.951.72

165.04106.38
(0.0002)
109.0080.96
(0.0299)
73.3126.75

Liver

12
hpi
24
hpi
48
hpi
6 hpi

220.9071.93

38.8917.43

34.16
21.18

12hpi

435.81145.21

0.320.14

1531.352009.4

24
hpi

3435.632069.5
5 (0.0001)

138.1485.33

2.050.75

16.781.26

44.5813.07

202

9.954.84

6.374.04
612.19176.53
(0.0015)
155.2280.33

6.901.90
52.7620.32

Table A3 (continued)

t-bet

Nitr9

Nkla

500.66435.05

269.98148.81

543.08502.89

Kidney

48
hpi
6 hpi

339.69184.66

7.223.83

29.1311.36

266.05149.78

2.160.73

2168.24756.85
(0.0001)
255.35120.63

39.2010.92

118.0549.41
(0.0029)
14.727.22

291.8196.43

5.002.07

Liver

12
hpi
24
hpi
48
hpi
6 hpi

25.0126.20

314.3475.17

329.56252.22

472.25501.76

687.51261.57

38.9850.43

586.32458.59

133.2179.68

7.7410.01

727.52664.59

233.83179.79

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

Liver

12
hpi
24
hpi
48
hpi
6 hpi

46060.722186
3.54
38450.672267
0.11
138659.09225
02.72
122789.99453
1.83
4.501.20

43092.0122030
.56
74564.9950454
.61
24256.953904.
60
14272.794531.
83
70.6112.38

3479.651030.1
5
113274.49754
65.53
5510.682292.0
1
49539.494620
1.41
37631.196570
6.75
33.3731.31

94.1641.06

28.771.85

200.1674.26

359.10114.05
(0.0013)
49.4628.35

383.37288.43

63.5126.45

948.39284.44

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

0.030.01

0.080.04

1.410.94

0.670.51

2.381.29

0.080.03

4.816.61

1.510.23

1.121.56

1.170.85

0.610.22

0.140.14

Liver

12
hpi
24
hpi
48
hpi
6 hpi

2.720.72

23.8622.14

10.755.98

12
hpi
24
hpi

9.663.19

26.778.38

0.370.40

123.4127.15

19.8627.15

6.194.15

203

2.141.85

Table A3 (continued)
48
hpi
6 hpi

980.18422.02
(0.0001)
7.154.54

82.1333.52
1.450.78

298.480322.20
(0.0284)
13.149.95

12
hpi
24
hpi

1.291.09

2.921.07

0.010.02

165.94133.89
(0.0001)

2.241.08

2.141.69

180.1176.35
4.780.45

13.450.29
(0.0001)
93.5285.30

3.072.12

Liver

48
hpi
6 hpi

30.2040.28

34.0515.78

0.520.90

110.0317.89

38.9426.06

22.5124.92

1079.57465.37
(0.0001)
446.26165.13

47.8521.11

227.03200.91

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

21.9710.06

849.78803.26
4637.384055.5
3
22518.52

475.24289.39
666.44379.35

2335.703036.0
7
234.37211.06

Liver

12
hpi
24
hpi
48
hpi
6 hpi

2051.521329.9
6
211.9362.01

10.182.07

126.6029.15

168.99183.16

12
hpi
24 hp

27.5311.84

257.44186.13

1.942.18

1315.66763.59

89.5536.92

5.573.58

48
hpi

12345.628618.
66
(0.0001)
68.7144.21

15.596.29

9.954.84

81.7849.60

283.95161.04

12
hpi
24
hpi
48
hpi

74.0180.52

79.1235.94

0.020.02

878.15486.15
(0.0012)
3455.31813.90
(0.0001)

43.1921.08

40.856.03

14.887.77

104.7229.51

6 hpi

3.351.27

21.447.60

32.2810.54

12
hpi

20.6516.82

79.4534.81

1.220.88

Kidney

nklb

nklc

Kidney

nkld

Liver

6 hpi

204

17.1113.14

1.381.41

Table A3 (continued)

R848 +
RE33

Ifnγ

t-bet

224.47200.59

25.6215.75

6.374.04

1710.82799.97
(0.0001)
23.5611.43

44.2927.75

612.19176.53

Kidney

24
hpi
48
hpi
6 hpi

37.5033.06

19.5115.22

17.533.19

415.25239.42
(0.0054)
1611.86440.36
(0.0001)
272.60101.16

17.0912.57

6.901.90

5.711.15

52.7620.32

Liver

12
hpi
24
hpi
48
hpi
6 hpi

155.2280.33
(0.0091)
0.850.31

46.132.22

34.16
21.18

12hpi

413.55299.22

18.514.42

1531.352009.4
4
(0.0033)

409.95107.55

106.40111.26

2.050.75

2572.192607.7
7
10.157.58

1126.93445.83
(0.0001)
62.7226.77

543.08502.89

Kidney

24
hpi
48
hpi
6 hpi

419.26247.54

2.240.79

118.0549.41

287.95230.77

0.210.04

14.727.22

1104.27718.25
(0.0001)
384.0183.86

1210.85336.08

5.002.07

Liver

12
hpi
24
hpi
48
hpi
6 hpi

499.89241.82

329.56252.22

156.9128.68

65.7815.98

38.9850.43

432.3796.84

141.87104.05

7.7410.01

4883.43664.59

139.96179.79

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

169154.27831
0.30
220147.09135
282.08
50343.088449.
56
92057.634531.
83

41416.1013932
.68
24955.695560.
68
80945.9126099
.41
35149.17

3479.651030.1
5
113274.49754
65.53
5510.682292.0
1
49539.494620
1.41
37631.196570
6.75

12
hpi
24
hpi
48
hpi

205

29.1311.36

Table A3 (continued)
Nitr9

Nkla

nklb

nklc

Liver

6 hpi

284.5096.64

80.3624.50

33.3731.31

355.48257.49

89.2043.84

28.771.85

1162.78719.85
(0.0002)
888.51800.75

225.29277.85
(0.0489)
129.1244.74

2.141.85

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

2.101.36

0.190.11

1.410.94

0.620.30

0.140.00

0.080.03

0.190.13

0.250.05

1.121.56

4.706.65

0.540.23

0.140.14

Liver

12
hpi
24
hpi
48
hpi
6 hpi

0.030.02

7.902.59

10.755.98

28.3821.79

44.4123.96

0.370.40

52.8916.49

3.323.24

6.194.15

1010.81307.61
(0.0001)
0.960.17

50.8323.92

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

3.220.58

298.480322.20
(0.0091)
13.149.95

8.203.33

5.535.06

0.010.02

27.8825.00

4.270.61

2.141.69

141.6652.85
(0.0004)
474.57120.52

5.663.85
(0.0001)
8.7312.12

3.072.12

Liver

12
hpi
24
hpi
48
hpi
6 hpi

39.575.96

44.423.75

0.520.90

109.7541.30

9.159.85

22.5124.92

573.40152.77
(0.0002)
2729.82743.27

116.0076.89

227.03200.91

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

8.767.19

21.9710.06

12
hpi

8963.7911231.
59

596.48368.12

1.381.41

24
hpi
48
hpi
6 hpi

4459.863310.3
5
10226.274209.
44
767.01594.25

9.397.05

2335.703036.0
7
234.37211.06

Liver

206

2470.302460.7
6
224.65135.28

948.39284.44

17.1113.14

168.99183.16

Table A3 (continued)

nkld

12
hpi
24 hp

136.5467.23

102.50135.46

1.942.18

301.93117.23

135.46112.59

5.573.58

48
hpi

6991.833146.4
1
(0.0002)
82.3239.54

251.17145.51

9.954.84

138.977.19

283.95161.04

Kidney

6 hpi

138.6863.30

46.25120.68

0.020.02

187.93173.23

120.6829.08

40.856.03

775.17161.97
(0.0117)
16.724.20

109.9073.97

104.7229.51

Liver

12
hpi
24
hpi
48
hpi
6 hpi

36.4516.05

32.2810.54

36.2622.92

64.5019.59

1.220.88

113.5176.29

12.729.43

6.374.04

1347.18219.53
(0.0001)
7.052.74

118.62100.25

612.19176.53

Kidney

12
hpi
24
hpi
48
hpi
6 hpi

75.8750.28

155.2280.33

12
hpi
24
hpi
48
hpi

107.2730.07

48.8419.30

0.850.31

39.369.81

106.9232.30
(0.0347)
117.4080.89

6.901.90

461.40273.30
(0.0028)

52.7620.32

Treatments included intra-coelomically injected WT E. ictaluri, RE-33®, β glucan or
R848 and co-administration of β glucan or R848 with RE-33®. Control treatment was
PBS. Level of expression is relative to time zero samples in rag1-/- mutant Zebrafish. The
numbers highlighted grey denote statistical significance.
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